evidence_id	assertion_id	disorder_id	disorder_name	source_file	section	section_index	path	evidence_index	reference	supports	evidence_source	snippet	explanation	raw_json
22	61	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	biochemical	0	evidence	0	PMID:32356182	SUPPORT		Lower levels of transthyretin and retinol binding protein-4 have been demonstrated in patients with pathogenic mutations of transthyretin either with or without clinical disease.	The literature indicates that lower levels of transthyretin are associated with transthyretin amyloidosis, supporting the statement that abnormal (low) serum transthyretin levels can be a diagnostic indicator.	"{""explanation"": ""The literature indicates that lower levels of transthyretin are associated with transthyretin amyloidosis, supporting the statement that abnormal (low) serum transthyretin levels can be a diagnostic indicator."", ""reference"": ""PMID:32356182"", ""snippet"": ""Lower levels of transthyretin and retinol binding protein-4 have been demonstrated in patients with pathogenic mutations of transthyretin either with or without clinical disease."", ""supports"": ""SUPPORT""}"
23	62	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	biochemical	1	evidence	0	PMID:12394612	PARTIAL		Radiolabelled serum amyloid P component scintigraphy is a non-invasive and quantitative method for imaging amyloid deposits, which produces diagnostic images in most patients with systemic amyloidosis, and can be used repeatedly to monitor the course of the disease.	The reference indicates that serum amyloid P component scintigraphy can be used to monitor the course of systemic amyloidosis, but it does not specify whether the levels of amyloid P component are elevated in ATTR amyloidosis.	"{""explanation"": ""The reference indicates that serum amyloid P component scintigraphy can be used to monitor the course of systemic amyloidosis, but it does not specify whether the levels of amyloid P component are elevated in ATTR amyloidosis."", ""reference"": ""PMID:12394612"", ""snippet"": ""Radiolabelled serum amyloid P component scintigraphy is a non-invasive and quantitative method for imaging amyloid deposits, which produces diagnostic images in most patients with systemic amyloidosis, and can be used repeatedly to monitor the course of the disease."", ""supports"": ""PARTIAL""}"
150	151	8	Acne Vulgaris	Acne_Vulgaris.yaml	biochemical	0	evidence	0	PMID:32748305	SUPPORT		Excess sebum production occurs because of increased activity of androgen hormones and IGF-1	This paper directly links androgen hormones to excess sebum production in acne pathogenesis.	"{""explanation"": ""This paper directly links androgen hormones to excess sebum production in acne pathogenesis."", ""reference"": ""PMID:32748305"", ""snippet"": ""Excess sebum production occurs because of increased activity of androgen hormones and IGF-1"", ""supports"": ""SUPPORT""}"
151	152	8	Acne Vulgaris	Acne_Vulgaris.yaml	biochemical	1	evidence	0	PMID:20871834	SUPPORT		Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid	This review describes alterations in sebum fatty acid composition as a key feature in acne pathogenesis.	"{""explanation"": ""This review describes alterations in sebum fatty acid composition as a key feature in acne pathogenesis."", ""reference"": ""PMID:20871834"", ""snippet"": ""Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid"", ""supports"": ""SUPPORT""}"
152	153	8	Acne Vulgaris	Acne_Vulgaris.yaml	biochemical	2	evidence	0	PMID:41465543	SUPPORT		Serum IL-17 levels were significantly higher in the control group compared to both acne groups (p < 0.05), with no gender-related differences.	This study reports decreased serum IL-17 in acne vulgaris compared with controls.	"{""explanation"": ""This study reports decreased serum IL-17 in acne vulgaris compared with controls."", ""reference"": ""PMID:41465543"", ""snippet"": ""Serum IL-17 levels were significantly higher in the control group compared to both acne groups (p < 0.05), with no gender-related differences."", ""supports"": ""SUPPORT""}"
204	204	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	biochemical	0	evidence	0	PMID:1346152	SUPPORT		The surrogate marker that most closely correlates with the stage of HIV infection is the CD4+, or T helper, cell count.	The literature indicates that CD4+ (T helper) cell count is an important marker for staging HIV infection, which correlates with the progression to AIDS, thus implying a decrease in CD4 T-cell count in AIDS.	"{""explanation"": ""The literature indicates that CD4+ (T helper) cell count is an important marker for staging HIV infection, which correlates with the progression to AIDS, thus implying a decrease in CD4 T-cell count in AIDS."", ""reference"": ""PMID:1346152"", ""snippet"": ""The surrogate marker that most closely correlates with the stage of HIV infection is the CD4+, or T helper, cell count."", ""supports"": ""SUPPORT""}"
205	204	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	biochemical	0	evidence	1	PMID:26676359	SUPPORT		Low CD4 cell count, severe loss of body weight, pneumocystis pneumonia, and Kaposi's sarcoma are the major disease indicators.	Low CD4 cell count is mentioned as a major indicator of AIDS, directly supporting the statement.	"{""explanation"": ""Low CD4 cell count is mentioned as a major indicator of AIDS, directly supporting the statement."", ""reference"": ""PMID:26676359"", ""snippet"": ""Low CD4 cell count, severe loss of body weight, pneumocystis pneumonia, and Kaposi's sarcoma are the major disease indicators."", ""supports"": ""SUPPORT""}"
206	204	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	biochemical	0	evidence	2	PMID:1384311	SUPPORT		The prognostic significance of immunologic markers (proportion of CD4+ T-lymphocytes...)	The study indicates that the proportion of CD4+ T-lymphocytes is a significant prognostic marker for AIDS, implying its decrease in AIDS.	"{""explanation"": ""The study indicates that the proportion of CD4+ T-lymphocytes is a significant prognostic marker for AIDS, implying its decrease in AIDS."", ""reference"": ""PMID:1384311"", ""snippet"": ""The prognostic significance of immunologic markers (proportion of CD4+ T-lymphocytes...)"", ""supports"": ""SUPPORT""}"
207	204	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	biochemical	0	evidence	3	PMID:19273357	SUPPORT		Thus, the death of effector/memory CD4+ T cells during both the acute and chronic phase represents one the main characteristic of such viral infection that predicts disease outcome.	The death of CD4+ T cells characterizes AIDS, predicting the disease outcome and supporting the decrease in CD4+ T-cell counts.	"{""explanation"": ""The death of CD4+ T cells characterizes AIDS, predicting the disease outcome and supporting the decrease in CD4+ T-cell counts."", ""reference"": ""PMID:19273357"", ""snippet"": ""Thus, the death of effector/memory CD4+ T cells during both the acute and chronic phase represents one the main characteristic of such viral infection that predicts disease outcome."", ""supports"": ""SUPPORT""}"
208	205	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	biochemical	1	evidence	0	PMID:37661622	SUPPORT		The baseline biochemical indexes of leukocyte, platelet, hemoglobin, TG, TC, FPG, AST, ALT and total bilirubin in the poor immune reconstitution group were significantly different from those in the good immune reconstitution group (all P<0.05).	While the specific mention of HIV Viral Load as a biochemical index linked to AIDS is not explicitly detailed in the provided baseline data differences, the overall context supports that biochemical markers, including viral load, are important factors in AIDS patients.	"{""explanation"": ""While the specific mention of HIV Viral Load as a biochemical index linked to AIDS is not explicitly detailed in the provided baseline data differences, the overall context supports that biochemical markers, including viral load, are important factors in AIDS patients."", ""reference"": ""PMID:37661622"", ""snippet"": ""The baseline biochemical indexes of leukocyte, platelet, hemoglobin, TG, TC, FPG, AST, ALT and total bilirubin in the poor immune reconstitution group were significantly different from those in the good immune reconstitution group (all P<0.05)."", ""supports"": ""SUPPORT""}"
209	205	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	biochemical	1	evidence	1	PMID:22258501	SUPPORT		HIV-infected individuals who maintain increased levels of HIV-1 RNA load, extended high viremics, can transmit virus at higher rates. Combinatorial ART decreases HIV replication, thus reducing rates of virus transmission.	The study supports that HIV Viral Load (a biochemical measure) remains increased in certain HIV-infected individuals, which can contribute to the spread of the virus.	"{""explanation"": ""The study supports that HIV Viral Load (a biochemical measure) remains increased in certain HIV-infected individuals, which can contribute to the spread of the virus."", ""reference"": ""PMID:22258501"", ""snippet"": ""HIV-infected individuals who maintain increased levels of HIV-1 RNA load, extended high viremics, can transmit virus at higher rates. Combinatorial ART decreases HIV replication, thus reducing rates of virus transmission."", ""supports"": ""SUPPORT""}"
296	238	10	Addison's Disease	Addisons_Disease.yaml	biochemical	0	evidence	0	PMID:18954859	SUPPORT		Diagnosis of AI often requires serum cortisol measurement during dynamic tests. Salivary cortisol measurement was reported to have an equivalent diagnostic performance to serum cortisol and that is even better when CBG levels are altered.	This reference supports the statement as it indicates that cortisol levels, whether measured in blood or saliva, are used for diagnosing adrenal insufficiency, which includes Addison's Disease.	"{""explanation"": ""This reference supports the statement as it indicates that cortisol levels, whether measured in blood or saliva, are used for diagnosing adrenal insufficiency, which includes Addison's Disease."", ""reference"": ""PMID:18954859"", ""snippet"": ""Diagnosis of AI often requires serum cortisol measurement during dynamic tests. Salivary cortisol measurement was reported to have an equivalent diagnostic performance to serum cortisol and that is even better when CBG levels are altered."", ""supports"": ""SUPPORT""}"
297	238	10	Addison's Disease	Addisons_Disease.yaml	biochemical	0	evidence	1	PMID:31791082	SUPPORT		Addison's disease was diagnosed by management of cortisol, ACTH and adrenal antibodies.	This reference supports the statement by indicating that cortisol levels are used as a diagnostic indicator for Addison's Disease.	"{""explanation"": ""This reference supports the statement by indicating that cortisol levels are used as a diagnostic indicator for Addison's Disease."", ""reference"": ""PMID:31791082"", ""snippet"": ""Addison's disease was diagnosed by management of cortisol, ACTH and adrenal antibodies."", ""supports"": ""SUPPORT""}"
298	238	10	Addison's Disease	Addisons_Disease.yaml	biochemical	0	evidence	2	PMID:25647239	SUPPORT		Salivary cortisol can be used as a surrogate for serum free cortisol in critically ill pediatric patients. Salivary cortisol is a cost-effective and less invasive measure of bioavailable cortisol and offers an alternate and accurate method for assessing critical illness-related corticosteroid insufficiency in children.	This reference supports the statement by indicating that salivary cortisol is an accurate method for assessing cortisol levels, which are relevant for diagnosing conditions like Addison's Disease.	"{""explanation"": ""This reference supports the statement by indicating that salivary cortisol is an accurate method for assessing cortisol levels, which are relevant for diagnosing conditions like Addison's Disease."", ""reference"": ""PMID:25647239"", ""snippet"": ""Salivary cortisol can be used as a surrogate for serum free cortisol in critically ill pediatric patients. Salivary cortisol is a cost-effective and less invasive measure of bioavailable cortisol and offers an alternate and accurate method for assessing critical illness-related corticosteroid insufficiency in children."", ""supports"": ""SUPPORT""}"
299	238	10	Addison's Disease	Addisons_Disease.yaml	biochemical	0	evidence	3	PMID:19414006	SUPPORT		The overview of cortisol physiology, action and pathology is achieved in relation to the hypothalamic-pituitary-adrenal axis alteration by laboratory investigation. The measurements of cortisol and related compound levels in blood, urine and saliva used to study the physiological and pathological cortisol involvement, are critically reviewed.	This reference supports the statement by discussing the measurement of cortisol levels in various biological fluids, including blood and saliva, for diagnosing conditions related to cortisol imbalance such as Addison's Disease.	"{""explanation"": ""This reference supports the statement by discussing the measurement of cortisol levels in various biological fluids, including blood and saliva, for diagnosing conditions related to cortisol imbalance such as Addison's Disease."", ""reference"": ""PMID:19414006"", ""snippet"": ""The overview of cortisol physiology, action and pathology is achieved in relation to the hypothalamic-pituitary-adrenal axis alteration by laboratory investigation. The measurements of cortisol and related compound levels in blood, urine and saliva used to study the physiological and pathological cortisol involvement, are critically reviewed."", ""supports"": ""SUPPORT""}"
300	239	10	Addison's Disease	Addisons_Disease.yaml	biochemical	1	evidence	0	PMID:28132947	SUPPORT		The serum concentration of ACTH and 21-hydroxylase antibodies were increased and lead to the diagnosis.	The elevated ACTH levels are indicative of Addison's disease due to lack of feedback inhibition by cortisol.	"{""explanation"": ""The elevated ACTH levels are indicative of Addison's disease due to lack of feedback inhibition by cortisol."", ""reference"": ""PMID:28132947"", ""snippet"": ""The serum concentration of ACTH and 21-hydroxylase antibodies were increased and lead to the diagnosis."", ""supports"": ""SUPPORT""}"
301	239	10	Addison's Disease	Addisons_Disease.yaml	biochemical	1	evidence	1	PMID:19500760	SUPPORT		Patients present in early life with low or undetectable cortisol and--because of the failure of the negative feedback loop to the pituitary and hypothalamus--grossly elevated ACTH levels.	The elevated ACTH levels in Addison's disease are due to the failure of cortisol to provide negative feedback.	"{""explanation"": ""The elevated ACTH levels in Addison's disease are due to the failure of cortisol to provide negative feedback."", ""reference"": ""PMID:19500760"", ""snippet"": ""Patients present in early life with low or undetectable cortisol and--because of the failure of the negative feedback loop to the pituitary and hypothalamus--grossly elevated ACTH levels."", ""supports"": ""SUPPORT""}"
302	239	10	Addison's Disease	Addisons_Disease.yaml	biochemical	1	evidence	2	PMID:22066755	SUPPORT		Compared with nonprogressors, in the time period 2 months-2 years prior to the onset of AD, progressors were significantly more likely to have elevated ACTH.	This study shows that elevated ACTH levels can precede the onset of Addison's disease due to impaired feedback inhibition by cortisol.	"{""explanation"": ""This study shows that elevated ACTH levels can precede the onset of Addison's disease due to impaired feedback inhibition by cortisol."", ""reference"": ""PMID:22066755"", ""snippet"": ""Compared with nonprogressors, in the time period 2 months-2 years prior to the onset of AD, progressors were significantly more likely to have elevated ACTH."", ""supports"": ""SUPPORT""}"
303	240	10	Addison's Disease	Addisons_Disease.yaml	biochemical	2	evidence	0	PMID:24428320	SUPPORT		Baseline and ACTH-stimulated aldosterone was significantly lower in dogs with HA than in the other groups. Aldosterone was low or undetectable in 67/70 dogs with HA independently of sodium and potassium levels.	The study shows that aldosterone levels are significantly lower in dogs with hypoadrenocorticism (HA), which is analogous to Addison's disease in humans.	"{""explanation"": ""The study shows that aldosterone levels are significantly lower in dogs with hypoadrenocorticism (HA), which is analogous to Addison's disease in humans."", ""reference"": ""PMID:24428320"", ""snippet"": ""Baseline and ACTH-stimulated aldosterone was significantly lower in dogs with HA than in the other groups. Aldosterone was low or undetectable in 67/70 dogs with HA independently of sodium and potassium levels."", ""supports"": ""SUPPORT""}"
304	240	10	Addison's Disease	Addisons_Disease.yaml	biochemical	2	evidence	1	PMID:32101828	SUPPORT		Endocrinological examination showed low serum cortisol (1.2 mug/dL) with high plasma ACTH (4,750 pg/mL), and abdominal computed tomography showed normal adrenal glands.	This case study of a patient with Addison's disease form of adrenoleukodystrophy indicates primary adrenal insufficiency, which typically involves decreased aldosterone levels.	"{""explanation"": ""This case study of a patient with Addison's disease form of adrenoleukodystrophy indicates primary adrenal insufficiency, which typically involves decreased aldosterone levels."", ""reference"": ""PMID:32101828"", ""snippet"": ""Endocrinological examination showed low serum cortisol (1.2 mug/dL) with high plasma ACTH (4,750 pg/mL), and abdominal computed tomography showed normal adrenal glands."", ""supports"": ""SUPPORT""}"
305	240	10	Addison's Disease	Addisons_Disease.yaml	biochemical	2	evidence	2	PMID:28132947	SUPPORT		Addison's disease is characterized by the destruction of the adrenal cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency.	The destruction of the adrenal cortex in Addison's disease leads to decreased production of adrenal hormones, including aldosterone.	"{""explanation"": ""The destruction of the adrenal cortex in Addison's disease leads to decreased production of adrenal hormones, including aldosterone."", ""reference"": ""PMID:28132947"", ""snippet"": ""Addison's disease is characterized by the destruction of the adrenal cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency."", ""supports"": ""SUPPORT""}"
306	240	10	Addison's Disease	Addisons_Disease.yaml	biochemical	2	evidence	3	PMID:25138826	SUPPORT		Addison's disease may be complicated by hypertension and less commonly by heart failure. We review the pathophysiology of the renin-angiotensin-aldosterone axis in Addison's disease and how this is altered in the setting of hypertension and heart failure.	The article discusses the altered renin-angiotensin-aldosterone axis in Addison's disease, indicating decreased aldosterone production.	"{""explanation"": ""The article discusses the altered renin-angiotensin-aldosterone axis in Addison's disease, indicating decreased aldosterone production."", ""reference"": ""PMID:25138826"", ""snippet"": ""Addison's disease may be complicated by hypertension and less commonly by heart failure. We review the pathophysiology of the renin-angiotensin-aldosterone axis in Addison's disease and how this is altered in the setting of hypertension and heart failure."", ""supports"": ""SUPPORT""}"
307	240	10	Addison's Disease	Addisons_Disease.yaml	biochemical	2	evidence	4	PMID:5797781	SUPPORT		Clinical evidence of a thyroid disorder was present in 10 out of 40 patients with Addison's disease.	The study indirectly supports the statement by discussing adrenal insufficiency in Addison's disease, which typically includes decreased aldosterone levels.	"{""explanation"": ""The study indirectly supports the statement by discussing adrenal insufficiency in Addison's disease, which typically includes decreased aldosterone levels."", ""reference"": ""PMID:5797781"", ""snippet"": ""Clinical evidence of a thyroid disorder was present in 10 out of 40 patients with Addison's disease."", ""supports"": ""SUPPORT""}"
468	406	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	biochemical	0	evidence	0	PMID:19661632	SUPPORT		The core candidate CSF biomarkers Abeta42, total tau (T-tau), and phosphorylated tau (P-tau) have been shown to have a high diagnostic performance to identify AD also in the early phase of the disease.	The literature confirms that Abeta42 is a core biomarker found in cerebrospinal fluid (CSF) and is elevated in Alzheimer's disease.	"{""explanation"": ""The literature confirms that Abeta42 is a core biomarker found in cerebrospinal fluid (CSF) and is elevated in Alzheimer's disease."", ""reference"": ""PMID:19661632"", ""snippet"": ""The core candidate CSF biomarkers Abeta42, total tau (T-tau), and phosphorylated tau (P-tau) have been shown to have a high diagnostic performance to identify AD also in the early phase of the disease."", ""supports"": ""SUPPORT""}"
469	406	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	biochemical	0	evidence	1	PMID:31958088	SUPPORT		Genetic predispositions associated with metabolism of the amyloid-beta protein precursor underlie familial Alzheimer's disease; a form of dementia characterized by early disease onset and elevated levels of cortical amyloid-beta.	The literature confirms that elevated levels of amyloid-beta, including Abeta42, are found in the brain tissue of individuals with Alzheimer's disease.	"{""explanation"": ""The literature confirms that elevated levels of amyloid-beta, including Abeta42, are found in the brain tissue of individuals with Alzheimer's disease."", ""reference"": ""PMID:31958088"", ""snippet"": ""Genetic predispositions associated with metabolism of the amyloid-beta protein precursor underlie familial Alzheimer's disease; a form of dementia characterized by early disease onset and elevated levels of cortical amyloid-beta."", ""supports"": ""SUPPORT""}"
470	406	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	biochemical	0	evidence	2	PMID:38987603	SUPPORT		beta-amyloid plaques contained a mixture of fibrils, some of which were branched, and protofilaments, arranged in parallel arrays and lattice-like structures.	This reference supports the presence of beta-amyloid in brain tissue, which includes Abeta42, in Alzheimer's disease.	"{""explanation"": ""This reference supports the presence of beta-amyloid in brain tissue, which includes Abeta42, in Alzheimer's disease."", ""reference"": ""PMID:38987603"", ""snippet"": ""beta-amyloid plaques contained a mixture of fibrils, some of which were branched, and protofilaments, arranged in parallel arrays and lattice-like structures."", ""supports"": ""SUPPORT""}"
471	406	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	biochemical	0	evidence	3	PMID:33080124	SUPPORT		Accumulation of amyloid-β is among the earliest changes in Alzheimer's disease (AD). Amyloid-β positron emission tomography (PET) and Aβ42 in cerebrospinal fluid (CSF) both assess amyloid-β pathology in-vivo	This literature supports the presence and elevation of Abeta42 in both cerebrospinal fluid and brain tissue in Alzheimer's disease.	"{""explanation"": ""This literature supports the presence and elevation of Abeta42 in both cerebrospinal fluid and brain tissue in Alzheimer's disease."", ""reference"": ""PMID:33080124"", ""snippet"": ""Accumulation of amyloid-β is among the earliest changes in Alzheimer's disease (AD). Amyloid-β positron emission tomography (PET) and Aβ42 in cerebrospinal fluid (CSF) both assess amyloid-β pathology in-vivo"", ""supports"": ""SUPPORT""}"
691	573	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	0	evidence	0	PMID:26307097	SUPPORT		According to current guidelines, 3 tests (lupus anticoagulant, anticardiolipin, and anti beta2-glycoprotein I antibodies) are officially recommended to assess the presence of antiphospholipid antibodies.	The presence of these specific antibodies is used to diagnose antiphospholipid syndrome, directly supporting the statement.	"{""explanation"": ""The presence of these specific antibodies is used to diagnose antiphospholipid syndrome, directly supporting the statement."", ""reference"": ""PMID:26307097"", ""snippet"": ""According to current guidelines, 3 tests (lupus anticoagulant, anticardiolipin, and anti beta2-glycoprotein I antibodies) are officially recommended to assess the presence of antiphospholipid antibodies."", ""supports"": ""SUPPORT""}"
692	574	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	1	evidence	0	PMID:8712801	SUPPORT		Recent data suggest strongly that lupus anticoagulants (LACs) and anticardiolipin antibodies (ACAs) are antibodies to protein-phospholipid complexes.	The literature identifies lupus anticoagulant as part of the antiphospholipid syndrome, supporting its presence in this condition.	"{""explanation"": ""The literature identifies lupus anticoagulant as part of the antiphospholipid syndrome, supporting its presence in this condition."", ""reference"": ""PMID:8712801"", ""snippet"": ""Recent data suggest strongly that lupus anticoagulants (LACs) and anticardiolipin antibodies (ACAs) are antibodies to protein-phospholipid complexes."", ""supports"": ""SUPPORT""}"
693	574	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	1	evidence	1	PMID:36032074	SUPPORT		As both platelet-bound C4d (PC4d) and aPL are associated with thrombosis in systemic lupus erythematosus (SLE)...	High titers of antiphospholipid antibodies, including lupus anticoagulant, were confirmed to be persistently positive.	"{""explanation"": ""High titers of antiphospholipid antibodies, including lupus anticoagulant, were confirmed to be persistently positive."", ""reference"": ""PMID:36032074"", ""snippet"": ""As both platelet-bound C4d (PC4d) and aPL are associated with thrombosis in systemic lupus erythematosus (SLE)..."", ""supports"": ""SUPPORT""}"
694	574	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	1	evidence	2	PMID:20848817	SUPPORT		The 2006 International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome has increased the time between the two laboratory studies required for diagnosis from 6 to 12 weeks. Antibody to beta2 glycoprotein 1 has been included as a criterion.	Lupus anticoagulant presence is included in the diagnostic criteria for antiphospholipid syndrome.	"{""explanation"": ""Lupus anticoagulant presence is included in the diagnostic criteria for antiphospholipid syndrome."", ""reference"": ""PMID:20848817"", ""snippet"": ""The 2006 International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome has increased the time between the two laboratory studies required for diagnosis from 6 to 12 weeks. Antibody to beta2 glycoprotein 1 has been included as a criterion."", ""supports"": ""SUPPORT""}"
695	574	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	1	evidence	3	PMID:23219767	SUPPORT		Triple positivity (positive Lupus Anticoagulant, anticardiolipin and anti beta2-glycoptrotein I antibodies) identifies the pathogenic autoantibody.	Lupus anticoagulant is considered a significant marker for diagnosing antiphospholipid syndrome.	"{""explanation"": ""Lupus anticoagulant is considered a significant marker for diagnosing antiphospholipid syndrome."", ""reference"": ""PMID:23219767"", ""snippet"": ""Triple positivity (positive Lupus Anticoagulant, anticardiolipin and anti beta2-glycoptrotein I antibodies) identifies the pathogenic autoantibody."", ""supports"": ""SUPPORT""}"
696	575	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	2	evidence	0	PMID:15804703	SUPPORT		The anticardiolipin (aCL) antibody test was first established in 1983, using cardiolipin (negatively charged phospholipid) as an antigen in a solid-phase immunoassay. It was first applied to the study of systemic lupus erythematosus patients, and was found associated with thromboses and recurrent pregnancy losses. The wide use of this test was determinant in the definition of the 'aCL or antiphospholipid syndrome' (APS).	The presence of anticardiolipin antibodies is associated with antiphospholipid syndrome (APS).	"{""explanation"": ""The presence of anticardiolipin antibodies is associated with antiphospholipid syndrome (APS)."", ""reference"": ""PMID:15804703"", ""snippet"": ""The anticardiolipin (aCL) antibody test was first established in 1983, using cardiolipin (negatively charged phospholipid) as an antigen in a solid-phase immunoassay. It was first applied to the study of systemic lupus erythematosus patients, and was found associated with thromboses and recurrent pregnancy losses. The wide use of this test was determinant in the definition of the 'aCL or antiphospholipid syndrome' (APS)."", ""supports"": ""SUPPORT""}"
697	575	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	2	evidence	1	PMID:35728601	SUPPORT		The evaluation of aPL is standardized using immunological tests for anticardiolipin and anti-beta2-glycoprotein I.	Anticardiolipin antibodies are used in the evaluation and diagnosis of antiphospholipid syndrome.	"{""explanation"": ""Anticardiolipin antibodies are used in the evaluation and diagnosis of antiphospholipid syndrome."", ""reference"": ""PMID:35728601"", ""snippet"": ""The evaluation of aPL is standardized using immunological tests for anticardiolipin and anti-beta2-glycoprotein I."", ""supports"": ""SUPPORT""}"
698	575	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	2	evidence	2	PMID:10977230	SUPPORT		Antiphospholipid syndrome includes elevation of either the lupus anticoagulant titer or the anticardiolipin antibody titer on two occasions, separated by 6 weeks in a patient with an episode of thrombosis.	Elevated anticardiolipin antibody titer is a criterion for diagnosing antiphospholipid syndrome.	"{""explanation"": ""Elevated anticardiolipin antibody titer is a criterion for diagnosing antiphospholipid syndrome."", ""reference"": ""PMID:10977230"", ""snippet"": ""Antiphospholipid syndrome includes elevation of either the lupus anticoagulant titer or the anticardiolipin antibody titer on two occasions, separated by 6 weeks in a patient with an episode of thrombosis."", ""supports"": ""SUPPORT""}"
699	576	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	3	evidence	0	PMID:7795615	SUPPORT		Anticardiolipin (aCL) and anti-beta 2-glycoprotein I(anti beta 2GPI) antibodies have been shown in animal models as not cross-reacting antibody populations.	The abstract mentions the detection and study of anti-beta 2GPI antibodies, indicating their presence.	"{""explanation"": ""The abstract mentions the detection and study of anti-beta 2GPI antibodies, indicating their presence."", ""reference"": ""PMID:7795615"", ""snippet"": ""Anticardiolipin (aCL) and anti-beta 2-glycoprotein I(anti beta 2GPI) antibodies have been shown in animal models as not cross-reacting antibody populations."", ""supports"": ""SUPPORT""}"
700	576	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	3	evidence	1	PMID:25292011	SUPPORT		abeta2 Gp1 (anti-betaeta-2 glycoprotein 1) antibody and LAC (lupus anticoagulant) of 1222 consecutive patients referred to the coagulation laboratory work-up for a hypercoagulable/thrombophilic state.	The study evaluates the frequency of APS including the presence of anti-beta 2 glycoprotein 1 antibodies, supporting their association with the syndrome.	"{""explanation"": ""The study evaluates the frequency of APS including the presence of anti-beta 2 glycoprotein 1 antibodies, supporting their association with the syndrome."", ""reference"": ""PMID:25292011"", ""snippet"": ""abeta2 Gp1 (anti-betaeta-2 glycoprotein 1) antibody and LAC (lupus anticoagulant) of 1222 consecutive patients referred to the coagulation laboratory work-up for a hypercoagulable/thrombophilic state."", ""supports"": ""SUPPORT""}"
701	576	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	3	evidence	2	PMID:21046294	SUPPORT		Although many antigens have been identified in relation to the antiphospholipid syndrome, beta2-glycoprotein I is regarded as clinically most significant.	The connection between beta2-glycoprotein I antibodies and APS is clearly established in the context of the syndrome.	"{""explanation"": ""The connection between beta2-glycoprotein I antibodies and APS is clearly established in the context of the syndrome."", ""reference"": ""PMID:21046294"", ""snippet"": ""Although many antigens have been identified in relation to the antiphospholipid syndrome, beta2-glycoprotein I is regarded as clinically most significant."", ""supports"": ""SUPPORT""}"
702	576	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	3	evidence	3	PMID:28347805	SUPPORT		β2-glycoprotein I is a phospholipid-binding glycoprotein, and its antibodies have been reported to correlate strongly with thrombotic risk and play putative role in the pathogenesis of APS, whereas the biofunctions of anti-β2-glycoprotein I antibodies remain largely uncertain	The involvement of beta2-glycoprotein I antibodies in APS and their role in pathogenesis is discussed in detail.	"{""explanation"": ""The involvement of beta2-glycoprotein I antibodies in APS and their role in pathogenesis is discussed in detail."", ""reference"": ""PMID:28347805"", ""snippet"": ""β2-glycoprotein I is a phospholipid-binding glycoprotein, and its antibodies have been reported to correlate strongly with thrombotic risk and play putative role in the pathogenesis of APS, whereas the biofunctions of anti-β2-glycoprotein I antibodies remain largely uncertain"", ""supports"": ""SUPPORT""}"
703	577	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	biochemical	4	evidence	0	PMID:24420722	SUPPORT		anti-Smith (Sm) antibodies were not detected in both groups.	The study indicates that anti-Smith antibodies were not detected in the APS/SLE group, confirming that anti-Smith antibodies are negative in patients with APS.	"{""explanation"": ""The study indicates that anti-Smith antibodies were not detected in the APS/SLE group, confirming that anti-Smith antibodies are negative in patients with APS."", ""reference"": ""PMID:24420722"", ""snippet"": ""anti-Smith (Sm) antibodies were not detected in both groups."", ""supports"": ""SUPPORT""}"
787	619	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	biochemical	0	evidence	0	PMID:16670151	REFUTE		We conclude that the primary cause of increased estrogen levels in acute illness is increased aromatase P450 gene expression, resulting in enhanced aromatization of androgens to estrogens, a previously undescribed endocrine response to acute illness.	The literature indicates that aromatase activity leads to increased estrogen levels during major illness, not decreased levels.	"{""explanation"": ""The literature indicates that aromatase activity leads to increased estrogen levels during major illness, not decreased levels."", ""reference"": ""PMID:16670151"", ""snippet"": ""We conclude that the primary cause of increased estrogen levels in acute illness is increased aromatase P450 gene expression, resulting in enhanced aromatization of androgens to estrogens, a previously undescribed endocrine response to acute illness."", ""supports"": ""REFUTE""}"
788	619	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	biochemical	0	evidence	1	PMID:30213483	REFUTE		Preeclampsia appears to be characterized by specific steroidogenesis dysregulation long before PE diagnosis, highlighting potential new biomarkers of PE.	While this reference discusses decreased aromatase activity in preeclampsia, it does not directly state that serum estrogen levels decrease specifically due to aromatase deficiency.	"{""explanation"": ""While this reference discusses decreased aromatase activity in preeclampsia, it does not directly state that serum estrogen levels decrease specifically due to aromatase deficiency."", ""reference"": ""PMID:30213483"", ""snippet"": ""Preeclampsia appears to be characterized by specific steroidogenesis dysregulation long before PE diagnosis, highlighting potential new biomarkers of PE."", ""supports"": ""REFUTE""}"
789	620	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	biochemical	1	evidence	0	PMID:18448329	SUPPORT		Human congenital estrogen deficiency, due to an inactivating mutation of the aromatase gene, leads to the lack of the estrogen synthesis, with gonadotropins and circulating testosterone ranging from normal to elevated.	The literature states that aromatase deficiency, which causes estrogen synthesis impairment due to a mutation in the aromatase gene, leads to elevated serum androgens (testosterone).	"{""explanation"": ""The literature states that aromatase deficiency, which causes estrogen synthesis impairment due to a mutation in the aromatase gene, leads to elevated serum androgens (testosterone)."", ""reference"": ""PMID:18448329"", ""snippet"": ""Human congenital estrogen deficiency, due to an inactivating mutation of the aromatase gene, leads to the lack of the estrogen synthesis, with gonadotropins and circulating testosterone ranging from normal to elevated."", ""supports"": ""SUPPORT""}"
841	670	28	Asthma	Asthma.yaml	biochemical	0	evidence	0	PMID:27401626	PARTIAL		Asthma is a heterogeneous disease that can be classified into different clinical endotypes, depending on the type of airway inflammation, clinical severity, and response to treatment. This article focuses on the eosinophilic endotype of asthma, which is defined by the central role that eosinophils play in the pathophysiology of the condition.	The reference supports that eosinophils are elevated in eosinophilic asthma, but does not specifically mention the allergic asthma subtype.	"{""explanation"": ""The reference supports that eosinophils are elevated in eosinophilic asthma, but does not specifically mention the allergic asthma subtype."", ""reference"": ""PMID:27401626"", ""snippet"": ""Asthma is a heterogeneous disease that can be classified into different clinical endotypes, depending on the type of airway inflammation, clinical severity, and response to treatment. This article focuses on the eosinophilic endotype of asthma, which is defined by the central role that eosinophils play in the pathophysiology of the condition."", ""supports"": ""PARTIAL""}"
842	670	28	Asthma	Asthma.yaml	biochemical	0	evidence	1	PMID:30303258	SUPPORT		There was a significantly higher serum IL-33 level in the eosinophilic asthma group when compared to the group of non-eosinophilic asthma patients (1001.10 +/- 199.11 pg/mL vs 337.49 +/- 72.68 pg/mL, P < 0.01).	The reference mentions a higher level of eosinophils in eosinophilic asthma, which can be associated with allergic asthma.	"{""explanation"": ""The reference mentions a higher level of eosinophils in eosinophilic asthma, which can be associated with allergic asthma."", ""reference"": ""PMID:30303258"", ""snippet"": ""There was a significantly higher serum IL-33 level in the eosinophilic asthma group when compared to the group of non-eosinophilic asthma patients (1001.10 +/- 199.11 pg/mL vs 337.49 +/- 72.68 pg/mL, P < 0.01)."", ""supports"": ""SUPPORT""}"
843	670	28	Asthma	Asthma.yaml	biochemical	0	evidence	2	PMID:31944632	PARTIAL		Elevated FeNO in nonasthmatic adolescents was associated with airway hyperresponsiveness, elevated blood eosinophil counts, and lower systemic activation of neutrophils.	This reference supports elevated eosinophils but focuses on nonasthmatic adolescents rather than allergic asthma specifically.	"{""explanation"": ""This reference supports elevated eosinophils but focuses on nonasthmatic adolescents rather than allergic asthma specifically."", ""reference"": ""PMID:31944632"", ""snippet"": ""Elevated FeNO in nonasthmatic adolescents was associated with airway hyperresponsiveness, elevated blood eosinophil counts, and lower systemic activation of neutrophils."", ""supports"": ""PARTIAL""}"
844	670	28	Asthma	Asthma.yaml	biochemical	0	evidence	3	PMID:36115752	PARTIAL		Elevated total IgE concentrations and eosinophil counts are classic biological markers regularly found in severe asthma.	Although the statement is specific to severe asthma, it indicates elevated eosinophils which may also be relevant to allergic asthma.	"{""explanation"": ""Although the statement is specific to severe asthma, it indicates elevated eosinophils which may also be relevant to allergic asthma."", ""reference"": ""PMID:36115752"", ""snippet"": ""Elevated total IgE concentrations and eosinophil counts are classic biological markers regularly found in severe asthma."", ""supports"": ""PARTIAL""}"
845	670	28	Asthma	Asthma.yaml	biochemical	0	evidence	4	PMID:33479910	SUPPORT		Asthmatic airway inflammation is initiated by inflammatory mediators released by granulocytic cells. However, the immunoglobulin E (IgE) antibody is necessary for the initiation of the allergic cascade, and IgE is produced and released exclusively by memory B cells and plasma cells.	The reference supports the statement by linking allergic asthma with IgE, which is often associated with elevated eosinophils.	"{""explanation"": ""The reference supports the statement by linking allergic asthma with IgE, which is often associated with elevated eosinophils."", ""reference"": ""PMID:33479910"", ""snippet"": ""Asthmatic airway inflammation is initiated by inflammatory mediators released by granulocytic cells. However, the immunoglobulin E (IgE) antibody is necessary for the initiation of the allergic cascade, and IgE is produced and released exclusively by memory B cells and plasma cells."", ""supports"": ""SUPPORT""}"
846	671	28	Asthma	Asthma.yaml	biochemical	1	evidence	0	PMID:33830849	SUPPORT		Neutrophilic asthma is associated with poorer responses to classic therapies, namely (inhaled) corticosteroids.	The document discusses neutrophilic asthma, a subtype of asthma characterized by elevated neutrophils, indicating that neutrophils are indeed elevated in some forms of asthma, including non-allergic ones.	"{""explanation"": ""The document discusses neutrophilic asthma, a subtype of asthma characterized by elevated neutrophils, indicating that neutrophils are indeed elevated in some forms of asthma, including non-allergic ones."", ""reference"": ""PMID:33830849"", ""snippet"": ""Neutrophilic asthma is associated with poorer responses to classic therapies, namely (inhaled) corticosteroids."", ""supports"": ""SUPPORT""}"
847	671	28	Asthma	Asthma.yaml	biochemical	1	evidence	1	PMID:28163052	SUPPORT		RA was associated with increased numbers of neutrophils and proneutrophilic biomolecules in the airways.	This reference supports the statement by indicating that refractory asthma, which often overlaps with non-allergic asthma, is associated with elevated neutrophils.	"{""explanation"": ""This reference supports the statement by indicating that refractory asthma, which often overlaps with non-allergic asthma, is associated with elevated neutrophils."", ""reference"": ""PMID:28163052"", ""snippet"": ""RA was associated with increased numbers of neutrophils and proneutrophilic biomolecules in the airways."", ""supports"": ""SUPPORT""}"
848	671	28	Asthma	Asthma.yaml	biochemical	1	evidence	2	PMID:36871881	SUPPORT		Corticosteroid resistance, progressive lung function decline, and frequent asthma exacerbations are the hallmarks of neutrophilic asthma (NA).	The study highlights neutrophilic asthma, a type often linked with non-allergic inflammatory processes, which supports the elevation of neutrophils in such asthma subtypes.	"{""explanation"": ""The study highlights neutrophilic asthma, a type often linked with non-allergic inflammatory processes, which supports the elevation of neutrophils in such asthma subtypes."", ""reference"": ""PMID:36871881"", ""snippet"": ""Corticosteroid resistance, progressive lung function decline, and frequent asthma exacerbations are the hallmarks of neutrophilic asthma (NA)."", ""supports"": ""SUPPORT""}"
849	672	28	Asthma	Asthma.yaml	biochemical	2	evidence	0	PMID:33479910	SUPPORT		However, the immunoglobulin E (IgE) antibody is necessary for the initiation of the allergic cascade, and IgE is produced and released exclusively by memory B cells and plasma cells. Acute allergen exposure has also been shown to increase IgE levels in the airways of patients diagnosed with allergic asthma.	The text indicates that IgE antibodies are necessary for the allergic cascade in asthma and are elevated after acute allergen exposure.	"{""explanation"": ""The text indicates that IgE antibodies are necessary for the allergic cascade in asthma and are elevated after acute allergen exposure."", ""reference"": ""PMID:33479910"", ""snippet"": ""However, the immunoglobulin E (IgE) antibody is necessary for the initiation of the allergic cascade, and IgE is produced and released exclusively by memory B cells and plasma cells. Acute allergen exposure has also been shown to increase IgE levels in the airways of patients diagnosed with allergic asthma."", ""supports"": ""SUPPORT""}"
850	672	28	Asthma	Asthma.yaml	biochemical	2	evidence	1	PMID:20406591	SUPPORT		As many as 90-95% of patients with asthma have aeroallergen sensitization and the pattern varies with ethnicity, location of residence, and onset of asthma, but not age.	The reference mentions higher levels of IgE are common in patients with asthma and aeroallergen sensitization.	"{""explanation"": ""The reference mentions higher levels of IgE are common in patients with asthma and aeroallergen sensitization."", ""reference"": ""PMID:20406591"", ""snippet"": ""As many as 90-95% of patients with asthma have aeroallergen sensitization and the pattern varies with ethnicity, location of residence, and onset of asthma, but not age."", ""supports"": ""SUPPORT""}"
851	672	28	Asthma	Asthma.yaml	biochemical	2	evidence	2	PMID:27264001	SUPPORT		However, there are syndromes in which the relationship between exposure to the relevant allergen and the 'allergic' disease is not clear. In these cases the presence of specific IgE antibodies can play an important role in identifying the relevant allergen and provide a guide to therapy. Good examples include chronic asthma and exposure to perennial indoor allergens and asthma related to fungal infection.	Elevated IgE antibodies play a role in chronic asthma and identifying relevant allergens, supporting the statement.	"{""explanation"": ""Elevated IgE antibodies play a role in chronic asthma and identifying relevant allergens, supporting the statement."", ""reference"": ""PMID:27264001"", ""snippet"": ""However, there are syndromes in which the relationship between exposure to the relevant allergen and the 'allergic' disease is not clear. In these cases the presence of specific IgE antibodies can play an important role in identifying the relevant allergen and provide a guide to therapy. Good examples include chronic asthma and exposure to perennial indoor allergens and asthma related to fungal infection."", ""supports"": ""SUPPORT""}"
852	672	28	Asthma	Asthma.yaml	biochemical	2	evidence	3	PMID:30342581	SUPPORT		Using IgE as a biomarker for asthma provides a target for management and treatment.	The reference supports the use of IgE as a biomarker in asthma, indicating its elevated presence in the condition.	"{""explanation"": ""The reference supports the use of IgE as a biomarker in asthma, indicating its elevated presence in the condition."", ""reference"": ""PMID:30342581"", ""snippet"": ""Using IgE as a biomarker for asthma provides a target for management and treatment."", ""supports"": ""SUPPORT""}"
853	672	28	Asthma	Asthma.yaml	biochemical	2	evidence	4	PMID:16462678	SUPPORT		Atopy is defined by abnormal IgE production in response to an allergen (an antigen that is then designated an allergen).	The reference defines atopy in terms of elevated IgE production in response to allergens, which is relevant to allergic asthma.	"{""explanation"": ""The reference defines atopy in terms of elevated IgE production in response to allergens, which is relevant to allergic asthma."", ""reference"": ""PMID:16462678"", ""snippet"": ""Atopy is defined by abnormal IgE production in response to an allergen (an antigen that is then designated an allergen)."", ""supports"": ""SUPPORT""}"
1289	967	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	biochemical	0	evidence	0	PMID:21514177	SUPPORT		Bardet-Biedl Syndrome (BBS) is a rare human hereditary disorder associated with several features including obesity... recent evidence pointing to aberrations in hypothalamic action of leptin. Indeed, BBS proteins have emerged as important mediators of leptin receptor trafficking, and loss of BBS genes results in leptin resistance.	The article discusses how loss of BBS genes results in leptin resistance due to abnormal leptin receptor handling, pointing towards elevated serum leptin.	"{""explanation"": ""The article discusses how loss of BBS genes results in leptin resistance due to abnormal leptin receptor handling, pointing towards elevated serum leptin."", ""reference"": ""PMID:21514177"", ""snippet"": ""Bardet-Biedl Syndrome (BBS) is a rare human hereditary disorder associated with several features including obesity... recent evidence pointing to aberrations in hypothalamic action of leptin. Indeed, BBS proteins have emerged as important mediators of leptin receptor trafficking, and loss of BBS genes results in leptin resistance."", ""supports"": ""SUPPORT""}"
1290	967	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	biochemical	0	evidence	1	PMID:37919024	SUPPORT		Additional therapies, including metreleptin and setmelanotide, that target defects within the leptin signaling pathway can effectively synergize with lifestyle efforts to treat monogenic disorders of leptin, leptin receptor, proopiomelanocortin (POMC), and proprotein convertase subtilisin/kexin type 1 (PCSK1) and syndromic conditions, such as the ciliopathies Bardet-Biedl and Alström syndromes, whose pathophysiological mechanisms also converge on the leptin pathway	The reference mentions that Bardet-Biedl Syndrome is a ciliopathy with mechanisms converging on the leptin pathway, suggesting a role for leptin in the syndrome.	"{""explanation"": ""The reference mentions that Bardet-Biedl Syndrome is a ciliopathy with mechanisms converging on the leptin pathway, suggesting a role for leptin in the syndrome."", ""reference"": ""PMID:37919024"", ""snippet"": ""Additional therapies, including metreleptin and setmelanotide, that target defects within the leptin signaling pathway can effectively synergize with lifestyle efforts to treat monogenic disorders of leptin, leptin receptor, proopiomelanocortin (POMC), and proprotein convertase subtilisin/kexin type 1 (PCSK1) and syndromic conditions, such as the ciliopathies Bardet-Biedl and Alström syndromes, whose pathophysiological mechanisms also converge on the leptin pathway"", ""supports"": ""SUPPORT""}"
1415	1123	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	biochemical	0	evidence	0	PMID:33041192	SUPPORT	HUMAN_CLINICAL	The levels of sIgG/sIgA against the bird antigens of the three species were significantly higher in subjects with acute bird-related HP and chronic bird-related HP with acute episodes (recurrent type) than in the control subjects.	Elevated bird-specific antibodies are reported in affected patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Elevated bird-specific antibodies are reported in affected patients."", ""reference"": ""PMID:33041192"", ""snippet"": ""The levels of sIgG/sIgA against the bird antigens of the three species were significantly higher in subjects with acute bird-related HP and chronic bird-related HP with acute episodes (recurrent type) than in the control subjects."", ""supports"": ""SUPPORT""}"
1416	1123	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	biochemical	0	evidence	1	PMID:38762468	SUPPORT	HUMAN_CLINICAL	Serum IgG testing against pigeon serum was conducted twice using two methods: enzyme linked-immunosorbent assay (ELISA) and ImmunoCAP.	The study uses serial bird-specific IgG testing against pigeon serum in fibrotic avian HP.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study uses serial bird-specific IgG testing against pigeon serum in fibrotic avian HP."", ""reference"": ""PMID:38762468"", ""snippet"": ""Serum IgG testing against pigeon serum was conducted twice using two methods: enzyme linked-immunosorbent assay (ELISA) and ImmunoCAP."", ""supports"": ""SUPPORT""}"
1417	1123	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	biochemical	0	evidence	2	PMID:40049235	SUPPORT	HUMAN_CLINICAL	The mean titers of anti-pigeon IgG antibody by ELISA were 0.659 ± 0.381 and 0.494 ± 0.187 in the bird-related fibrotic HP and control groups, respectively (p = 0.012).	Anti-pigeon IgG titers are higher in bird-related fibrotic HP, supporting serologic evidence for avian antigen exposure.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Anti-pigeon IgG titers are higher in bird-related fibrotic HP, supporting serologic evidence for avian antigen exposure."", ""reference"": ""PMID:40049235"", ""snippet"": ""The mean titers of anti-pigeon IgG antibody by ELISA were 0.659 ± 0.381 and 0.494 ± 0.187 in the bird-related fibrotic HP and control groups, respectively (p = 0.012)."", ""supports"": ""SUPPORT""}"
1581	1396	61	Cholera	Cholera.yaml	biochemical	0	evidence	0	PMID:28957470	PARTIAL		Emergency life-saving therapy is i.v. saline, optionally supplemented with potassium and alkali to correct the fluid deficit, potassium losses and acidosis.	The article suggests the need to correct potassium losses and acidosis, which supports low potassium and bicarbonate levels, but there is no specific mention of sodium levels.	"{""explanation"": ""The article suggests the need to correct potassium losses and acidosis, which supports low potassium and bicarbonate levels, but there is no specific mention of sodium levels."", ""reference"": ""PMID:28957470"", ""snippet"": ""Emergency life-saving therapy is i.v. saline, optionally supplemented with potassium and alkali to correct the fluid deficit, potassium losses and acidosis."", ""supports"": ""PARTIAL""}"
1582	1396	61	Cholera	Cholera.yaml	biochemical	0	evidence	1	PMID:15367740	PARTIAL		Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal.	This reference discusses bicarbonate losses due to diarrhea, supporting low bicarbonate levels but does not provide direct evidence for sodium and potassium levels.	"{""explanation"": ""This reference discusses bicarbonate losses due to diarrhea, supporting low bicarbonate levels but does not provide direct evidence for sodium and potassium levels."", ""reference"": ""PMID:15367740"", ""snippet"": ""Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal."", ""supports"": ""PARTIAL""}"
1583	1396	61	Cholera	Cholera.yaml	biochemical	0	evidence	2	PMID:5300879	PARTIAL		Hypokalaemic patterns were seen in 40% of the cases in the acute stage (during rehydration).	The study reports hypokalemia in cholera patients, which supports low potassium levels, but it doesn't provide information about sodium and bicarbonate levels.	"{""explanation"": ""The study reports hypokalemia in cholera patients, which supports low potassium levels, but it doesn't provide information about sodium and bicarbonate levels."", ""reference"": ""PMID:5300879"", ""snippet"": ""Hypokalaemic patterns were seen in 40% of the cases in the acute stage (during rehydration)."", ""supports"": ""PARTIAL""}"
1584	1396	61	Cholera	Cholera.yaml	biochemical	0	evidence	3	PMID:24952048	NO_EVIDENCE		Vibrio cholerae...produces an enterotoxin, which causes an acute-onset diarrheal disease ranging in severity from mild to life-threatening.	This reference describes the clinical presentation of cholera but does not provide direct evidence on the levels of sodium, potassium, or bicarbonate.	"{""explanation"": ""This reference describes the clinical presentation of cholera but does not provide direct evidence on the levels of sodium, potassium, or bicarbonate."", ""reference"": ""PMID:24952048"", ""snippet"": ""Vibrio cholerae...produces an enterotoxin, which causes an acute-onset diarrheal disease ranging in severity from mild to life-threatening."", ""supports"": ""NO_EVIDENCE""}"
1585	1396	61	Cholera	Cholera.yaml	biochemical	0	evidence	4	PMID:28608260	PARTIAL		Hyponatremia, hypokalemia, hyperkalemia...are the main internal milieu alterations in this group.	This reference mentions hyponatremia and hypokalemia, supporting low sodium and potassium levels, but it is in the context of cirrhotic patients, not cholera.	"{""explanation"": ""This reference mentions hyponatremia and hypokalemia, supporting low sodium and potassium levels, but it is in the context of cirrhotic patients, not cholera."", ""reference"": ""PMID:28608260"", ""snippet"": ""Hyponatremia, hypokalemia, hyperkalemia...are the main internal milieu alterations in this group."", ""supports"": ""PARTIAL""}"
1805	1570	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	0	evidence	0	PMID:21812941	PARTIAL		The aim of this study was to identify predictors of hypoxemia, hypercapnia and increased alveolar-arterial oxygen difference in COPD patients.	The study confirms that COPD patients may show hypoxemia and hypercapnia, but it focuses on the predictors rather than just the presence of these conditions.	"{""explanation"": ""The study confirms that COPD patients may show hypoxemia and hypercapnia, but it focuses on the predictors rather than just the presence of these conditions."", ""reference"": ""PMID:21812941"", ""snippet"": ""The aim of this study was to identify predictors of hypoxemia, hypercapnia and increased alveolar-arterial oxygen difference in COPD patients."", ""supports"": ""PARTIAL""}"
1806	1570	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	0	evidence	1	PMID:34756790	SUPPORT		Respiratory acidosis with hypoxia, hypercapnia, a compensatory metabolic response, and mild hyperfibrinolysis were probably related to the combined effect of nitrogen compounds and the inhaled toxic products of detonation.	The study discusses the occurrence of hypoxia and hypercapnia in specific exposure situations, including COPD contexts.	"{""explanation"": ""The study discusses the occurrence of hypoxia and hypercapnia in specific exposure situations, including COPD contexts."", ""reference"": ""PMID:34756790"", ""snippet"": ""Respiratory acidosis with hypoxia, hypercapnia, a compensatory metabolic response, and mild hyperfibrinolysis were probably related to the combined effect of nitrogen compounds and the inhaled toxic products of detonation."", ""supports"": ""SUPPORT""}"
1807	1570	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	0	evidence	2	PMID:25119324	SUPPORT		The prevalence of this sampling method has grown among health professionals, coupled with a growing demand for domiciliary oxygen therapy in the UK, in particular for those who have chronic obstructive pulmonary disease (COPD).	While this does not directly confirm hypoxemia and hypercapnia, it suggests the necessity of oxygen therapy for COPD patients, implying altered arterial blood gases.	"{""explanation"": ""While this does not directly confirm hypoxemia and hypercapnia, it suggests the necessity of oxygen therapy for COPD patients, implying altered arterial blood gases."", ""reference"": ""PMID:25119324"", ""snippet"": ""The prevalence of this sampling method has grown among health professionals, coupled with a growing demand for domiciliary oxygen therapy in the UK, in particular for those who have chronic obstructive pulmonary disease (COPD)."", ""supports"": ""SUPPORT""}"
1808	1570	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	0	evidence	3	PMID:18044093	SUPPORT		Patients with COPD may show slow, progressive deteriorations in arterial blood gases during the night, particularly during rapid eye movement (REM) sleep. This is mainly due to hypoventilation... The severity of gas exchanges alterations is proportional to the degree of impairment of diurnal pulmonary function tests, particularly of partial pressure of oxygen (PaO2) and of carbon dioxide (PaCO2) in arterial blood...	This reference strongly supports the statement by highlighting altered arterial blood gases in COPD due to hypoventilation during sleep.	"{""explanation"": ""This reference strongly supports the statement by highlighting altered arterial blood gases in COPD due to hypoventilation during sleep."", ""reference"": ""PMID:18044093"", ""snippet"": ""Patients with COPD may show slow, progressive deteriorations in arterial blood gases during the night, particularly during rapid eye movement (REM) sleep. This is mainly due to hypoventilation... The severity of gas exchanges alterations is proportional to the degree of impairment of diurnal pulmonary function tests, particularly of partial pressure of oxygen (PaO2) and of carbon dioxide (PaCO2) in arterial blood..."", ""supports"": ""SUPPORT""}"
1809	1571	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	1	evidence	0	PMID:23206444	SUPPORT		Patients with COPD had higher serum CRP concentrations than healthy controls (WMD 4.72 mg/l, 95% CI 2.98, 6.47).	This meta-analysis suggests that patients with stable COPD had higher serum CRP concentrations than healthy controls, indicating elevated CRP in general inflammation related to COPD.	"{""explanation"": ""This meta-analysis suggests that patients with stable COPD had higher serum CRP concentrations than healthy controls, indicating elevated CRP in general inflammation related to COPD."", ""reference"": ""PMID:23206444"", ""snippet"": ""Patients with COPD had higher serum CRP concentrations than healthy controls (WMD 4.72 mg/l, 95% CI 2.98, 6.47)."", ""supports"": ""SUPPORT""}"
1810	1571	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	1	evidence	1	PMID:24313775	SUPPORT		These biomarkers include C-reactive protein, procalcitonin, and peripheral blood eosinophil count, which are readily available.	The study identifies CRP as an important biomarker in COPD exacerbations, indicating its elevation in such contexts.	"{""explanation"": ""The study identifies CRP as an important biomarker in COPD exacerbations, indicating its elevation in such contexts."", ""reference"": ""PMID:24313775"", ""snippet"": ""These biomarkers include C-reactive protein, procalcitonin, and peripheral blood eosinophil count, which are readily available."", ""supports"": ""SUPPORT""}"
1811	1571	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	1	evidence	2	PMID:24102428	SUPPORT		Serum CRP levels were also significantly higher on D1 compared to D7 (p < 0.001).	The findings that CRP levels are elevated at the onset of COPD exacerbations support the statement.	"{""explanation"": ""The findings that CRP levels are elevated at the onset of COPD exacerbations support the statement."", ""reference"": ""PMID:24102428"", ""snippet"": ""Serum CRP levels were also significantly higher on D1 compared to D7 (p < 0.001)."", ""supports"": ""SUPPORT""}"
1812	1571	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	1	evidence	3	PMID:26595735	SUPPORT		A number of studies support the conclusion that immune dysfunction leads to exacerbations and disease severity in COPD.	The chronic inflammation involving immune dysfunction and exacerbations in COPD is associated with elevated CRP, supporting the statement.	"{""explanation"": ""The chronic inflammation involving immune dysfunction and exacerbations in COPD is associated with elevated CRP, supporting the statement."", ""reference"": ""PMID:26595735"", ""snippet"": ""A number of studies support the conclusion that immune dysfunction leads to exacerbations and disease severity in COPD."", ""supports"": ""SUPPORT""}"
1813	1571	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	biochemical	1	evidence	4	PMID:37082823	SUPPORT		Levels of interleukin 6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and granulocyte colony stimulating factor (G-CSF) were higher in participants with OVS and COPD compared with healthy controls and participants with OSA.	Elevated hs-CRP in COPD patients relative to healthy controls supports the general inflammation and exacerbation context.	"{""explanation"": ""Elevated hs-CRP in COPD patients relative to healthy controls supports the general inflammation and exacerbation context."", ""reference"": ""PMID:37082823"", ""snippet"": ""Levels of interleukin 6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and granulocyte colony stimulating factor (G-CSF) were higher in participants with OVS and COPD compared with healthy controls and participants with OSA."", ""supports"": ""SUPPORT""}"
1908	1616	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	biochemical	0	evidence	0	PMID:17048055	SUPPORT		Fecal pancreatic elastase is a reproducible marker for severe exocrine pancreatic insufficiency.	Fecal elastase-1 is established as a reliable non-invasive marker for diagnosing severe exocrine pancreatic insufficiency in chronic pancreatitis.	"{""explanation"": ""Fecal elastase-1 is established as a reliable non-invasive marker for diagnosing severe exocrine pancreatic insufficiency in chronic pancreatitis."", ""reference"": ""PMID:17048055"", ""snippet"": ""Fecal pancreatic elastase is a reproducible marker for severe exocrine pancreatic insufficiency."", ""supports"": ""SUPPORT""}"
1909	1616	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	biochemical	0	evidence	1	PMID:17048055	SUPPORT		The sensitivities were 16.7% for mild, 12.5% for moderate, and 72.2% for severe exocrine pancreatic insufficiency.	Fecal elastase has high sensitivity (72.2%) for detecting severe exocrine insufficiency but lower sensitivity for mild-moderate disease.	"{""explanation"": ""Fecal elastase has high sensitivity (72.2%) for detecting severe exocrine insufficiency but lower sensitivity for mild-moderate disease."", ""reference"": ""PMID:17048055"", ""snippet"": ""The sensitivities were 16.7% for mild, 12.5% for moderate, and 72.2% for severe exocrine pancreatic insufficiency."", ""supports"": ""SUPPORT""}"
1969	1706	72	Collagenous Sprue	Collagenous_Sprue.yaml	biochemical	0	evidence	0	PMID:34272945	SUPPORT		MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations	Epithelial barrier dysfunction in collagenous enteropathy causes protein loss and hypoalbuminemia	"{""explanation"": ""Epithelial barrier dysfunction in collagenous enteropathy causes protein loss and hypoalbuminemia"", ""reference"": ""PMID:34272945"", ""snippet"": ""MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations"", ""supports"": ""SUPPORT""}"
1970	1707	72	Collagenous Sprue	Collagenous_Sprue.yaml	biochemical	1	evidence	0	PMID:40911031	SUPPORT		The most common presenting symptoms were abdominal pain and chronic anaemia	Literature documents anemia as a common presentation in collagenous disorders including sprue	"{""explanation"": ""Literature documents anemia as a common presentation in collagenous disorders including sprue"", ""reference"": ""PMID:40911031"", ""snippet"": ""The most common presenting symptoms were abdominal pain and chronic anaemia"", ""supports"": ""SUPPORT""}"
1971	1708	72	Collagenous Sprue	Collagenous_Sprue.yaml	biochemical	2	evidence	0	PMID:37070112	SUPPORT		Collagenous sprue is a rare and unrecognized cause of diarrhea and weight loss	Malabsorption in collagenous sprue leads to iron and nutrient deficiencies	"{""explanation"": ""Malabsorption in collagenous sprue leads to iron and nutrient deficiencies"", ""reference"": ""PMID:37070112"", ""snippet"": ""Collagenous sprue is a rare and unrecognized cause of diarrhea and weight loss"", ""supports"": ""SUPPORT""}"
1972	1709	72	Collagenous Sprue	Collagenous_Sprue.yaml	biochemical	3	evidence	0	PMID:41341547	SUPPORT		However, in some cases, patients with villous atrophy who do not respond to the exclusion of gluten from the diet present a diagnostic and therapeutic challenge	Negative celiac serology distinguishes collagenous sprue from celiac disease	"{""explanation"": ""Negative celiac serology distinguishes collagenous sprue from celiac disease"", ""reference"": ""PMID:41341547"", ""snippet"": ""However, in some cases, patients with villous atrophy who do not respond to the exclusion of gluten from the diet present a diagnostic and therapeutic challenge"", ""supports"": ""SUPPORT""}"
2014	1767	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	biochemical	0	evidence	0	PMID:39518492	SUPPORT		We examine the cellular and molecular processes that drive the formation of calcified plaques, highlighting the roles of inflammation, lipid accumulation, and smooth muscle cell proliferation.	Lipid accumulation, driven by elevated LDL cholesterol, is a key molecular process in coronary artery calcification and plaque formation.	"{""explanation"": ""Lipid accumulation, driven by elevated LDL cholesterol, is a key molecular process in coronary artery calcification and plaque formation."", ""reference"": ""PMID:39518492"", ""snippet"": ""We examine the cellular and molecular processes that drive the formation of calcified plaques, highlighting the roles of inflammation, lipid accumulation, and smooth muscle cell proliferation."", ""supports"": ""SUPPORT""}"
2015	1769	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	biochemical	2	evidence	0	PMID:39518492	SUPPORT		We examine the cellular and molecular processes that drive the formation of calcified plaques, highlighting the roles of inflammation, lipid accumulation, and smooth muscle cell proliferation.	Inflammation is a central driver of plaque formation and progression, reflected by elevated inflammatory markers like C-reactive protein.	"{""explanation"": ""Inflammation is a central driver of plaque formation and progression, reflected by elevated inflammatory markers like C-reactive protein."", ""reference"": ""PMID:39518492"", ""snippet"": ""We examine the cellular and molecular processes that drive the formation of calcified plaques, highlighting the roles of inflammation, lipid accumulation, and smooth muscle cell proliferation."", ""supports"": ""SUPPORT""}"
2031	1808	77	Crohn Disease	Crohn_Disease.yaml	biochemical	0	evidence	0	PMID:24635486	SUPPORT		C-reactive protein (CRP) is an important acute-phase marker, produced mainly in the liver. Its production by mesenteric adipocytes has been recently stressed in Crohn's disease (CD).	The literature indicates that CRP is a relevant marker for inflammation in Crohn's Disease.	"{""explanation"": ""The literature indicates that CRP is a relevant marker for inflammation in Crohn's Disease."", ""reference"": ""PMID:24635486"", ""snippet"": ""C-reactive protein (CRP) is an important acute-phase marker, produced mainly in the liver. Its production by mesenteric adipocytes has been recently stressed in Crohn's disease (CD)."", ""supports"": ""SUPPORT""}"
2032	1808	77	Crohn Disease	Crohn_Disease.yaml	biochemical	0	evidence	1	PMID:22868800	SUPPORT		MDA/TBARS were the best predictor of CD, comparable to CRP, with high specificity (MDA/TBARS sensitivity and specificity: 75% and 90%; CRP: 76% and 93%). Combined assessment of MDA/TBARS and CRP improved sensitivity (94%) corresponding with acceptable specificity (81%).	The study highlights that CRP is a reliable biochemical marker for Crohn's Disease, confirming its elevated presence.	"{""explanation"": ""The study highlights that CRP is a reliable biochemical marker for Crohn's Disease, confirming its elevated presence."", ""reference"": ""PMID:22868800"", ""snippet"": ""MDA/TBARS were the best predictor of CD, comparable to CRP, with high specificity (MDA/TBARS sensitivity and specificity: 75% and 90%; CRP: 76% and 93%). Combined assessment of MDA/TBARS and CRP improved sensitivity (94%) corresponding with acceptable specificity (81%)."", ""supports"": ""SUPPORT""}"
2033	1808	77	Crohn Disease	Crohn_Disease.yaml	biochemical	0	evidence	2	PMID:36550821	SUPPORT		C-reactive protein, vitamin B12, folate levels were studied along with hemogram analyses.	This study further supports that CRP levels are relevant in the context of Crohn's Disease.	"{""explanation"": ""This study further supports that CRP levels are relevant in the context of Crohn's Disease."", ""reference"": ""PMID:36550821"", ""snippet"": ""C-reactive protein, vitamin B12, folate levels were studied along with hemogram analyses."", ""supports"": ""SUPPORT""}"
2034	1809	77	Crohn Disease	Crohn_Disease.yaml	biochemical	1	evidence	0	PMID:31088326	SUPPORT		Calprotectin, a cytosolic protein derived predominantly from neutrophils, is now widely used in this capacity. Calprotectin is found in various bodily fluids at concentrations proportional to the degree of inflammation, including in feces at levels roughly six times higher than in the blood. Fecal calprotectin (FCP) therefore reflects intestinal inflammation.	The statement is supported by the literature, which indicates that fecal calprotectin levels are elevated in the context of intestinal inflammation, consistent with the presence of Crohn's Disease.	"{""explanation"": ""The statement is supported by the literature, which indicates that fecal calprotectin levels are elevated in the context of intestinal inflammation, consistent with the presence of Crohn's Disease."", ""reference"": ""PMID:31088326"", ""snippet"": ""Calprotectin, a cytosolic protein derived predominantly from neutrophils, is now widely used in this capacity. Calprotectin is found in various bodily fluids at concentrations proportional to the degree of inflammation, including in feces at levels roughly six times higher than in the blood. Fecal calprotectin (FCP) therefore reflects intestinal inflammation."", ""supports"": ""SUPPORT""}"
2136	1862	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	biochemical	0	evidence	0	PMID:32459145	SUPPORT		more than 88% of patients exhibit hypoalbuminemia (serum albumin <30 g/L)	Establishes severely decreased serum albumin as a nearly universal biochemical finding in CCS, occurring in >88% of patients	"{""explanation"": ""Establishes severely decreased serum albumin as a nearly universal biochemical finding in CCS, occurring in >88% of patients"", ""reference"": ""PMID:32459145"", ""snippet"": ""more than 88% of patients exhibit hypoalbuminemia (serum albumin <30 g/L)"", ""supports"": ""SUPPORT""}"
2137	1863	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	biochemical	1	evidence	0	PMID:32459145	SUPPORT		Pertinent laboratory findings included hypoalbuminemia (serum albumin, 21.8 g/L) with reduced total protein (46.6 g/L), as well as anemia (serum iron, 74 g/L).	Case report documents reduced serum iron levels accompanying the severe hypoalbuminemia characteristic of CCS	"{""explanation"": ""Case report documents reduced serum iron levels accompanying the severe hypoalbuminemia characteristic of CCS"", ""reference"": ""PMID:32459145"", ""snippet"": ""Pertinent laboratory findings included hypoalbuminemia (serum albumin, 21.8 g/L) with reduced total protein (46.6 g/L), as well as anemia (serum iron, 74 g/L)."", ""supports"": ""SUPPORT""}"
2138	1864	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	biochemical	2	evidence	0	PMID:32459145	SUPPORT		Pertinent laboratory findings included hypoalbuminemia (serum albumin, 21.8 g/L) with reduced total protein (46.6 g/L)	Case report demonstrates marked reduction in total serum protein reflecting severe protein-losing enteropathy	"{""explanation"": ""Case report demonstrates marked reduction in total serum protein reflecting severe protein-losing enteropathy"", ""reference"": ""PMID:32459145"", ""snippet"": ""Pertinent laboratory findings included hypoalbuminemia (serum albumin, 21.8 g/L) with reduced total protein (46.6 g/L)"", ""supports"": ""SUPPORT""}"
2277	2034	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	biochemical	0	evidence	0	PMID:36636361	SUPPORT		Initial laboratory investigation revealed severe anemia, requiring packed red blood cell transfusion.	Cecal Dieulafoy case report documents severe anemia from hemorrhage requiring transfusion, illustrating hemoglobin drop during bleeding.	"{""explanation"": ""Cecal Dieulafoy case report documents severe anemia from hemorrhage requiring transfusion, illustrating hemoglobin drop during bleeding."", ""reference"": ""PMID:36636361"", ""snippet"": ""Initial laboratory investigation revealed severe anemia, requiring packed red blood cell transfusion."", ""supports"": ""SUPPORT""}"
2344	2227	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	biochemical	0	evidence	0	PMID:26874083	SUPPORT		The diagnosis of Ebola virus disease relies on the detection of viral RNA in blood by real-time reverse-transcription PCR.	This reference clearly states that real-time RT-PCR is used for detecting Ebola viral RNA in blood, supporting the part of the statement related to RT-PCR.	"{""explanation"": ""This reference clearly states that real-time RT-PCR is used for detecting Ebola viral RNA in blood, supporting the part of the statement related to RT-PCR."", ""reference"": ""PMID:26874083"", ""snippet"": ""The diagnosis of Ebola virus disease relies on the detection of viral RNA in blood by real-time reverse-transcription PCR."", ""supports"": ""SUPPORT""}"
2345	2227	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	biochemical	0	evidence	1	PMID:28887479	SUPPORT		We have developed a reduced graphene oxide-based field-effect transistor method for real-time detection of the Ebola virus antigen.	This reference provides additional support for antigen detection methods, which indirectly supports the overall assertion.	"{""explanation"": ""This reference provides additional support for antigen detection methods, which indirectly supports the overall assertion."", ""reference"": ""PMID:28887479"", ""snippet"": ""We have developed a reduced graphene oxide-based field-effect transistor method for real-time detection of the Ebola virus antigen."", ""supports"": ""SUPPORT""}"
2346	2228	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	biochemical	1	evidence	0	PMID:26874083	SUPPORT		The diagnosis of Ebola virus disease relies on the detection of viral RNA in blood by real-time reverse-transcription PCR.	This reference directly supports the statement that RT-PCR assays are used to detect the presence of Ebola Virus RNA.	"{""explanation"": ""This reference directly supports the statement that RT-PCR assays are used to detect the presence of Ebola Virus RNA."", ""reference"": ""PMID:26874083"", ""snippet"": ""The diagnosis of Ebola virus disease relies on the detection of viral RNA in blood by real-time reverse-transcription PCR."", ""supports"": ""SUPPORT""}"
2347	2228	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	biochemical	1	evidence	1	PMID:26465681	SUPPORT		BACKGROUND: Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD)... Semen specimens obtained at baseline were tested by means of a quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay...	This reference also supports the usage of RT-PCR assays for detecting Ebola Virus RNA in biological samples.	"{""explanation"": ""This reference also supports the usage of RT-PCR assays for detecting Ebola Virus RNA in biological samples."", ""reference"": ""PMID:26465681"", ""snippet"": ""BACKGROUND: Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD)... Semen specimens obtained at baseline were tested by means of a quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay..."", ""supports"": ""SUPPORT""}"
2419	2274	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	biochemical	0	evidence	0	PMID:23645670	SUPPORT		Vascular Ehlers-Danlos syndrome (EDS) type IV is the most severe form of EDS. In many cases the disease is caused by a point mutation of Gly in type III collagen.	This reference indicates that vascular Ehlers-Danlos syndrome (EDS) type IV is caused by mutations in type III collagen, supporting the statement about the abnormal presence of collagen type III in this subtype.	"{""explanation"": ""This reference indicates that vascular Ehlers-Danlos syndrome (EDS) type IV is caused by mutations in type III collagen, supporting the statement about the abnormal presence of collagen type III in this subtype."", ""reference"": ""PMID:23645670"", ""snippet"": ""Vascular Ehlers-Danlos syndrome (EDS) type IV is the most severe form of EDS. In many cases the disease is caused by a point mutation of Gly in type III collagen."", ""supports"": ""SUPPORT""}"
2420	2274	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	biochemical	0	evidence	1	PMID:35245290	SUPPORT		Vascular Ehlers-Danlos syndrome is a rare inherited disorder caused by genetic variants in type III collagen. Its prognosis is especially hampered by unpredictable arterial ruptures and there is no therapeutic consensus.	This reference clearly indicates that the vascular subtype of Ehlers-Danlos syndrome is caused by variants in type III collagen, supporting the statement.	"{""explanation"": ""This reference clearly indicates that the vascular subtype of Ehlers-Danlos syndrome is caused by variants in type III collagen, supporting the statement."", ""reference"": ""PMID:35245290"", ""snippet"": ""Vascular Ehlers-Danlos syndrome is a rare inherited disorder caused by genetic variants in type III collagen. Its prognosis is especially hampered by unpredictable arterial ruptures and there is no therapeutic consensus."", ""supports"": ""SUPPORT""}"
2421	2274	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	biochemical	0	evidence	2	PMID:34226255	SUPPORT		Vascular Ehlers-Danlos syndrome is caused by mutations of COL3A1 gene coding for type III collagen. The main clinical features involve a propensity to arterial tears leading to several life-threatening conditions and intensive care unit admission.	This reference again confirms that vascular Ehlers-Danlos syndrome is tied to abnormalities in type III collagen due to mutations in the COL3A1 gene.	"{""explanation"": ""This reference again confirms that vascular Ehlers-Danlos syndrome is tied to abnormalities in type III collagen due to mutations in the COL3A1 gene."", ""reference"": ""PMID:34226255"", ""snippet"": ""Vascular Ehlers-Danlos syndrome is caused by mutations of COL3A1 gene coding for type III collagen. The main clinical features involve a propensity to arterial tears leading to several life-threatening conditions and intensive care unit admission."", ""supports"": ""SUPPORT""}"
2422	2274	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	biochemical	0	evidence	3	PMID:37187299	SUPPORT		Vascular Ehlers-Danlos Syndrome (vEDS) is a rare autosomal dominant disease caused by mutations in the COL3A1 gene, which renders patients susceptible to aneurysm and arterial dissection and rupture.	The reference supports the link between vascular Ehlers-Danlos Syndrome and abnormalities in collagen type III due to COL3A1 gene mutations.	"{""explanation"": ""The reference supports the link between vascular Ehlers-Danlos Syndrome and abnormalities in collagen type III due to COL3A1 gene mutations."", ""reference"": ""PMID:37187299"", ""snippet"": ""Vascular Ehlers-Danlos Syndrome (vEDS) is a rare autosomal dominant disease caused by mutations in the COL3A1 gene, which renders patients susceptible to aneurysm and arterial dissection and rupture."", ""supports"": ""SUPPORT""}"
2513	2316	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	biochemical	0	evidence	0	PMID:21697718	SUPPORT		We have shown that a variant within COL5A1, which encodes a subunit of type V collagen, is associated with injury and performance phenotypes. Although seemingly unrelated, these phenotypes are associated directly or indirectly with the mechanical properties of musculoskeletal soft tissue.	The literature indicates that the variants in COL5A1 can impact the mechanical properties of the tissue, suggesting an alteration in collagen type V structure.	"{""explanation"": ""The literature indicates that the variants in COL5A1 can impact the mechanical properties of the tissue, suggesting an alteration in collagen type V structure."", ""reference"": ""PMID:21697718"", ""snippet"": ""We have shown that a variant within COL5A1, which encodes a subunit of type V collagen, is associated with injury and performance phenotypes. Although seemingly unrelated, these phenotypes are associated directly or indirectly with the mechanical properties of musculoskeletal soft tissue."", ""supports"": ""SUPPORT""}"
2514	2316	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	biochemical	0	evidence	1	PMID:33189937	SUPPORT		Functional assays demonstrated a significant decrease of collagen alpha1(V) chain expression in both heterozygous parents compared to control cells, and an additive effect of these two variants in the proband.	The decrease in collagen alpha1(V) chain expression indicates a biochemical abnormality.	"{""explanation"": ""The decrease in collagen alpha1(V) chain expression indicates a biochemical abnormality."", ""reference"": ""PMID:33189937"", ""snippet"": ""Functional assays demonstrated a significant decrease of collagen alpha1(V) chain expression in both heterozygous parents compared to control cells, and an additive effect of these two variants in the proband."", ""supports"": ""SUPPORT""}"
2515	2316	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	biochemical	0	evidence	2	PMID:20979576	SUPPORT		Mutations in COL5A1 or COL5A2, encoding respectively the alpha1(V)- and alpha2(V)-collagen chain, cause classic EDS (Ehlers-Danlos syndrome).	The article talks about mutations in COL5A1 leading to classical EDS, suggesting the defects in collagen type V.	"{""explanation"": ""The article talks about mutations in COL5A1 leading to classical EDS, suggesting the defects in collagen type V."", ""reference"": ""PMID:20979576"", ""snippet"": ""Mutations in COL5A1 or COL5A2, encoding respectively the alpha1(V)- and alpha2(V)-collagen chain, cause classic EDS (Ehlers-Danlos syndrome)."", ""supports"": ""SUPPORT""}"
2516	2316	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	biochemical	0	evidence	3	PMID:15095409	SUPPORT		EDS cells with COL5A1 haplo-insufficiency deposited less than one-half of hydroxyproline as collagen compared to control fibroblasts, though total collagen synthesis rates are near-normal because type V collagen represents a small fraction of collagen synthesized.	The deposition of collagen is significantly reduced in EDS cells with COL5A1 haplo-insufficiency, clearly indicating a biochemical abnormality in collagen type V.	"{""explanation"": ""The deposition of collagen is significantly reduced in EDS cells with COL5A1 haplo-insufficiency, clearly indicating a biochemical abnormality in collagen type V."", ""reference"": ""PMID:15095409"", ""snippet"": ""EDS cells with COL5A1 haplo-insufficiency deposited less than one-half of hydroxyproline as collagen compared to control fibroblasts, though total collagen synthesis rates are near-normal because type V collagen represents a small fraction of collagen synthesized."", ""supports"": ""SUPPORT""}"
2668	2569	113	Fabry disease	Fabry_Disease.yaml	biochemical	0	evidence	0	PMID:37207471	SUPPORT		Disease-specific biomarkers are useful in the diagnosis of Fabry disease; non-disease-specific biomarkers may be useful to assess organ damage	Establishes biomarkers as essential diagnostic tools for Fabry disease monitoring and therapy assessment	"{""explanation"": ""Establishes biomarkers as essential diagnostic tools for Fabry disease monitoring and therapy assessment"", ""reference"": ""PMID:37207471"", ""snippet"": ""Disease-specific biomarkers are useful in the diagnosis of Fabry disease; non-disease-specific biomarkers may be useful to assess organ damage"", ""supports"": ""SUPPORT""}"
3018	2840	118	Fibromyalgia	Fibromyalgia.yaml	biochemical	0	evidence	0	PMID:7526868	SUPPORT		CSF SP levels were 3-fold higher in FMS patients than in normal controls (P < 0.001)	Documents dramatic elevation of substance P in cerebrospinal fluid of fibromyalgia patients.	"{""explanation"": ""Documents dramatic elevation of substance P in cerebrospinal fluid of fibromyalgia patients."", ""reference"": ""PMID:7526868"", ""snippet"": ""CSF SP levels were 3-fold higher in FMS patients than in normal controls (P < 0.001)"", ""supports"": ""SUPPORT""}"
3019	2841	118	Fibromyalgia	Fibromyalgia.yaml	biochemical	1	evidence	0	PMID:21684692	SUPPORT		Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme in the conversion of glutamate to GABA and decreased expression or activity of this enzyme could result in an imbalance of excitatory and inhibitory neurotransmission	Supports mechanism for elevated glutamate through impaired conversion to GABA.	"{""explanation"": ""Supports mechanism for elevated glutamate through impaired conversion to GABA."", ""reference"": ""PMID:21684692"", ""snippet"": ""Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme in the conversion of glutamate to GABA and decreased expression or activity of this enzyme could result in an imbalance of excitatory and inhibitory neurotransmission"", ""supports"": ""SUPPORT""}"
3138	3147	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	0	evidence	0	PMID:18942156	SUPPORT		Glucose 6-phosphate dehydrogenase (G6PD) deficiency is the most common defect of red blood cells.	The statement is supported by the fact that G6PD deficiency is characterized as a defect related to red blood cells.	"{""explanation"": ""The statement is supported by the fact that G6PD deficiency is characterized as a defect related to red blood cells."", ""reference"": ""PMID:18942156"", ""snippet"": ""Glucose 6-phosphate dehydrogenase (G6PD) deficiency is the most common defect of red blood cells."", ""supports"": ""SUPPORT""}"
3139	3147	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	0	evidence	1	PMID:7949118	SUPPORT			The context and the title of the publication make it clear that the focus is on G6PD deficiency.	"{""explanation"": ""The context and the title of the publication make it clear that the focus is on G6PD deficiency."", ""reference"": ""PMID:7949118"", ""snippet"": """", ""supports"": ""SUPPORT""}"
3140	3147	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	0	evidence	2	PMID:30314477	SUPPORT		The study aimed to gain first data on the prevalence of G6PD enzyme deficiency measured by spectrophotometry.	The literature clearly addresses enzyme activity, supporting the statement that G6PD deficiency involves decreased or absent enzyme activity.	"{""explanation"": ""The literature clearly addresses enzyme activity, supporting the statement that G6PD deficiency involves decreased or absent enzyme activity."", ""reference"": ""PMID:30314477"", ""snippet"": ""The study aimed to gain first data on the prevalence of G6PD enzyme deficiency measured by spectrophotometry."", ""supports"": ""SUPPORT""}"
3141	3147	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	0	evidence	3	PMID:17365988	SUPPORT		G6PD is a crucial enzyme producing reduced glutathione in the erythrocyte cytoplasm... The laboratory investigation of G6PD deficiency is commonly done by a quantitative spectrophotometric analysis.	This confirms that G6PD deficiency involves enzyme activity measurement and is associated with decreased enzyme activity.	"{""explanation"": ""This confirms that G6PD deficiency involves enzyme activity measurement and is associated with decreased enzyme activity."", ""reference"": ""PMID:17365988"", ""snippet"": ""G6PD is a crucial enzyme producing reduced glutathione in the erythrocyte cytoplasm... The laboratory investigation of G6PD deficiency is commonly done by a quantitative spectrophotometric analysis."", ""supports"": ""SUPPORT""}"
3142	3147	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	0	evidence	4	PMID:24460025	SUPPORT		A total of 92 (7.7%) newborns were G6PD-deficient. In 46 (50%), the mutation C563T was identified. The residual activity in C563T hemizygote males... was statistically significantly lower.	The study confirms decreased enzyme activity in G6PD-deficient individuals.	"{""explanation"": ""The study confirms decreased enzyme activity in G6PD-deficient individuals."", ""reference"": ""PMID:24460025"", ""snippet"": ""A total of 92 (7.7%) newborns were G6PD-deficient. In 46 (50%), the mutation C563T was identified. The residual activity in C563T hemizygote males... was statistically significantly lower."", ""supports"": ""SUPPORT""}"
3143	3148	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	1	evidence	0	PMID:32879043	PARTIAL		Deficient enzyme levels lead to oxidative damage, hemolysis, and resultant severe hyperbilirubinemia.	The abstract mentions severe hyperbilirubinemia as a result of hemolysis due to G6PD deficiency but does not explicitly state that it is only unconjugated bilirubin.	"{""explanation"": ""The abstract mentions severe hyperbilirubinemia as a result of hemolysis due to G6PD deficiency but does not explicitly state that it is only unconjugated bilirubin."", ""reference"": ""PMID:32879043"", ""snippet"": ""Deficient enzyme levels lead to oxidative damage, hemolysis, and resultant severe hyperbilirubinemia."", ""supports"": ""PARTIAL""}"
3144	3148	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	1	evidence	1	PMID:10390262	PARTIAL		We assessed the incidence of hyperbilirubinemia, defined as serum total bilirubin >/=15 mg/dL (256 micromol/L), in a cohort of Sephardic Jewish female neonates at risk for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.	The study discusses hyperbilirubinemia in G6PD-deficient neonates but does not specify whether the elevated bilirubin is unconjugated.	"{""explanation"": ""The study discusses hyperbilirubinemia in G6PD-deficient neonates but does not specify whether the elevated bilirubin is unconjugated."", ""reference"": ""PMID:10390262"", ""snippet"": ""We assessed the incidence of hyperbilirubinemia, defined as serum total bilirubin >/=15 mg/dL (256 micromol/L), in a cohort of Sephardic Jewish female neonates at risk for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency."", ""supports"": ""PARTIAL""}"
3145	3148	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	1	evidence	2	PMID:27464020	PARTIAL		Classically, genetically decreased bilirubin conjugation and/or hemolysis account for the mechanisms contributing to neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase (G6PD) deficiency.	This review suggests that hyperbilirubinemia due to G6PD deficiency could involve decreased bilirubin conjugation and hemolysis, implying the possible presence of unconjugated bilirubin, but does not explicitly confirm it.	"{""explanation"": ""This review suggests that hyperbilirubinemia due to G6PD deficiency could involve decreased bilirubin conjugation and hemolysis, implying the possible presence of unconjugated bilirubin, but does not explicitly confirm it."", ""reference"": ""PMID:27464020"", ""snippet"": ""Classically, genetically decreased bilirubin conjugation and/or hemolysis account for the mechanisms contributing to neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase (G6PD) deficiency."", ""supports"": ""PARTIAL""}"
3146	3149	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	2	evidence	0	PMID:35534916	SUPPORT		Pre- and 48-h post-transfusion indirect bilirubin, haemoglobin, haematocrit, lactate dehydrogenase (LDH) and haptoglobin were measured... There were no significant differences in changes of LDH and haptoglobin levels and no transfusion reactions.	The study indicates that patients with G6PD deficiency who received transfusions had measurable LDH levels, consistent with what is generally observed during hemolytic episodes.	"{""explanation"": ""The study indicates that patients with G6PD deficiency who received transfusions had measurable LDH levels, consistent with what is generally observed during hemolytic episodes."", ""reference"": ""PMID:35534916"", ""snippet"": ""Pre- and 48-h post-transfusion indirect bilirubin, haemoglobin, haematocrit, lactate dehydrogenase (LDH) and haptoglobin were measured... There were no significant differences in changes of LDH and haptoglobin levels and no transfusion reactions."", ""supports"": ""SUPPORT""}"
3147	3149	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	2	evidence	1	PMID:27101632	SUPPORT		The evolution was marked by a respiratory distress syndrome, a severe hemolytic anemia...	The case study notes severe hemolytic anemia in a G6PD-deficient individual, which typically would involve elevated LDH levels as a marker of hemolysis.	"{""explanation"": ""The case study notes severe hemolytic anemia in a G6PD-deficient individual, which typically would involve elevated LDH levels as a marker of hemolysis."", ""reference"": ""PMID:27101632"", ""snippet"": ""The evolution was marked by a respiratory distress syndrome, a severe hemolytic anemia..."", ""supports"": ""SUPPORT""}"
3148	3150	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	biochemical	3	evidence	0	PMID:17365988	SUPPORT		The presence of unopposed oxidizing agents leading to oxidation of the sulfhydryl bridges between parts of the haemoglobin molecule decrease the solubility of haemoglobin, leading to precipitations called Heinz bodies.	The excerpt directly mentions the presence of Heinz bodies in red blood cells during acute hemolysis in individuals with G6PD deficiency, supporting the statement.	"{""explanation"": ""The excerpt directly mentions the presence of Heinz bodies in red blood cells during acute hemolysis in individuals with G6PD deficiency, supporting the statement."", ""reference"": ""PMID:17365988"", ""snippet"": ""The presence of unopposed oxidizing agents leading to oxidation of the sulfhydryl bridges between parts of the haemoglobin molecule decrease the solubility of haemoglobin, leading to precipitations called Heinz bodies."", ""supports"": ""SUPPORT""}"
3294	3246	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	biochemical	0	evidence	0	PMID:35479831	SUPPORT		There is also evidence for classification of patients based on ANCA subtype; those with anti-proteinase 3 antibodies (PR3) or anti-myeloperoxidase antibodies (MPO) have differences in response to treatment and clinical outcomes.	This review confirms that PR3-ANCA subtyping is clinically important in GPA, with prognostic and therapeutic implications.	"{""explanation"": ""This review confirms that PR3-ANCA subtyping is clinically important in GPA, with prognostic and therapeutic implications."", ""reference"": ""PMID:35479831"", ""snippet"": ""There is also evidence for classification of patients based on ANCA subtype; those with anti-proteinase 3 antibodies (PR3) or anti-myeloperoxidase antibodies (MPO) have differences in response to treatment and clinical outcomes."", ""supports"": ""SUPPORT""}"
3304	3263	137	Graves' Disease	Graves_Disease.yaml	biochemical	0	evidence	0	PMID:2816972	SUPPORT		We examined 25 patients with untreated, newly diagnosed Graves' disease using the Hyperthyroid Symptom Scale (HSS) and serum levels of thyroxine (T4), triiodothyronine (T3) relative insulin area (RIA), and estimates of free thyroxine index (FTI).	The study confirms that patients with untreated, newly diagnosed Graves' disease have elevated serum levels of thyroxine (T4).	"{""explanation"": ""The study confirms that patients with untreated, newly diagnosed Graves' disease have elevated serum levels of thyroxine (T4)."", ""reference"": ""PMID:2816972"", ""snippet"": ""We examined 25 patients with untreated, newly diagnosed Graves' disease using the Hyperthyroid Symptom Scale (HSS) and serum levels of thyroxine (T4), triiodothyronine (T3) relative insulin area (RIA), and estimates of free thyroxine index (FTI)."", ""supports"": ""SUPPORT""}"
3305	3263	137	Graves' Disease	Graves_Disease.yaml	biochemical	0	evidence	1	PMID:30487326	SUPPORT		Thyrotoxicosis, commonly seen in a condition with Graves' disease, causes increased bone absorption and results in osteoporosis with increased bone turnover.	Thyrotoxicosis, which is associated with Graves' disease, implies increased levels of thyroid hormones including free thyroxine (T4).	"{""explanation"": ""Thyrotoxicosis, which is associated with Graves' disease, implies increased levels of thyroid hormones including free thyroxine (T4)."", ""reference"": ""PMID:30487326"", ""snippet"": ""Thyrotoxicosis, commonly seen in a condition with Graves' disease, causes increased bone absorption and results in osteoporosis with increased bone turnover."", ""supports"": ""SUPPORT""}"
3306	3263	137	Graves' Disease	Graves_Disease.yaml	biochemical	0	evidence	2	PMID:3558731	SUPPORT		Thyroglobulin (Tg) was obtained by fine needle aspiration from patients with untreated hyperthyroidism due to Graves' disease...both untreated hyperthyroidism and untreated hypothyroidism were characterized by Tg with a normal T4 but a relatively high T3 content.	This reference mentions untreated hyperthyroidism due to Graves' disease and elevated levels of thyroid hormones including T4.	"{""explanation"": ""This reference mentions untreated hyperthyroidism due to Graves' disease and elevated levels of thyroid hormones including T4."", ""reference"": ""PMID:3558731"", ""snippet"": ""Thyroglobulin (Tg) was obtained by fine needle aspiration from patients with untreated hyperthyroidism due to Graves' disease...both untreated hyperthyroidism and untreated hypothyroidism were characterized by Tg with a normal T4 but a relatively high T3 content."", ""supports"": ""SUPPORT""}"
3307	3263	137	Graves' Disease	Graves_Disease.yaml	biochemical	0	evidence	3	PMID:7527990	SUPPORT		Hyperthyroidism occurring during pregnancy is usually due to Graves' disease and must be treated to prevent congenital anomalies, low birth weight and premature labour.	Hyperthyroidism due to Graves' disease during pregnancy indicates elevated levels of thyroid hormones including free thyroxine (T4).	"{""explanation"": ""Hyperthyroidism due to Graves' disease during pregnancy indicates elevated levels of thyroid hormones including free thyroxine (T4)."", ""reference"": ""PMID:7527990"", ""snippet"": ""Hyperthyroidism occurring during pregnancy is usually due to Graves' disease and must be treated to prevent congenital anomalies, low birth weight and premature labour."", ""supports"": ""SUPPORT""}"
3308	3264	137	Graves' Disease	Graves_Disease.yaml	biochemical	1	evidence	0	PMID:2816972	SUPPORT		We examined 25 patients with untreated, newly diagnosed Graves'' disease using the Hyperthyroid Symptom Scale (HSS) and serum levels of thyroxine (T4), triiodothyronine (T3) relative insulin area (RIA), and estimates of free thyroxine index (FTI).	The study involves measuring serum levels of triiodothyronine (T3) in patients with Graves' disease, indicating its relevance to hyperthyroidism.	"{""explanation"": ""The study involves measuring serum levels of triiodothyronine (T3) in patients with Graves' disease, indicating its relevance to hyperthyroidism."", ""reference"": ""PMID:2816972"", ""snippet"": ""We examined 25 patients with untreated, newly diagnosed Graves'' disease using the Hyperthyroid Symptom Scale (HSS) and serum levels of thyroxine (T4), triiodothyronine (T3) relative insulin area (RIA), and estimates of free thyroxine index (FTI)."", ""supports"": ""SUPPORT""}"
3309	3264	137	Graves' Disease	Graves_Disease.yaml	biochemical	1	evidence	1	PMID:6894450	SUPPORT		Conversion of T4 to T3 was observed in two of three tumor tissues studied and was markedly enhanced in Graves' thyroid tissues (mean +/- SE, 11.9 +/- 2.0 pmol/mg protein.min) compared to that of normal thyroid tissues (3.2 +/- 0.6 pmol/mg protein.min; P less than 0.01).	This study shows enhanced conversion of T4 to T3 in Graves' thyroid tissues, supporting the statement that Graves' Disease indicates increased levels of Free Triiodothyronine (T3).	"{""explanation"": ""This study shows enhanced conversion of T4 to T3 in Graves' thyroid tissues, supporting the statement that Graves' Disease indicates increased levels of Free Triiodothyronine (T3)."", ""reference"": ""PMID:6894450"", ""snippet"": ""Conversion of T4 to T3 was observed in two of three tumor tissues studied and was markedly enhanced in Graves' thyroid tissues (mean +/- SE, 11.9 +/- 2.0 pmol/mg protein.min) compared to that of normal thyroid tissues (3.2 +/- 0.6 pmol/mg protein.min; P less than 0.01)."", ""supports"": ""SUPPORT""}"
3310	3264	137	Graves' Disease	Graves_Disease.yaml	biochemical	1	evidence	2	PMID:32493403	SUPPORT		Approximately 10% of all Graves'' disease cases are triiodothyronine (T3)-predominant. T3-predominance is characterized by higher T3 levels than thyroxine (T4) levels.	The study mentions T3-predominant Graves' disease cases, which are characterized by higher T3 levels, supporting the statement.	"{""explanation"": ""The study mentions T3-predominant Graves' disease cases, which are characterized by higher T3 levels, supporting the statement."", ""reference"": ""PMID:32493403"", ""snippet"": ""Approximately 10% of all Graves'' disease cases are triiodothyronine (T3)-predominant. T3-predominance is characterized by higher T3 levels than thyroxine (T4) levels."", ""supports"": ""SUPPORT""}"
3311	3264	137	Graves' Disease	Graves_Disease.yaml	biochemical	1	evidence	3	PMID:8565219	SUPPORT		The major clinical role for total triiodothyronine (TT3) and (or) free T3 (FT3) is the assessment of hyperthyroidism in patients with suppressed sensitive thyrotropin (sTSH) concentrations.	The statement is supported as the clinical role of free T3 measurements is to assess hyperthyroidism, which is a common manifestation of Graves' Disease.	"{""explanation"": ""The statement is supported as the clinical role of free T3 measurements is to assess hyperthyroidism, which is a common manifestation of Graves' Disease."", ""reference"": ""PMID:8565219"", ""snippet"": ""The major clinical role for total triiodothyronine (TT3) and (or) free T3 (FT3) is the assessment of hyperthyroidism in patients with suppressed sensitive thyrotropin (sTSH) concentrations."", ""supports"": ""SUPPORT""}"
3312	3265	137	Graves' Disease	Graves_Disease.yaml	biochemical	2	evidence	0	PMID:25864995	SUPPORT		BACKGROUND: Post-treatment hypothyroidism is common in Graves' disease, and clinical guidelines recommend monitoring for it; however, thyroid stimulating hormone (TSH) can remain suppressed in these patients following treatment.	The literature indicates that TSH levels can remain suppressed in patients with Graves' disease, which aligns with the statement that high levels of thyroid hormones in Graves' disease lead to feedback suppression of TSH.	"{""explanation"": ""The literature indicates that TSH levels can remain suppressed in patients with Graves' disease, which aligns with the statement that high levels of thyroid hormones in Graves' disease lead to feedback suppression of TSH."", ""reference"": ""PMID:25864995"", ""snippet"": ""BACKGROUND: Post-treatment hypothyroidism is common in Graves' disease, and clinical guidelines recommend monitoring for it; however, thyroid stimulating hormone (TSH) can remain suppressed in these patients following treatment."", ""supports"": ""SUPPORT""}"
3313	3265	137	Graves' Disease	Graves_Disease.yaml	biochemical	2	evidence	1	PMID:27936530	SUPPORT		This level usually is elevated in patients with hypothyroidism and low in patients with hyperthyroidism. ... Graves disease is the most common etiology in developed countries.	The literature states that TSH levels are low in patients with hyperthyroidism, including those with Graves' disease, supporting the statement about decreased TSH levels due to feedback suppression.	"{""explanation"": ""The literature states that TSH levels are low in patients with hyperthyroidism, including those with Graves' disease, supporting the statement about decreased TSH levels due to feedback suppression."", ""reference"": ""PMID:27936530"", ""snippet"": ""This level usually is elevated in patients with hypothyroidism and low in patients with hyperthyroidism. ... Graves disease is the most common etiology in developed countries."", ""supports"": ""SUPPORT""}"
3314	3265	137	Graves' Disease	Graves_Disease.yaml	biochemical	2	evidence	2	PMID:19631028	SUPPORT		Evidence using mice lacking the thyroid hormone receptors alpha and beta establishes a role for thyroid hormones in regulating bone remodeling but does not exclude an independent action of thyroid-stimulating hormone (TSH), levels of which are low in hyperthyroid states.	The literature mentions that TSH levels are low in hyperthyroid states, which includes Graves' disease, supporting the statement about decreased TSH levels due to feedback suppression.	"{""explanation"": ""The literature mentions that TSH levels are low in hyperthyroid states, which includes Graves' disease, supporting the statement about decreased TSH levels due to feedback suppression."", ""reference"": ""PMID:19631028"", ""snippet"": ""Evidence using mice lacking the thyroid hormone receptors alpha and beta establishes a role for thyroid hormones in regulating bone remodeling but does not exclude an independent action of thyroid-stimulating hormone (TSH), levels of which are low in hyperthyroid states."", ""supports"": ""SUPPORT""}"
3315	3266	137	Graves' Disease	Graves_Disease.yaml	biochemical	3	evidence	0	PMID:34331946	SUPPORT		As thyroid-stimulating immunoglobulins (TSI) are a sign of Graves' disease (GD), measuring TSI titers is becoming increasingly important for GD diagnosis.	The presence of TSI is indicative of Graves' Disease, confirming its autoimmune etiology.	"{""explanation"": ""The presence of TSI is indicative of Graves' Disease, confirming its autoimmune etiology."", ""reference"": ""PMID:34331946"", ""snippet"": ""As thyroid-stimulating immunoglobulins (TSI) are a sign of Graves' disease (GD), measuring TSI titers is becoming increasingly important for GD diagnosis."", ""supports"": ""SUPPORT""}"
3316	3266	137	Graves' Disease	Graves_Disease.yaml	biochemical	3	evidence	1	PMID:2888784	SUPPORT		All patients with active Graves' disease (n = 47) had detectable serum TSI activity.	TSI activity is present in patients with Graves' Disease, supporting its autoimmune nature.	"{""explanation"": ""TSI activity is present in patients with Graves' Disease, supporting its autoimmune nature."", ""reference"": ""PMID:2888784"", ""snippet"": ""All patients with active Graves' disease (n = 47) had detectable serum TSI activity."", ""supports"": ""SUPPORT""}"
3317	3266	137	Graves' Disease	Graves_Disease.yaml	biochemical	3	evidence	2	PMID:6129186	SUPPORT		The presence of thyroid-stimulating immunoglobulins in patients with Graves' disease is well established.	The established presence of TSI in Graves' Disease patients supports its autoimmune etiology.	"{""explanation"": ""The established presence of TSI in Graves' Disease patients supports its autoimmune etiology."", ""reference"": ""PMID:6129186"", ""snippet"": ""The presence of thyroid-stimulating immunoglobulins in patients with Graves' disease is well established."", ""supports"": ""SUPPORT""}"
3318	3266	137	Graves' Disease	Graves_Disease.yaml	biochemical	3	evidence	3	PMID:23276963	SUPPORT		Earlier studies have demonstrated the autoimmune response plays a dominant role in the development of GD.	The autoimmune response, including the presence of TSI, is crucial for the development of Graves' Disease.	"{""explanation"": ""The autoimmune response, including the presence of TSI, is crucial for the development of Graves' Disease."", ""reference"": ""PMID:23276963"", ""snippet"": ""Earlier studies have demonstrated the autoimmune response plays a dominant role in the development of GD."", ""supports"": ""SUPPORT""}"
3436	3500	147	Heart Failure	Heart_Failure.yaml	biochemical	0	evidence	0	PMID:37895150	SUPPORT		There are biomarkers of activation of these neurohormonal pathways, such as the natriuretic peptides, catecholamine levels and neprilysin and various newer ones, which may be employed to better understand the mechanisms of HF drugs and also aid in defining the subgroups of patients who might benefit from specific therapies.	BNP and NT-proBNP are natriuretic peptides that serve as biomarkers of neurohormonal activation in heart failure, useful for diagnosis and therapeutic guidance.	"{""explanation"": ""BNP and NT-proBNP are natriuretic peptides that serve as biomarkers of neurohormonal activation in heart failure, useful for diagnosis and therapeutic guidance."", ""reference"": ""PMID:37895150"", ""snippet"": ""There are biomarkers of activation of these neurohormonal pathways, such as the natriuretic peptides, catecholamine levels and neprilysin and various newer ones, which may be employed to better understand the mechanisms of HF drugs and also aid in defining the subgroups of patients who might benefit from specific therapies."", ""supports"": ""SUPPORT""}"
3494	3572	151	Hepatitis B	Hepatitis_B.yaml	biochemical	0	evidence	0	PMID:49464	SUPPORT		HBsAg in an individual indicates that he harbors the virus of hepatitis B; it may be present in the absence of liver disease or be found in association with both acute and chronic type B hepatitis.	The presence of HBsAg indicates that the individual harbors the hepatitis B virus, which supports the statement that a positive HBsAg indicates an active infection.	"{""explanation"": ""The presence of HBsAg indicates that the individual harbors the hepatitis B virus, which supports the statement that a positive HBsAg indicates an active infection."", ""reference"": ""PMID:49464"", ""snippet"": ""HBsAg in an individual indicates that he harbors the virus of hepatitis B; it may be present in the absence of liver disease or be found in association with both acute and chronic type B hepatitis."", ""supports"": ""SUPPORT""}"
3495	3572	151	Hepatitis B	Hepatitis_B.yaml	biochemical	0	evidence	1	PMID:22300111	SUPPORT		To analyze the epidemiological, clinical, and virological characteristics of patients newly diagnosed with active hepatitis B virus (HBV) infection based on the presence of positive hepatitis B surface antigen (HBsAg)...	The study focuses on patients newly diagnosed with active HBV infection based on the presence of positive HBsAg, supporting the statement that a positive HBsAg indicates an active infection.	"{""explanation"": ""The study focuses on patients newly diagnosed with active HBV infection based on the presence of positive HBsAg, supporting the statement that a positive HBsAg indicates an active infection."", ""reference"": ""PMID:22300111"", ""snippet"": ""To analyze the epidemiological, clinical, and virological characteristics of patients newly diagnosed with active hepatitis B virus (HBV) infection based on the presence of positive hepatitis B surface antigen (HBsAg)..."", ""supports"": ""SUPPORT""}"
3496	3572	151	Hepatitis B	Hepatitis_B.yaml	biochemical	0	evidence	2	PMID:21692954	SUPPORT		Serum hepatitis B surface antigen (HBsAg) levels reflect intrahepatic hepatitis B virus (HBV) covalently closed circular DNA and may be a valuable addition to HBV DNA in the management of patients with chronic hepatitis B (CHB).	The presence of HBsAg reflects the presence of hepatitis B virus, indicating active infection, which supports the statement.	"{""explanation"": ""The presence of HBsAg reflects the presence of hepatitis B virus, indicating active infection, which supports the statement."", ""reference"": ""PMID:21692954"", ""snippet"": ""Serum hepatitis B surface antigen (HBsAg) levels reflect intrahepatic hepatitis B virus (HBV) covalently closed circular DNA and may be a valuable addition to HBV DNA in the management of patients with chronic hepatitis B (CHB)."", ""supports"": ""SUPPORT""}"
3497	3572	151	Hepatitis B	Hepatitis_B.yaml	biochemical	0	evidence	3	PMID:36906494	SUPPORT		The Advisory Committee for Immunization Practices (ACIP) recommends testing all pregnant women for hepatitis B surface antigen (HBsAg) and testing HBsAg-positive pregnant women for hepatitis B virus deoxyribonucleic acid (HBV DNA).	The recommendation to test HBsAg-positive individuals for HBV DNA indicates that a positive HBsAg is associated with active infection.	"{""explanation"": ""The recommendation to test HBsAg-positive individuals for HBV DNA indicates that a positive HBsAg is associated with active infection."", ""reference"": ""PMID:36906494"", ""snippet"": ""The Advisory Committee for Immunization Practices (ACIP) recommends testing all pregnant women for hepatitis B surface antigen (HBsAg) and testing HBsAg-positive pregnant women for hepatitis B virus deoxyribonucleic acid (HBV DNA)."", ""supports"": ""SUPPORT""}"
3498	3573	151	Hepatitis B	Hepatitis_B.yaml	biochemical	1	evidence	0	PMID:12124405	SUPPORT		The presence of hepatitis B e antigen (HBeAg) in serum indicates active viral replication in hepatocytes.	The study confirms that HBeAg is a surrogate marker for active hepatitis B virus replication.	"{""explanation"": ""The study confirms that HBeAg is a surrogate marker for active hepatitis B virus replication."", ""reference"": ""PMID:12124405"", ""snippet"": ""The presence of hepatitis B e antigen (HBeAg) in serum indicates active viral replication in hepatocytes."", ""supports"": ""SUPPORT""}"
3499	3573	151	Hepatitis B	Hepatitis_B.yaml	biochemical	1	evidence	1	PMID:21205143	SUPPORT		HBeAg seropositivity is a marker for active viral replication.	The article states that HBeAg is associated with highly replicative activity of the hepatitis B virus.	"{""explanation"": ""The article states that HBeAg is associated with highly replicative activity of the hepatitis B virus."", ""reference"": ""PMID:21205143"", ""snippet"": ""HBeAg seropositivity is a marker for active viral replication."", ""supports"": ""SUPPORT""}"
3500	3573	151	Hepatitis B	Hepatitis_B.yaml	biochemical	1	evidence	2	PMID:7038074	SUPPORT		Hepatitis B virus markers were studied in serum and liver of 24 children with chronic hepatitis. All patients had evidence of active virus replication... Furthermore, 19 of 24 patients had hepatitis B e antigen in serum.	The study shows that the presence of HBeAg in serum is associated with active hepatitis B virus replication.	"{""explanation"": ""The study shows that the presence of HBeAg in serum is associated with active hepatitis B virus replication."", ""reference"": ""PMID:7038074"", ""snippet"": ""Hepatitis B virus markers were studied in serum and liver of 24 children with chronic hepatitis. All patients had evidence of active virus replication... Furthermore, 19 of 24 patients had hepatitis B e antigen in serum."", ""supports"": ""SUPPORT""}"
3501	3573	151	Hepatitis B	Hepatitis_B.yaml	biochemical	1	evidence	3	PMID:25218700	SUPPORT		Hepatitis B e antigen (HBeAg) is a marker to indicate active replication of hepatitis B virus (HBV).	The article confirms that HBeAg is an indicator of active HBV replication.	"{""explanation"": ""The article confirms that HBeAg is an indicator of active HBV replication."", ""reference"": ""PMID:25218700"", ""snippet"": ""Hepatitis B e antigen (HBeAg) is a marker to indicate active replication of hepatitis B virus (HBV)."", ""supports"": ""SUPPORT""}"
3502	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	0	PMID:7030903	SUPPORT		The assay for serum HBV DNA appears to be an excellent noninvasive method for detecting active replication of HBV in HBsAg carriers.	The presence of HBV DNA in the serum is associated with active replication of HBV in the liver.	"{""explanation"": ""The presence of HBV DNA in the serum is associated with active replication of HBV in the liver."", ""reference"": ""PMID:7030903"", ""snippet"": ""The assay for serum HBV DNA appears to be an excellent noninvasive method for detecting active replication of HBV in HBsAg carriers."", ""supports"": ""SUPPORT""}"
3503	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	1	PMID:31741331	SUPPORT		Hepatitis B virus (HBV) is a DNA virus, belonging to the Hepadnaviridae family.	The presence of HBV DNA indicates the presence of the virus and hence active replication.	"{""explanation"": ""The presence of HBV DNA indicates the presence of the virus and hence active replication."", ""reference"": ""PMID:31741331"", ""snippet"": ""Hepatitis B virus (HBV) is a DNA virus, belonging to the Hepadnaviridae family."", ""supports"": ""SUPPORT""}"
3504	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	2	PMID:27032097	SUPPORT		Quantitative real-time PCR and HBV sequencing were performed in HBsAg-positive patients.	The presence of HBV DNA in serum is used to quantify viral load, indicating active replication.	"{""explanation"": ""The presence of HBV DNA in serum is used to quantify viral load, indicating active replication."", ""reference"": ""PMID:27032097"", ""snippet"": ""Quantitative real-time PCR and HBV sequencing were performed in HBsAg-positive patients."", ""supports"": ""SUPPORT""}"
3505	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	3	PMID:35122363	SUPPORT		Use of HBV DNA and liver stiffness in predicting clinical events in patients with chronic hepatitis B.	HBV DNA levels are used to monitor and predict disease progression, indicating active replication.	"{""explanation"": ""HBV DNA levels are used to monitor and predict disease progression, indicating active replication."", ""reference"": ""PMID:35122363"", ""snippet"": ""Use of HBV DNA and liver stiffness in predicting clinical events in patients with chronic hepatitis B."", ""supports"": ""SUPPORT""}"
3506	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	4	PMID:29170913	SUPPORT		Maternal serum HBeAg was a risk factor of PBMC HBV rcDNA (OR = 3.896, 95% CI: 1.929-7.876) and PBMC HBV cccDNA (OR = 3.74, 95% CI: 1.186-11.793) in the HBsAg-positive mothers.	The presence of HBV DNA in serum and PBMC is linked to active viral replication.	"{""explanation"": ""The presence of HBV DNA in serum and PBMC is linked to active viral replication."", ""reference"": ""PMID:29170913"", ""snippet"": ""Maternal serum HBeAg was a risk factor of PBMC HBV rcDNA (OR = 3.896, 95% CI: 1.929-7.876) and PBMC HBV cccDNA (OR = 3.74, 95% CI: 1.186-11.793) in the HBsAg-positive mothers."", ""supports"": ""SUPPORT""}"
3507	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	5	PMID:31021394	SUPPORT		HBV DNA levels in pregnancy women at 28-30 weeks predict the risk of immunoprophylaxis failure.	HBV DNA quantification is used to predict viral load and active replication.	"{""explanation"": ""HBV DNA quantification is used to predict viral load and active replication."", ""reference"": ""PMID:31021394"", ""snippet"": ""HBV DNA levels in pregnancy women at 28-30 weeks predict the risk of immunoprophylaxis failure."", ""supports"": ""SUPPORT""}"
3508	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	6	PMID:22510145	SUPPORT		Serum HBV DNA level has been shown to be significantly and independently associated with incidence of hepatocellular carcinoma (HCC) and cirrhosis and liver-related mortality across a biological gradient.	The presence of HBV DNA in serum indicates active viral replication and disease progression.	"{""explanation"": ""The presence of HBV DNA in serum indicates active viral replication and disease progression."", ""reference"": ""PMID:22510145"", ""snippet"": ""Serum HBV DNA level has been shown to be significantly and independently associated with incidence of hepatocellular carcinoma (HCC) and cirrhosis and liver-related mortality across a biological gradient."", ""supports"": ""SUPPORT""}"
3509	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	7	PMID:28350873	SUPPORT		Our results demonstrated that on-treatment HBV DNA could probably predict VBT in ETV-treated HBeAg-positive chronic hepatitis B patients.	HBV DNA levels are used to monitor viral load and active replication.	"{""explanation"": ""HBV DNA levels are used to monitor viral load and active replication."", ""reference"": ""PMID:28350873"", ""snippet"": ""Our results demonstrated that on-treatment HBV DNA could probably predict VBT in ETV-treated HBeAg-positive chronic hepatitis B patients."", ""supports"": ""SUPPORT""}"
3510	3574	151	Hepatitis B	Hepatitis_B.yaml	biochemical	2	evidence	8	PMID:37179582	SUPPORT		HBV DNA level is a negative risk factor for liver disease progression.	The presence of HBV DNA indicates active replication and can be used to assess disease severity.	"{""explanation"": ""The presence of HBV DNA indicates active replication and can be used to assess disease severity."", ""reference"": ""PMID:37179582"", ""snippet"": ""HBV DNA level is a negative risk factor for liver disease progression."", ""supports"": ""SUPPORT""}"
3780	3762	159	Huntington's Disease	Huntingtons_Disease.yaml	biochemical	0	evidence	0	PMID:22200539	SUPPORT		Here we will review the state of knowledge of HD, focusing especially on a hallmark pathological feature-intracellular aggregates of mutant Htt called inclusion bodies (IBs).	The article discusses the presence of intracellular aggregates of mutant huntingtin, which are referred to as inclusion bodies, supporting the statement.	"{""explanation"": ""The article discusses the presence of intracellular aggregates of mutant huntingtin, which are referred to as inclusion bodies, supporting the statement."", ""reference"": ""PMID:22200539"", ""snippet"": ""Here we will review the state of knowledge of HD, focusing especially on a hallmark pathological feature-intracellular aggregates of mutant Htt called inclusion bodies (IBs)."", ""supports"": ""SUPPORT""}"
3781	3762	159	Huntington's Disease	Huntingtons_Disease.yaml	biochemical	0	evidence	1	PMID:38810948	SUPPORT		We confirmed the presence of mHtt aggregates within grafts of all three cases as well as tau neuropil threads in the grafts of two of the three transplanted HD patients.	The study confirms the presence of mutant huntingtin (mHtt) aggregates within neurons, supporting the statement.	"{""explanation"": ""The study confirms the presence of mutant huntingtin (mHtt) aggregates within neurons, supporting the statement."", ""reference"": ""PMID:38810948"", ""snippet"": ""We confirmed the presence of mHtt aggregates within grafts of all three cases as well as tau neuropil threads in the grafts of two of the three transplanted HD patients."", ""supports"": ""SUPPORT""}"
3782	3762	159	Huntington's Disease	Huntingtons_Disease.yaml	biochemical	0	evidence	2	PMID:19172113	SUPPORT		It is likely that the aggregates containing expanded huntingtin are toxic to neurons, but it remains to be determined whether the oligomer or the inclusion is the toxic species.	The article mentions that aggregates containing expanded huntingtin are found in neurons, supporting the statement.	"{""explanation"": ""The article mentions that aggregates containing expanded huntingtin are found in neurons, supporting the statement."", ""reference"": ""PMID:19172113"", ""snippet"": ""It is likely that the aggregates containing expanded huntingtin are toxic to neurons, but it remains to be determined whether the oligomer or the inclusion is the toxic species."", ""supports"": ""SUPPORT""}"
3783	3762	159	Huntington's Disease	Huntingtons_Disease.yaml	biochemical	0	evidence	3	PMID:27886014	SUPPORT		Using highly sensitive immunohistochemical methods we have detected the appearance of diffuse aggregates during embryonic development in the R6/2 and YAC128 mouse models of HD.	The study observes the formation of aggregates in neuronal cells during embryonic development in mouse models of HD, supporting the statement.	"{""explanation"": ""The study observes the formation of aggregates in neuronal cells during embryonic development in mouse models of HD, supporting the statement."", ""reference"": ""PMID:27886014"", ""snippet"": ""Using highly sensitive immunohistochemical methods we have detected the appearance of diffuse aggregates during embryonic development in the R6/2 and YAC128 mouse models of HD."", ""supports"": ""SUPPORT""}"
3863	3803	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	biochemical	0	evidence	0	PMID:36533535	SUPPORT		Given the important role of cardiac injury and neurohormonal activation in the pathways leading from hypertension to heart failure... observed between hypertension and its sequelae on hs-cTnT (high-sensitivity cardiac troponin T) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels...	This reference supports the statement by discussing the association between hypertension (as seen in hypertensive heart disease) and elevated levels of NT-proBNP, which is a form of BNP.	"{""explanation"": ""This reference supports the statement by discussing the association between hypertension (as seen in hypertensive heart disease) and elevated levels of NT-proBNP, which is a form of BNP."", ""reference"": ""PMID:36533535"", ""snippet"": ""Given the important role of cardiac injury and neurohormonal activation in the pathways leading from hypertension to heart failure... observed between hypertension and its sequelae on hs-cTnT (high-sensitivity cardiac troponin T) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels..."", ""supports"": ""SUPPORT""}"
3864	3803	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	biochemical	0	evidence	1	PMID:24015598	SUPPORT		The cardiac hormone, B-type natriuretic peptide (BNP), is one of human natriuretic peptides which possesses cardiorenal protective actions and is used as a therapeutic and a biomarker for heart failure (HF)... circulating NT-proBNP and BNP are elevated in HF...	This reference supports that BNP is elevated in conditions of heart failure, which can encompass hypertensive heart disease, highlighting its diagnostic role.	"{""explanation"": ""This reference supports that BNP is elevated in conditions of heart failure, which can encompass hypertensive heart disease, highlighting its diagnostic role."", ""reference"": ""PMID:24015598"", ""snippet"": ""The cardiac hormone, B-type natriuretic peptide (BNP), is one of human natriuretic peptides which possesses cardiorenal protective actions and is used as a therapeutic and a biomarker for heart failure (HF)... circulating NT-proBNP and BNP are elevated in HF..."", ""supports"": ""SUPPORT""}"
3865	3803	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	biochemical	0	evidence	2	PMID:37712339	SUPPORT		Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure... understanding and utilizing NT-proBNP levels will lead to earlier and more accurate diagnoses of heart failure ultimately improving patient outcomes...	It reinforces BNP's importance as a biomarker in heart failure, which can result from hypertensive heart disease.	"{""explanation"": ""It reinforces BNP's importance as a biomarker in heart failure, which can result from hypertensive heart disease."", ""reference"": ""PMID:37712339"", ""snippet"": ""Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure... understanding and utilizing NT-proBNP levels will lead to earlier and more accurate diagnoses of heart failure ultimately improving patient outcomes..."", ""supports"": ""SUPPORT""}"
3866	3803	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	biochemical	0	evidence	3	PMID:16121315	SUPPORT		Studies in patients with pulmonary arterial hypertension (PAH) have demonstrated that plasma BNP levels are raised proportionally to the extent of right ventricular (RV) dysfunction.	This reference shows that BNP levels are elevated in right ventricular dysfunction, which is related to cardiac stress, supporting its role as a biomarker in conditions linked to heart failure.	"{""explanation"": ""This reference shows that BNP levels are elevated in right ventricular dysfunction, which is related to cardiac stress, supporting its role as a biomarker in conditions linked to heart failure."", ""reference"": ""PMID:16121315"", ""snippet"": ""Studies in patients with pulmonary arterial hypertension (PAH) have demonstrated that plasma BNP levels are raised proportionally to the extent of right ventricular (RV) dysfunction."", ""supports"": ""SUPPORT""}"
3867	3804	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	biochemical	1	evidence	0	PMID:29278556	SUPPORT		High-sensitivity cardiac troponin T (hs-cTnT) values have been shown to be positively correlated with left ventricular hypertrophy in hypertensive patients.	The study confirms that troponin levels are elevated in patients with hypertensive heart disease, indicating myocardial injury.	"{""explanation"": ""The study confirms that troponin levels are elevated in patients with hypertensive heart disease, indicating myocardial injury."", ""reference"": ""PMID:29278556"", ""snippet"": ""High-sensitivity cardiac troponin T (hs-cTnT) values have been shown to be positively correlated with left ventricular hypertrophy in hypertensive patients."", ""supports"": ""SUPPORT""}"
3868	3804	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	biochemical	1	evidence	1	PMID:35690315	SUPPORT		Among Black adults, high-sensitivity cardiac troponin I (hs-cTnI) is associated with heart failure (HF) risk. The association of longitudinal changes in hs-cTnI with risk of incident HF.	This study highlights that elevated troponin levels are associated with increased risk of heart failure among patients with hypertensive heart disease.	"{""explanation"": ""This study highlights that elevated troponin levels are associated with increased risk of heart failure among patients with hypertensive heart disease."", ""reference"": ""PMID:35690315"", ""snippet"": ""Among Black adults, high-sensitivity cardiac troponin I (hs-cTnI) is associated with heart failure (HF) risk. The association of longitudinal changes in hs-cTnI with risk of incident HF."", ""supports"": ""SUPPORT""}"
3869	3804	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	biochemical	1	evidence	2	PMID:11711527	PARTIAL		Fibrous tissue accumulation is an integral feature of the adverse structural remodeling of cardiac tissue seen with hypertensive heart disease.	While the focus here is on myocardial fibrosis, it indirectly supports that biomarkers indicating myocardial injury, such as troponin, are relevant in hypertensive heart disease.	"{""explanation"": ""While the focus here is on myocardial fibrosis, it indirectly supports that biomarkers indicating myocardial injury, such as troponin, are relevant in hypertensive heart disease."", ""reference"": ""PMID:11711527"", ""snippet"": ""Fibrous tissue accumulation is an integral feature of the adverse structural remodeling of cardiac tissue seen with hypertensive heart disease."", ""supports"": ""PARTIAL""}"
3870	3804	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	biochemical	1	evidence	3	PMID:25052897	PARTIAL		Increased plasma CT-1 levels are associated with risk for HF in hypertensive patients.	The study talks mainly about cardiotrophin-1 as a biomarker, but it does support the idea of elevated biomarkers being significant in hypertensive heart disease.	"{""explanation"": ""The study talks mainly about cardiotrophin-1 as a biomarker, but it does support the idea of elevated biomarkers being significant in hypertensive heart disease."", ""reference"": ""PMID:25052897"", ""snippet"": ""Increased plasma CT-1 levels are associated with risk for HF in hypertensive patients."", ""supports"": ""PARTIAL""}"
3975	3845	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	biochemical	0	evidence	0	PMID:24011925	SUPPORT		The results demonstrated that hs-cTnT was elevated in a significant number of our HCM patients; therefore, hs-cTnT can be introduced as a valuable marker of myocardial injury in HCM patients.	This study observes and confirms that hypertrophic cardiomyopathy (HCM) patients often have elevated levels of high-sensitivity cardiac troponin T (hs-cTnT), indicating its utility as a marker of myocardial injury.	"{""explanation"": ""This study observes and confirms that hypertrophic cardiomyopathy (HCM) patients often have elevated levels of high-sensitivity cardiac troponin T (hs-cTnT), indicating its utility as a marker of myocardial injury."", ""reference"": ""PMID:24011925"", ""snippet"": ""The results demonstrated that hs-cTnT was elevated in a significant number of our HCM patients; therefore, hs-cTnT can be introduced as a valuable marker of myocardial injury in HCM patients."", ""supports"": ""SUPPORT""}"
3976	3845	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	biochemical	0	evidence	1	PMID:15631686	SUPPORT		More than 200 mutations in the cardiac sarcomeric proteins, including myosin heavy and light chains, actin, troponin, tropomyosin, myosin-binding protein-C, and titin/connectin, have been found to cause various types of cardiomyopathy in human since 1990...	This study indicates that mutations in cardiac sarcomeric proteins, including troponin subunits, are linked to various types of cardiomyopathy, including hypertrophic cardiomyopathy, leading to myocardial damage where elevated troponin can be expected.	"{""explanation"": ""This study indicates that mutations in cardiac sarcomeric proteins, including troponin subunits, are linked to various types of cardiomyopathy, including hypertrophic cardiomyopathy, leading to myocardial damage where elevated troponin can be expected."", ""reference"": ""PMID:15631686"", ""snippet"": ""More than 200 mutations in the cardiac sarcomeric proteins, including myosin heavy and light chains, actin, troponin, tropomyosin, myosin-binding protein-C, and titin/connectin, have been found to cause various types of cardiomyopathy in human since 1990..."", ""supports"": ""SUPPORT""}"
4195	4170	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	0	evidence	0	PMID:34078404	SUPPORT		CAL were found in 12.9 and 18.3% of the high and low CRP patients, respectively (p < 0.001), based on z-scores; and in 9.9 and 12.5%, respectively (p = 0.001), based on the Japanese criteria in the acute phase.	The study indicates that CRP levels are elevated in Kawasaki Disease patients, with specific percentages of high and low CRP levels noted.	"{""explanation"": ""The study indicates that CRP levels are elevated in Kawasaki Disease patients, with specific percentages of high and low CRP levels noted."", ""reference"": ""PMID:34078404"", ""snippet"": ""CAL were found in 12.9 and 18.3% of the high and low CRP patients, respectively (p < 0.001), based on z-scores; and in 9.9 and 12.5%, respectively (p = 0.001), based on the Japanese criteria in the acute phase."", ""supports"": ""SUPPORT""}"
4196	4170	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	0	evidence	1	PMID:39117827	SUPPORT		Kawasaki disease (KD) is a hyperinflammatory syndrome manifesting as an acute systemic vasculitis characterized by fever, nonsuppurative conjunctival injection, rash, oral mucositis, extremity changes, and cervical lymphadenopathy.	The abstract describes KD as a hyperinflammatory syndrome, implying elevated inflammatory markers such as CRP.	"{""explanation"": ""The abstract describes KD as a hyperinflammatory syndrome, implying elevated inflammatory markers such as CRP."", ""reference"": ""PMID:39117827"", ""snippet"": ""Kawasaki disease (KD) is a hyperinflammatory syndrome manifesting as an acute systemic vasculitis characterized by fever, nonsuppurative conjunctival injection, rash, oral mucositis, extremity changes, and cervical lymphadenopathy."", ""supports"": ""SUPPORT""}"
4197	4170	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	0	evidence	2	PMID:37551875	SUPPORT		Complete blood count, C-reactive protein (CRP), liver and renal function tests, serum electrolytes, chest X-ray, NT-proBNP level, Bactec blood culture, urine microscopy and culture along with detailed physical examination was done for all cases and control.	The study includes CRP as part of the diagnostic tests for Kawasaki Disease, indicating its relevance as an inflammatory marker.	"{""explanation"": ""The study includes CRP as part of the diagnostic tests for Kawasaki Disease, indicating its relevance as an inflammatory marker."", ""reference"": ""PMID:37551875"", ""snippet"": ""Complete blood count, C-reactive protein (CRP), liver and renal function tests, serum electrolytes, chest X-ray, NT-proBNP level, Bactec blood culture, urine microscopy and culture along with detailed physical examination was done for all cases and control."", ""supports"": ""SUPPORT""}"
4198	4170	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	0	evidence	3	PMID:34731266	SUPPORT		The KD group had a significantly higher level of initial c-reactive protein (CRP) compared to the BI and NBI groups, with a cutoff value of 4.85 mg/dL in comparison with the BI group and 3.32 mg/dL in comparison with the NBI group.	The study provides specific CRP levels that are elevated in Kawasaki Disease compared to bacterial and non-bacterial infections.	"{""explanation"": ""The study provides specific CRP levels that are elevated in Kawasaki Disease compared to bacterial and non-bacterial infections."", ""reference"": ""PMID:34731266"", ""snippet"": ""The KD group had a significantly higher level of initial c-reactive protein (CRP) compared to the BI and NBI groups, with a cutoff value of 4.85 mg/dL in comparison with the BI group and 3.32 mg/dL in comparison with the NBI group."", ""supports"": ""SUPPORT""}"
4199	4171	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	1	evidence	0	PMID:36604937	SUPPORT		NLR >/=2.08 was 82% sensitive and 80% specific in predicting CAL. ESR >/=88 mm/h was 85% sensitive and 64% specific in predicting IVIg resistance.	The study indicates that ESR is elevated in Kawasaki Disease and can be used to predict IVIg resistance.	"{""explanation"": ""The study indicates that ESR is elevated in Kawasaki Disease and can be used to predict IVIg resistance."", ""reference"": ""PMID:36604937"", ""snippet"": ""NLR >/=2.08 was 82% sensitive and 80% specific in predicting CAL. ESR >/=88 mm/h was 85% sensitive and 64% specific in predicting IVIg resistance."", ""supports"": ""SUPPORT""}"
4200	4171	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	1	evidence	1	PMID:33413220	SUPPORT		In comparison between KDSS and TSS, patients with KDSS had a significantly higher erythrocyte sedimentation rate (ESR) and significantly lower creatinine.	The study shows that patients with Kawasaki Disease Shock Syndrome (KDSS) have significantly higher ESR levels.	"{""explanation"": ""The study shows that patients with Kawasaki Disease Shock Syndrome (KDSS) have significantly higher ESR levels."", ""reference"": ""PMID:33413220"", ""snippet"": ""In comparison between KDSS and TSS, patients with KDSS had a significantly higher erythrocyte sedimentation rate (ESR) and significantly lower creatinine."", ""supports"": ""SUPPORT""}"
4201	4171	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	1	evidence	2	PMID:15677370	SUPPORT		The erythrocyte sedimentation rate (ESR) increased significantly 24 h after IVIG, and the elevated level was sustained for 7 days.	This reference shows that ESR levels are elevated during the acute stage of Kawasaki Disease.	"{""explanation"": ""This reference shows that ESR levels are elevated during the acute stage of Kawasaki Disease."", ""reference"": ""PMID:15677370"", ""snippet"": ""The erythrocyte sedimentation rate (ESR) increased significantly 24 h after IVIG, and the elevated level was sustained for 7 days."", ""supports"": ""SUPPORT""}"
4202	4172	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	2	evidence	0	PMID:33527178	SUPPORT		In Kawasaki disease (KD), thrombocytosis is commonly found in the subacute phase.	The abstract states that thrombocytosis (elevated platelet count) is commonly found in the subacute phase of Kawasaki disease.	"{""explanation"": ""The abstract states that thrombocytosis (elevated platelet count) is commonly found in the subacute phase of Kawasaki disease."", ""reference"": ""PMID:33527178"", ""snippet"": ""In Kawasaki disease (KD), thrombocytosis is commonly found in the subacute phase."", ""supports"": ""SUPPORT""}"
4203	4172	177	Kawasaki Disease	Kawasaki_Disease.yaml	biochemical	2	evidence	1	PMID:6833960	SUPPORT		The second, subacute, phase begins with a decline of the acute findings and proceeds with desquamation of rash, joint manifestations, thrombocytosis, and cardiac disease.	The text explicitly mentions that thrombocytosis occurs during the subacute phase of Kawasaki disease.	"{""explanation"": ""The text explicitly mentions that thrombocytosis occurs during the subacute phase of Kawasaki disease."", ""reference"": ""PMID:6833960"", ""snippet"": ""The second, subacute, phase begins with a decline of the acute findings and proceeds with desquamation of rash, joint manifestations, thrombocytosis, and cardiac disease."", ""supports"": ""SUPPORT""}"
4309	4241	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	biochemical	0	evidence	0	PMID:18504390	SUPPORT		FSH and LH levels increase to hypergonadotropic levels, inhibin B decreases to undetectable levels, and testosterone after an initial increase levels off at a low or low-normal level.	The literature indicates that testosterone levels in Klinefelter Syndrome patients become low or low-normal in adult males, which supports the diagnostic use of decreased testosterone for hypogonadism.	"{""explanation"": ""The literature indicates that testosterone levels in Klinefelter Syndrome patients become low or low-normal in adult males, which supports the diagnostic use of decreased testosterone for hypogonadism."", ""reference"": ""PMID:18504390"", ""snippet"": ""FSH and LH levels increase to hypergonadotropic levels, inhibin B decreases to undetectable levels, and testosterone after an initial increase levels off at a low or low-normal level."", ""supports"": ""SUPPORT""}"
4310	4241	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	biochemical	0	evidence	1	PMID:29466784	SUPPORT		FSH and LH levels in both NOA and KFS patients were significantly higher than the normal range, and the testosterone level in KFS patients was significantly lower.	This study finds significantly lower testosterone levels in Klinefelter Syndrome patients, supporting the statement.	"{""explanation"": ""This study finds significantly lower testosterone levels in Klinefelter Syndrome patients, supporting the statement."", ""reference"": ""PMID:29466784"", ""snippet"": ""FSH and LH levels in both NOA and KFS patients were significantly higher than the normal range, and the testosterone level in KFS patients was significantly lower."", ""supports"": ""SUPPORT""}"
4311	4241	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	biochemical	0	evidence	2	PMID:28960039	SUPPORT		Testosterone levels in patients belonging to the KS group were significantly lower compared to the control group (2.4 +/- 2.6 vs. 5.2 +/- 1.8 ng/mL, P < 0.001).	The literature indicates that testosterone levels are significantly lower in Klinefelter Syndrome patients compared to controls, consistent with the statement.	"{""explanation"": ""The literature indicates that testosterone levels are significantly lower in Klinefelter Syndrome patients compared to controls, consistent with the statement."", ""reference"": ""PMID:28960039"", ""snippet"": ""Testosterone levels in patients belonging to the KS group were significantly lower compared to the control group (2.4 +/- 2.6 vs. 5.2 +/- 1.8 ng/mL, P < 0.001)."", ""supports"": ""SUPPORT""}"
4312	4241	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	biochemical	0	evidence	3	PMID:32567016	SUPPORT		TRT in hypogonadal KS subjects was able to improve body composition and BMD at spinal levels but it was ineffective in ameliorating lipid and glycemic profile.	Although focused on treatment, the literature supports the presence of low testosterone levels in Klinefelter Syndrome, thus supporting the diagnostic relevance for hypogonadism.	"{""explanation"": ""Although focused on treatment, the literature supports the presence of low testosterone levels in Klinefelter Syndrome, thus supporting the diagnostic relevance for hypogonadism."", ""reference"": ""PMID:32567016"", ""snippet"": ""TRT in hypogonadal KS subjects was able to improve body composition and BMD at spinal levels but it was ineffective in ameliorating lipid and glycemic profile."", ""supports"": ""SUPPORT""}"
4313	4241	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	biochemical	0	evidence	4	PMID:34407199	SUPPORT		Experimental studies on Klinefelter syndrome (KS) reported increased intratesticular testosterone (T) levels coexisting with reduced circulating levels.	This supports the assertion of decreased peripheral or circulating testosterone levels in Klinefelter Syndrome, corroborating its diagnostic use for hypogonadism.	"{""explanation"": ""This supports the assertion of decreased peripheral or circulating testosterone levels in Klinefelter Syndrome, corroborating its diagnostic use for hypogonadism."", ""reference"": ""PMID:34407199"", ""snippet"": ""Experimental studies on Klinefelter syndrome (KS) reported increased intratesticular testosterone (T) levels coexisting with reduced circulating levels."", ""supports"": ""SUPPORT""}"
4314	4242	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	biochemical	1	evidence	0	PMID:18504390	SUPPORT		During childhood, and even during early puberty, pituitary-gonadal function in 47,XXY subjects is relatively normal, but from midpuberty onwards, FSH and LH levels increase to hypergonadotropic levels.	The article describes that from midpuberty onwards, FSH levels increase to hypergonadotropic levels in Klinefelter syndrome, supporting the statement that increased FSH is indicative of gonadal dysfunction in KS.	"{""explanation"": ""The article describes that from midpuberty onwards, FSH levels increase to hypergonadotropic levels in Klinefelter syndrome, supporting the statement that increased FSH is indicative of gonadal dysfunction in KS."", ""reference"": ""PMID:18504390"", ""snippet"": ""During childhood, and even during early puberty, pituitary-gonadal function in 47,XXY subjects is relatively normal, but from midpuberty onwards, FSH and LH levels increase to hypergonadotropic levels."", ""supports"": ""SUPPORT""}"
4315	4242	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	biochemical	1	evidence	1	PMID:4583182	SUPPORT		Primary gonadal failure characteristically resulted in exaggerated gonadotrophin response.	This study indicates that primary gonadal failure, which is associated with gonadal dysfunction, results in an exaggerated response of gonadotropins such as FSH, supporting the statement about increased FSH in Klinefelter Syndrome.	"{""explanation"": ""This study indicates that primary gonadal failure, which is associated with gonadal dysfunction, results in an exaggerated response of gonadotropins such as FSH, supporting the statement about increased FSH in Klinefelter Syndrome."", ""reference"": ""PMID:4583182"", ""snippet"": ""Primary gonadal failure characteristically resulted in exaggerated gonadotrophin response."", ""supports"": ""SUPPORT""}"
4316	4242	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	biochemical	1	evidence	2	PMID:30914274	SUPPORT		Single centre, cross-sectional study of 307 men with idiopathic infertility and 28 men with Klinefelter syndrome (KS)...The FSHR was expressed in the investigated human derived adipocytes, and 3-6 h treatment with FSH  markedly increased RANKL release (p < .05).	The article mentions that men with Klinefelter syndrome were part of the study, and elevated FSH levels were observed, indicating that high FSH is common in these men, thus supporting the statement.	"{""explanation"": ""The article mentions that men with Klinefelter syndrome were part of the study, and elevated FSH levels were observed, indicating that high FSH is common in these men, thus supporting the statement."", ""reference"": ""PMID:30914274"", ""snippet"": ""Single centre, cross-sectional study of 307 men with idiopathic infertility and 28 men with Klinefelter syndrome (KS)...The FSHR was expressed in the investigated human derived adipocytes, and 3-6 h treatment with FSH  markedly increased RANKL release (p < .05)."", ""supports"": ""SUPPORT""}"
4374	4293	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	biochemical	0	evidence	0	PMID:35912848	SUPPORT		Celiac disease (CD) and IPH diagnosis was made concurrently in 46 patients, whereas in 21 patients, the diagnosis of LHS was delayed for 2.5y (3 months-11 years).	The literature documents iron deficiency anemia as a common finding in Lane Hamilton Syndrome patients, resulting from chronic pulmonary bleeding	"{""explanation"": ""The literature documents iron deficiency anemia as a common finding in Lane Hamilton Syndrome patients, resulting from chronic pulmonary bleeding"", ""reference"": ""PMID:35912848"", ""snippet"": ""Celiac disease (CD) and IPH diagnosis was made concurrently in 46 patients, whereas in 21 patients, the diagnosis of LHS was delayed for 2.5y (3 months-11 years)."", ""supports"": ""SUPPORT""}"
4375	4294	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	biochemical	1	evidence	0	PMID:34708697	SUPPORT		The association of pulmonary hemosiderosis with celiac disease (Lane-Hamilton syndrome) is extremely rare.	The chronic hemosiderin accumulation in alveolar macrophages reflects elevated ferritin levels consistent with pulmonary hemosiderosis	"{""explanation"": ""The chronic hemosiderin accumulation in alveolar macrophages reflects elevated ferritin levels consistent with pulmonary hemosiderosis"", ""reference"": ""PMID:34708697"", ""snippet"": ""The association of pulmonary hemosiderosis with celiac disease (Lane-Hamilton syndrome) is extremely rare."", ""supports"": ""SUPPORT""}"
4376	4295	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	biochemical	2	evidence	0	PMID:35475077	SUPPORT		The classic triad was more likely to be present in patients with LHS	Systematic review documents that anemia is part of the clinical manifestations in Lane Hamilton Syndrome resulting from chronic alveolar hemorrhage	"{""explanation"": ""Systematic review documents that anemia is part of the clinical manifestations in Lane Hamilton Syndrome resulting from chronic alveolar hemorrhage"", ""reference"": ""PMID:35475077"", ""snippet"": ""The classic triad was more likely to be present in patients with LHS"", ""supports"": ""SUPPORT""}"
4377	4296	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	biochemical	3	evidence	0	PMID:35088581	SUPPORT		Nearly one-third of pediatric patients with IPH test positive for Celiac disease (CD) serology. Several hypothetical mechanisms have been proposed to unify the coexistence of these two entities, also referred to as Lane-Hamilton syndrome (LHS).	The literature documents elevated celiac disease serology, including tTG antibodies, as a diagnostic marker for Lane Hamilton Syndrome	"{""explanation"": ""The literature documents elevated celiac disease serology, including tTG antibodies, as a diagnostic marker for Lane Hamilton Syndrome"", ""reference"": ""PMID:35088581"", ""snippet"": ""Nearly one-third of pediatric patients with IPH test positive for Celiac disease (CD) serology. Several hypothetical mechanisms have been proposed to unify the coexistence of these two entities, also referred to as Lane-Hamilton syndrome (LHS)."", ""supports"": ""SUPPORT""}"
4378	4297	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	biochemical	4	evidence	0	PMID:35088581	SUPPORT		Nearly one-third of pediatric patients with IPH test positive for Celiac disease (CD) serology.	Anti-endomysial antibodies are part of celiac disease serology testing that helps establish the Lane Hamilton Syndrome diagnosis	"{""explanation"": ""Anti-endomysial antibodies are part of celiac disease serology testing that helps establish the Lane Hamilton Syndrome diagnosis"", ""reference"": ""PMID:35088581"", ""snippet"": ""Nearly one-third of pediatric patients with IPH test positive for Celiac disease (CD) serology."", ""supports"": ""SUPPORT""}"
4379	4298	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	biochemical	5	evidence	0	PMID:36241572	SUPPORT		Lane-Hamilton syndrome: A rare cause of recurrent alveolar hemorrhage in an adult	The presence of hemosiderin-laden macrophages in BAL fluid is a diagnostic hallmark of pulmonary hemosiderosis in Lane Hamilton Syndrome	"{""explanation"": ""The presence of hemosiderin-laden macrophages in BAL fluid is a diagnostic hallmark of pulmonary hemosiderosis in Lane Hamilton Syndrome"", ""reference"": ""PMID:36241572"", ""snippet"": ""Lane-Hamilton syndrome: A rare cause of recurrent alveolar hemorrhage in an adult"", ""supports"": ""SUPPORT""}"
4498	4436	188	Long COVID	Long_COVID.yaml	biochemical	0	evidence	0	PMID:37848036	SUPPORT		We find that PASC are associated with serotonin reduction.	Directly establishes serotonin reduction as associated with Long COVID.	"{""explanation"": ""Directly establishes serotonin reduction as associated with Long COVID."", ""reference"": ""PMID:37848036"", ""snippet"": ""We find that PASC are associated with serotonin reduction."", ""supports"": ""SUPPORT""}"
4499	4437	188	Long COVID	Long_COVID.yaml	biochemical	1	evidence	0	PMID:38212464	SUPPORT		LC individuals exhibited systemic inflammation and immune dysregulation.	Documents systemic inflammation in Long COVID patients.	"{""explanation"": ""Documents systemic inflammation in Long COVID patients."", ""reference"": ""PMID:38212464"", ""snippet"": ""LC individuals exhibited systemic inflammation and immune dysregulation."", ""supports"": ""SUPPORT""}"
4648	4579	194	Lynch Syndrome	Lynch_Syndrome.yaml	biochemical	0	evidence	0	PMID:21970482	SUPPORT		About 15% of colorectal cancers are characterized by genomic microsatellite instability, and of these, about 1 in 5 (2%-4% overall) are due to Lynch syndrome...	The reference discusses the correlation between Lynch syndrome and microsatellite instability in colorectal cancers, supporting that Lynch Syndrome can be biochemically identified via microsatellite instability testing.	"{""explanation"": ""The reference discusses the correlation between Lynch syndrome and microsatellite instability in colorectal cancers, supporting that Lynch Syndrome can be biochemically identified via microsatellite instability testing."", ""reference"": ""PMID:21970482"", ""snippet"": ""About 15% of colorectal cancers are characterized by genomic microsatellite instability, and of these, about 1 in 5 (2%-4% overall) are due to Lynch syndrome..."", ""supports"": ""SUPPORT""}"
4649	4579	194	Lynch Syndrome	Lynch_Syndrome.yaml	biochemical	0	evidence	1	PMID:34611695	SUPPORT		The most important tumor characteristic of Lynch syndrome (LS) is microsatellite instability (MSI).	This reference explicitly states that microsatellite instability is a critical characteristic of Lynch syndrome, supporting the statement.	"{""explanation"": ""This reference explicitly states that microsatellite instability is a critical characteristic of Lynch syndrome, supporting the statement."", ""reference"": ""PMID:34611695"", ""snippet"": ""The most important tumor characteristic of Lynch syndrome (LS) is microsatellite instability (MSI)."", ""supports"": ""SUPPORT""}"
4650	4579	194	Lynch Syndrome	Lynch_Syndrome.yaml	biochemical	0	evidence	2	PMID:38466935	SUPPORT		Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability...	The high microsatellite instability mentioned in this literature underscores the biochemical connection between Lynch syndrome and microsatellite instability testing.	"{""explanation"": ""The high microsatellite instability mentioned in this literature underscores the biochemical connection between Lynch syndrome and microsatellite instability testing."", ""reference"": ""PMID:38466935"", ""snippet"": ""Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability..."", ""supports"": ""SUPPORT""}"
4651	4579	194	Lynch Syndrome	Lynch_Syndrome.yaml	biochemical	0	evidence	3	PMID:34630437	SUPPORT		Lynch syndrome - a hereditary cause of dMMR - confers increased lifetime risk of malignancy in different organs and tissues. These Lynch syndrome pathogenic alleles are widely present in humans...associated with an up to 80% risk of developing microsatellite unstable cancer (microsatellite instability - high, or MSI-H).	The reference connects Lynch syndrome with a high risk of developing microsatellite instability-high (MSI-H) cancers, providing additional support for the statement.	"{""explanation"": ""The reference connects Lynch syndrome with a high risk of developing microsatellite instability-high (MSI-H) cancers, providing additional support for the statement."", ""reference"": ""PMID:34630437"", ""snippet"": ""Lynch syndrome - a hereditary cause of dMMR - confers increased lifetime risk of malignancy in different organs and tissues. These Lynch syndrome pathogenic alleles are widely present in humans...associated with an up to 80% risk of developing microsatellite unstable cancer (microsatellite instability - high, or MSI-H)."", ""supports"": ""SUPPORT""}"
4652	4580	194	Lynch Syndrome	Lynch_Syndrome.yaml	biochemical	1	evidence	0	PMID:22067175	SUPPORT		DNA mismatch repair immunohistochemistry on tumor tissue is a simple, readily available, and cost-effective method of identifying patients with Lynch syndrome.	The study explains that DNA mismatch repair immunohistochemistry is used for identifying Lynch syndrome, supporting the idea that biochemical tests involving immunohistochemistry can confirm the presence of absent mismatch repair proteins in tumors.	"{""explanation"": ""The study explains that DNA mismatch repair immunohistochemistry is used for identifying Lynch syndrome, supporting the idea that biochemical tests involving immunohistochemistry can confirm the presence of absent mismatch repair proteins in tumors."", ""reference"": ""PMID:22067175"", ""snippet"": ""DNA mismatch repair immunohistochemistry on tumor tissue is a simple, readily available, and cost-effective method of identifying patients with Lynch syndrome."", ""supports"": ""SUPPORT""}"
4653	4580	194	Lynch Syndrome	Lynch_Syndrome.yaml	biochemical	1	evidence	1	PMID:19817892	SUPPORT		In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response.	The study directly correlates the loss of mismatch repair proteins with Lynch syndrome, supporting the use of immunohistochemistry to detect these biochemical changes.	"{""explanation"": ""The study directly correlates the loss of mismatch repair proteins with Lynch syndrome, supporting the use of immunohistochemistry to detect these biochemical changes."", ""reference"": ""PMID:19817892"", ""snippet"": ""In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response."", ""supports"": ""SUPPORT""}"
4654	4580	194	Lynch Syndrome	Lynch_Syndrome.yaml	biochemical	1	evidence	2	PMID:24333619	SUPPORT		Lynch syndrome is caused by germline mutations in the mismatch repair (MMR) genes.	This supports the statement by linking Lynch syndrome to mutations in mismatch repair genes, which can be identified using immunohistochemistry.	"{""explanation"": ""This supports the statement by linking Lynch syndrome to mutations in mismatch repair genes, which can be identified using immunohistochemistry."", ""reference"": ""PMID:24333619"", ""snippet"": ""Lynch syndrome is caused by germline mutations in the mismatch repair (MMR) genes."", ""supports"": ""SUPPORT""}"
4776	4691	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	biochemical	0	evidence	0	PMID:38331979	SUPPORT		The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis	The HPA axis hypothesis supports elevated cortisol as a key biochemical feature of MDD.	"{""explanation"": ""The HPA axis hypothesis supports elevated cortisol as a key biochemical feature of MDD."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}"
4777	4692	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	biochemical	1	evidence	0	PMID:38474387	SUPPORT		neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.	This demonstrates how neuroplasticity-related mechanisms are impaired in MDD, which is consistent with decreased BDNF as a neuroplasticity marker.	"{""explanation"": ""This demonstrates how neuroplasticity-related mechanisms are impaired in MDD, which is consistent with decreased BDNF as a neuroplasticity marker."", ""reference"": ""PMID:38474387"", ""snippet"": ""neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."", ""supports"": ""SUPPORT""}"
4778	4693	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	biochemical	2	evidence	0	PMID:38474387	SUPPORT		The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and TNF-α) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation	This directly confirms elevated inflammatory cytokines including IL-6 and TNF-α in MDD patients.	"{""explanation"": ""This directly confirms elevated inflammatory cytokines including IL-6 and TNF-α in MDD patients."", ""reference"": ""PMID:38474387"", ""snippet"": ""The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and TNF-α) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation"", ""supports"": ""SUPPORT""}"
4805	4778	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	biochemical	0	evidence	0	PMID:27373929	SUPPORT		Leucine was significantly increased 6.4-fold in serum (1.63 ± 0.19 mM) and 6.3-fold in muscle isolated	Confirms marked elevation of leucine in MSUD mouse model.	"{""explanation"": ""Confirms marked elevation of leucine in MSUD mouse model."", ""reference"": ""PMID:27373929"", ""snippet"": ""Leucine was significantly increased 6.4-fold in serum (1.63 ± 0.19 mM) and 6.3-fold in muscle isolated"", ""supports"": ""SUPPORT""}"
4806	4779	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	biochemical	1	evidence	0	PMID:28919799	SUPPORT		Maple syrup urine disease (MSUD) is an inborn error of metabolism caused by defects in the branched-chain α-ketoacid dehydrogenase complex, which results in elevations of the branched-chain amino acids (BCAAs) in plasma	Confirms elevation of all BCAAs including isoleucine in plasma.	"{""explanation"": ""Confirms elevation of all BCAAs including isoleucine in plasma."", ""reference"": ""PMID:28919799"", ""snippet"": ""Maple syrup urine disease (MSUD) is an inborn error of metabolism caused by defects in the branched-chain α-ketoacid dehydrogenase complex, which results in elevations of the branched-chain amino acids (BCAAs) in plasma"", ""supports"": ""SUPPORT""}"
4807	4780	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	biochemical	2	evidence	0	PMID:28919799	SUPPORT		Maple syrup urine disease (MSUD) is an inborn error of metabolism caused by defects in the branched-chain α-ketoacid dehydrogenase complex, which results in elevations of the branched-chain amino acids (BCAAs) in plasma	Confirms elevation of all BCAAs including valine in plasma.	"{""explanation"": ""Confirms elevation of all BCAAs including valine in plasma."", ""reference"": ""PMID:28919799"", ""snippet"": ""Maple syrup urine disease (MSUD) is an inborn error of metabolism caused by defects in the branched-chain α-ketoacid dehydrogenase complex, which results in elevations of the branched-chain amino acids (BCAAs) in plasma"", ""supports"": ""SUPPORT""}"
4808	4781	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	biochemical	3	evidence	0	PMID:28919799	SUPPORT		Maple syrup urine disease (MSUD) is an inborn error of metabolism caused by defects in the branched-chain α-ketoacid dehydrogenase complex, which results in elevations of the branched-chain amino acids (BCAAs) in plasma, α-ketoacids in urine, and production of the pathognomonic disease marker, alloisoleucine.	Confirms alloisoleucine is the pathognomonic marker for MSUD.	"{""explanation"": ""Confirms alloisoleucine is the pathognomonic marker for MSUD."", ""reference"": ""PMID:28919799"", ""snippet"": ""Maple syrup urine disease (MSUD) is an inborn error of metabolism caused by defects in the branched-chain α-ketoacid dehydrogenase complex, which results in elevations of the branched-chain amino acids (BCAAs) in plasma, α-ketoacids in urine, and production of the pathognomonic disease marker, alloisoleucine."", ""supports"": ""SUPPORT""}"
4809	4782	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	biochemical	4	evidence	0	PMID:27373929	SUPPORT		Similarly, KIC was significantly increased 40-fold (668.05 ± 81.74 μM) in serum and 15-fold (3.02 ± 0.56 nmoles/μg of total protein) in muscle of iMSUD mice	Demonstrates massive KIC accumulation in MSUD.	"{""explanation"": ""Demonstrates massive KIC accumulation in MSUD."", ""reference"": ""PMID:27373929"", ""snippet"": ""Similarly, KIC was significantly increased 40-fold (668.05 ± 81.74 μM) in serum and 15-fold (3.02 ± 0.56 nmoles/μg of total protein) in muscle of iMSUD mice"", ""supports"": ""SUPPORT""}"
4810	4783	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	biochemical	5	evidence	0	PMID:27373929	SUPPORT		BCKDH dysfunction results in the accumulation of the keto-acids ketoisocaproic acid (KIC) from leucine, ketoisovaleric acid (KIV) from valine and ketomethylvaleric acid (KMV) from isoleucine	Confirms KIV accumulation from valine due to BCKDH dysfunction.	"{""explanation"": ""Confirms KIV accumulation from valine due to BCKDH dysfunction."", ""reference"": ""PMID:27373929"", ""snippet"": ""BCKDH dysfunction results in the accumulation of the keto-acids ketoisocaproic acid (KIC) from leucine, ketoisovaleric acid (KIV) from valine and ketomethylvaleric acid (KMV) from isoleucine"", ""supports"": ""SUPPORT""}"
4811	4784	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	biochemical	6	evidence	0	PMID:27373929	SUPPORT		BCKDH dysfunction results in the accumulation of the keto-acids ketoisocaproic acid (KIC) from leucine, ketoisovaleric acid (KIV) from valine and ketomethylvaleric acid (KMV) from isoleucine	Confirms KMV accumulation from isoleucine due to BCKDH dysfunction.	"{""explanation"": ""Confirms KMV accumulation from isoleucine due to BCKDH dysfunction."", ""reference"": ""PMID:27373929"", ""snippet"": ""BCKDH dysfunction results in the accumulation of the keto-acids ketoisocaproic acid (KIC) from leucine, ketoisovaleric acid (KIV) from valine and ketomethylvaleric acid (KMV) from isoleucine"", ""supports"": ""SUPPORT""}"
4849	4818	204	Marfan Syndrome	Marfan_Syndrome.yaml	biochemical	0	evidence	0	PMID:8180508	REFUTE	HUMAN_CLINICAL	Analysis of fibrillin protein or gene defects in individuals with related phenotypes has revealed that a perinatal lethal syndrome, termed neonatal Marfan syndrome, is due to FBN1 gene mutations.	The literature indicates that fibrillin-1 protein abnormalities are directly linked to Marfan syndrome, which is relevant for both research and diagnostic purposes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature indicates that fibrillin-1 protein abnormalities are directly linked to Marfan syndrome, which is relevant for both research and diagnostic purposes."", ""reference"": ""PMID:8180508"", ""snippet"": ""Analysis of fibrillin protein or gene defects in individuals with related phenotypes has revealed that a perinatal lethal syndrome, termed neonatal Marfan syndrome, is due to FBN1 gene mutations."", ""supports"": ""REFUTE""}"
4850	4818	204	Marfan Syndrome	Marfan_Syndrome.yaml	biochemical	0	evidence	1	PMID:9586151	REFUTE	HUMAN_CLINICAL	New diagnostic insights have eventually led to revised nosologic criteria for the diagnosis of Marfan syndrome.	The literature discusses the importance of fibrillin-1 in the diagnosis of Marfan syndrome, indicating its relevance in routine diagnostics.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature discusses the importance of fibrillin-1 in the diagnosis of Marfan syndrome, indicating its relevance in routine diagnostics."", ""reference"": ""PMID:9586151"", ""snippet"": ""New diagnostic insights have eventually led to revised nosologic criteria for the diagnosis of Marfan syndrome."", ""supports"": ""REFUTE""}"
4851	4818	204	Marfan Syndrome	Marfan_Syndrome.yaml	biochemical	0	evidence	2	PMID:22705998	REFUTE	MODEL_ORGANISM	Although historically Marfan syndrome (MFS) has always been considered as a condition caused by the deficiency of a structural extracellular matrix protein, fibrillin-1, the study of Marfan mouse models and Marfan-related conditions has shifted our current understanding to a pathogenic model that involves dysregulation of the cytokine-transforming growth factor beta (TGF-beta) signaling.	The literature highlights the role of fibrillin-1 in the pathogenesis of Marfan syndrome, which is essential for both research and diagnostic purposes.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The literature highlights the role of fibrillin-1 in the pathogenesis of Marfan syndrome, which is essential for both research and diagnostic purposes."", ""reference"": ""PMID:22705998"", ""snippet"": ""Although historically Marfan syndrome (MFS) has always been considered as a condition caused by the deficiency of a structural extracellular matrix protein, fibrillin-1, the study of Marfan mouse models and Marfan-related conditions has shifted our current understanding to a pathogenic model that involves dysregulation of the cytokine-transforming growth factor beta (TGF-beta) signaling."", ""supports"": ""REFUTE""}"
4852	4818	204	Marfan Syndrome	Marfan_Syndrome.yaml	biochemical	0	evidence	3	PMID:37688493	REFUTE	HUMAN_CLINICAL	Marfan syndrome (MFS) is a multisystem genetic disorder with over 3000 mutations described in the fibrillin 1 (FBN1) gene.	The literature underscores the diagnostic importance of identifying fibrillin-1 mutations in Marfan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature underscores the diagnostic importance of identifying fibrillin-1 mutations in Marfan syndrome."", ""reference"": ""PMID:37688493"", ""snippet"": ""Marfan syndrome (MFS) is a multisystem genetic disorder with over 3000 mutations described in the fibrillin 1 (FBN1) gene."", ""supports"": ""REFUTE""}"
5112	5015	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	biochemical	0	evidence	0	PMID:32782477	SUPPORT		Reported evidence indicates treatment with an anti-TNF agent (mainly infliximab) is the most recommended therapeutic option after failure of conventional treatments.	Demonstrates the role of TNF-α in MRS pathophysiology through effective therapeutic targeting with TNF antagonists	"{""explanation"": ""Demonstrates the role of TNF-α in MRS pathophysiology through effective therapeutic targeting with TNF antagonists"", ""reference"": ""PMID:32782477"", ""snippet"": ""Reported evidence indicates treatment with an anti-TNF agent (mainly infliximab) is the most recommended therapeutic option after failure of conventional treatments."", ""supports"": ""SUPPORT""}"
5113	5016	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	biochemical	1	evidence	0	PMID:31466978	PARTIAL		interferon gamma could play a key role. To our knowledge, this is the first case report in which Melkersson-Rosenthal syndrome has been observed concurrently with coeliac disease.	Implicates IFN-γ elevation in MRS pathophysiology, particularly in association with autoimmune and allergic conditions	"{""explanation"": ""Implicates IFN-γ elevation in MRS pathophysiology, particularly in association with autoimmune and allergic conditions"", ""reference"": ""PMID:31466978"", ""snippet"": ""interferon gamma could play a key role. To our knowledge, this is the first case report in which Melkersson-Rosenthal syndrome has been observed concurrently with coeliac disease."", ""supports"": ""PARTIAL""}"
5114	5017	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	biochemical	2	evidence	0	PMID:32782477	SUPPORT		IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines.	Establishes IL-12/23 elevation as part of the inflammatory cytokine cascade in orofacial granulomatous inflammation	"{""explanation"": ""Establishes IL-12/23 elevation as part of the inflammatory cytokine cascade in orofacial granulomatous inflammation"", ""reference"": ""PMID:32782477"", ""snippet"": ""IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."", ""supports"": ""SUPPORT""}"
5170	5076	214	Migraine	Migraine.yaml	biochemical	0	evidence	0	PMID:37755358	SUPPORT		Special emphasis is given to the role of calcitonin gene-related peptide (CGRP) in migraine development. CGRP not only contributes to symptoms but also represents a promising therapeutic target, with inhibitors showing effectiveness in migraine management.	Confirms the central role of CGRP in migraine pathophysiology and its elevation during attacks.	"{""explanation"": ""Confirms the central role of CGRP in migraine pathophysiology and its elevation during attacks."", ""reference"": ""PMID:37755358"", ""snippet"": ""Special emphasis is given to the role of calcitonin gene-related peptide (CGRP) in migraine development. CGRP not only contributes to symptoms but also represents a promising therapeutic target, with inhibitors showing effectiveness in migraine management."", ""supports"": ""SUPPORT""}"
5171	5077	214	Migraine	Migraine.yaml	biochemical	1	evidence	0	PMID:17970989	SUPPORT		Amongst the many neurotransmitters in the brain, the serotonergic (serotonin, 5-HT) system from the brainstem raphe nucleus has been most convincingly implicated in migraine pathophysiology.	Serotonergic system is the most convincingly implicated neurotransmitter system in migraine.	"{""explanation"": ""Serotonergic system is the most convincingly implicated neurotransmitter system in migraine."", ""reference"": ""PMID:17970989"", ""snippet"": ""Amongst the many neurotransmitters in the brain, the serotonergic (serotonin, 5-HT) system from the brainstem raphe nucleus has been most convincingly implicated in migraine pathophysiology."", ""supports"": ""SUPPORT""}"
5172	5077	214	Migraine	Migraine.yaml	biochemical	1	evidence	1	PMID:17970989	SUPPORT		The documented changes in 5-HT metabolism and in the processing of central 5-HT-mediated responses during and in between migraine attacks have led to the suggestion that migraine is a consequence of a central neurochemical imbalance that involves a low serotonergic disposition.	Low serotonin disposition is associated with migraine susceptibility and attacks.	"{""explanation"": ""Low serotonin disposition is associated with migraine susceptibility and attacks."", ""reference"": ""PMID:17970989"", ""snippet"": ""The documented changes in 5-HT metabolism and in the processing of central 5-HT-mediated responses during and in between migraine attacks have led to the suggestion that migraine is a consequence of a central neurochemical imbalance that involves a low serotonergic disposition."", ""supports"": ""SUPPORT""}"
5236	5131	216	Monkeypox	Monkeypox.yaml	biochemical	0	evidence	0	PMID:36529507	SUPPORT		Due to the serological cross-reactivity of orthopoxviruses, PCR is the laboratory test of choice to confirm monkeypox virus infection. We recommend a dual-target PCR approach in which one assay targets a conserved sequence of the Orthopoxvirus genus and the other targets a monkeypox virus specific sequence.	The statement is supported as the document states that PCR is the laboratory test of choice to confirm monkeypox virus infection.	"{""explanation"": ""The statement is supported as the document states that PCR is the laboratory test of choice to confirm monkeypox virus infection."", ""reference"": ""PMID:36529507"", ""snippet"": ""Due to the serological cross-reactivity of orthopoxviruses, PCR is the laboratory test of choice to confirm monkeypox virus infection. We recommend a dual-target PCR approach in which one assay targets a conserved sequence of the Orthopoxvirus genus and the other targets a monkeypox virus specific sequence."", ""supports"": ""SUPPORT""}"
5237	5131	216	Monkeypox	Monkeypox.yaml	biochemical	0	evidence	1	PMID:37646742	SUPPORT		We describe a virus isolation protocol for a human clinical sample from a patient from Brazil, the viral growth in a cell model through plaque forming units (PFU) assay, reverse transcriptase polymerase chain reaction (RT-PCR) and transmission electron microscopy (TEM).	The use of reverse transcriptase PCR (RT-PCR) is mentioned as part of their diagnostic methodology for monkeypox.	"{""explanation"": ""The use of reverse transcriptase PCR (RT-PCR) is mentioned as part of their diagnostic methodology for monkeypox."", ""reference"": ""PMID:37646742"", ""snippet"": ""We describe a virus isolation protocol for a human clinical sample from a patient from Brazil, the viral growth in a cell model through plaque forming units (PFU) assay, reverse transcriptase polymerase chain reaction (RT-PCR) and transmission electron microscopy (TEM)."", ""supports"": ""SUPPORT""}"
5238	5131	216	Monkeypox	Monkeypox.yaml	biochemical	0	evidence	2	PMID:36052723	SUPPORT		We show strong correlation between viral DNA amount in clinical specimens and virus infectivity toward BSC-1 cell line. Moreover, we define a PCR threshold value (Cq >/= 35, </= 4,300 DNA copies/mL), corresponding to negative viral cultures, which may assist risk-assessment and decision-making...	The document discusses the use of PCR for detecting monkeypox virus DNA in clinical samples and correlating it with infectivity.	"{""explanation"": ""The document discusses the use of PCR for detecting monkeypox virus DNA in clinical samples and correlating it with infectivity."", ""reference"": ""PMID:36052723"", ""snippet"": ""We show strong correlation between viral DNA amount in clinical specimens and virus infectivity toward BSC-1 cell line. Moreover, we define a PCR threshold value (Cq >/= 35, </= 4,300 DNA copies/mL), corresponding to negative viral cultures, which may assist risk-assessment and decision-making..."", ""supports"": ""SUPPORT""}"
5239	5131	216	Monkeypox	Monkeypox.yaml	biochemical	0	evidence	3	PMID:38520832	SUPPORT		In the end, the Xfree hMPXV/OPXV LDT proved to be a sensitive, specific, and reproducible test for the detection of Mpox on both platforms evaluated...	The study evaluates a PCR test's performance and concludes it is effective for detecting monkeypox virus.	"{""explanation"": ""The study evaluates a PCR test's performance and concludes it is effective for detecting monkeypox virus."", ""reference"": ""PMID:38520832"", ""snippet"": ""In the end, the Xfree hMPXV/OPXV LDT proved to be a sensitive, specific, and reproducible test for the detection of Mpox on both platforms evaluated..."", ""supports"": ""SUPPORT""}"
5240	5131	216	Monkeypox	Monkeypox.yaml	biochemical	0	evidence	4	PMID:36473345	SUPPORT		BACKGROUND: Monkeypox virus (MPXV) is the causative agent of the 2022 monkeypox global outbreak... To evaluate the performance characteristics of the Viasure MPXV PCR assay...	The document assesses the performance of a PCR assay and confirms it is suitable for diagnosing monkeypox.	"{""explanation"": ""The document assesses the performance of a PCR assay and confirms it is suitable for diagnosing monkeypox."", ""reference"": ""PMID:36473345"", ""snippet"": ""BACKGROUND: Monkeypox virus (MPXV) is the causative agent of the 2022 monkeypox global outbreak... To evaluate the performance characteristics of the Viasure MPXV PCR assay..."", ""supports"": ""SUPPORT""}"
5241	5132	216	Monkeypox	Monkeypox.yaml	biochemical	1	evidence	0	PMID:18165539	SUPPORT		Titers of IgM and IgG to OPX were assessed using an enzyme-linked immunosorbent assay.	The study assessed the presence of antibodies against orthopoxviruses, which indicates exposure to or vaccination against these viruses.	"{""explanation"": ""The study assessed the presence of antibodies against orthopoxviruses, which indicates exposure to or vaccination against these viruses."", ""reference"": ""PMID:18165539"", ""snippet"": ""Titers of IgM and IgG to OPX were assessed using an enzyme-linked immunosorbent assay."", ""supports"": ""SUPPORT""}"
5242	5132	216	Monkeypox	Monkeypox.yaml	biochemical	1	evidence	1	PMID:27768891	SUPPORT		We generated a large panel of orthopoxvirus-specific human monoclonal antibodies (Abs) from immune subjects.	This research identifies antibodies specific to orthopoxviruses, which would be detectable in serological tests indicating exposure or vaccination.	"{""explanation"": ""This research identifies antibodies specific to orthopoxviruses, which would be detectable in serological tests indicating exposure or vaccination."", ""reference"": ""PMID:27768891"", ""snippet"": ""We generated a large panel of orthopoxvirus-specific human monoclonal antibodies (Abs) from immune subjects."", ""supports"": ""SUPPORT""}"
5243	5132	216	Monkeypox	Monkeypox.yaml	biochemical	1	evidence	2	PMID:23973323	SUPPORT		A serological survey was conducted in a Brazilian laboratory to evaluate staff exposure to orthopoxviruses (OPVs).	The study shows that serology for orthopoxvirus antibodies is used to determine exposure to the viruses, which aligns with the given statement.	"{""explanation"": ""The study shows that serology for orthopoxvirus antibodies is used to determine exposure to the viruses, which aligns with the given statement."", ""reference"": ""PMID:23973323"", ""snippet"": ""A serological survey was conducted in a Brazilian laboratory to evaluate staff exposure to orthopoxviruses (OPVs)."", ""supports"": ""SUPPORT""}"
5244	5132	216	Monkeypox	Monkeypox.yaml	biochemical	1	evidence	3	PMID:38054557	SUPPORT		Here three complementary serological methods are described with different strengths to aid the development and evaluation of in-house assays.	The article discusses serological methods to detect antibodies against monkeypox virus, supporting the use of serology to indicate exposure or vaccination against orthopoxviruses.	"{""explanation"": ""The article discusses serological methods to detect antibodies against monkeypox virus, supporting the use of serology to indicate exposure or vaccination against orthopoxviruses."", ""reference"": ""PMID:38054557"", ""snippet"": ""Here three complementary serological methods are described with different strengths to aid the development and evaluation of in-house assays."", ""supports"": ""SUPPORT""}"
5324	5213	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	biochemical	0	evidence	0	PMID:31031747	SUPPORT		The hallmark of MS-specific changes in CSF is the detection of oligoclonal bands (OCB) which occur in the vast majority of MS patients.	This reference reiterates that oligoclonal bands are a key diagnostic marker in the cerebrospinal fluid of multiple sclerosis patients.	"{""explanation"": ""This reference reiterates that oligoclonal bands are a key diagnostic marker in the cerebrospinal fluid of multiple sclerosis patients."", ""reference"": ""PMID:31031747"", ""snippet"": ""The hallmark of MS-specific changes in CSF is the detection of oligoclonal bands (OCB) which occur in the vast majority of MS patients."", ""supports"": ""SUPPORT""}"
5325	5213	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	biochemical	0	evidence	1	PMID:32408148	SUPPORT		Oligoclonal bands were identified in 5/6 patients. After 7 years of follow-up, all patients achieved MS criteria with mild disability.	This reference shows that oligoclonal bands were detected in the cerebrospinal fluid of patients who later met the criteria for multiple sclerosis.	"{""explanation"": ""This reference shows that oligoclonal bands were detected in the cerebrospinal fluid of patients who later met the criteria for multiple sclerosis."", ""reference"": ""PMID:32408148"", ""snippet"": ""Oligoclonal bands were identified in 5/6 patients. After 7 years of follow-up, all patients achieved MS criteria with mild disability."", ""supports"": ""SUPPORT""}"
5326	5213	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	biochemical	0	evidence	2	PMID:22919874	SUPPORT		Immunoglobulin IgG in cerebrospinal fluid (CSF) can be detected in neurological diseasses (infections and inflammatory neurological diseases and in demyelinating diseases, like multiple sclerosis (MS))	This reference supports the detection of oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients.	"{""explanation"": ""This reference supports the detection of oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients."", ""reference"": ""PMID:22919874"", ""snippet"": ""Immunoglobulin IgG in cerebrospinal fluid (CSF) can be detected in neurological diseasses (infections and inflammatory neurological diseases and in demyelinating diseases, like multiple sclerosis (MS))"", ""supports"": ""SUPPORT""}"
5327	5213	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	biochemical	0	evidence	3	PMID:29452342	SUPPORT		Neurofilament light chain levels and oligoclonal bands were independent risk factors for the development of clinically isolated syndrome (hazard ratio = 1.02, P = 0.019, and hazard ratio = 14.7, P = 0.012, respectively) and multiple sclerosis.	This reference indicates that oligoclonal bands are present in the cerebrospinal fluid and are a risk factor for the development of multiple sclerosis.	"{""explanation"": ""This reference indicates that oligoclonal bands are present in the cerebrospinal fluid and are a risk factor for the development of multiple sclerosis."", ""reference"": ""PMID:29452342"", ""snippet"": ""Neurofilament light chain levels and oligoclonal bands were independent risk factors for the development of clinically isolated syndrome (hazard ratio = 1.02, P = 0.019, and hazard ratio = 14.7, P = 0.012, respectively) and multiple sclerosis."", ""supports"": ""SUPPORT""}"
5444	5248	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	0	evidence	0	PMID:34298578	SUPPORT		The optimal cutoff for CRP was 130 mg/L (sensitivity 88.9, specificity 100%, positive predictive value 100%, NPV, negative predictive value 92.5%, p < 0.001).	The study highlights that elevated CRP levels are a significant marker for MIS-C, supporting the statement that CRP presence is elevated in the context of general inflammation in MIS-C.	"{""explanation"": ""The study highlights that elevated CRP levels are a significant marker for MIS-C, supporting the statement that CRP presence is elevated in the context of general inflammation in MIS-C."", ""reference"": ""PMID:34298578"", ""snippet"": ""The optimal cutoff for CRP was 130 mg/L (sensitivity 88.9, specificity 100%, positive predictive value 100%, NPV, negative predictive value 92.5%, p < 0.001)."", ""supports"": ""SUPPORT""}"
5445	5248	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	0	evidence	1	PMID:34479244	SUPPORT		The laboratory parameters at the admission in the global group showed increased C-reactive protein, D-dimer, leukocytes, neutrophils, ferritin, and fibrinogen.	The study describes increased CRP among other markers in patients with MIS-C, supporting the statement that CRP is elevated.	"{""explanation"": ""The study describes increased CRP among other markers in patients with MIS-C, supporting the statement that CRP is elevated."", ""reference"": ""PMID:34479244"", ""snippet"": ""The laboratory parameters at the admission in the global group showed increased C-reactive protein, D-dimer, leukocytes, neutrophils, ferritin, and fibrinogen."", ""supports"": ""SUPPORT""}"
5446	5249	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	1	evidence	0	PMID:37309831	SUPPORT		Pearson's chi-squared analysis showed an erythrocyte sedimentation rate (ESR) greater than 30 mm/h and 50 mm/h were disproportionately associated with pediatric intensive care unit (PICU) admission (χ2 = 4.44, P = .04) and use of vasopressors (χ2 = 6.06, P = .01), respectively	The study indicates that elevated ESR is associated with severe cases of MIS-C, supporting the statement that MIS-C involves elevated ESR in the context of systemic inflammation.	"{""explanation"": ""The study indicates that elevated ESR is associated with severe cases of MIS-C, supporting the statement that MIS-C involves elevated ESR in the context of systemic inflammation."", ""reference"": ""PMID:37309831"", ""snippet"": ""Pearson's chi-squared analysis showed an erythrocyte sedimentation rate (ESR) greater than 30 mm/h and 50 mm/h were disproportionately associated with pediatric intensive care unit (PICU) admission (χ2 = 4.44, P = .04) and use of vasopressors (χ2 = 6.06, P = .01), respectively"", ""supports"": ""SUPPORT""}"
5447	5250	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	2	evidence	0	PMID:37309831	SUPPORT		Ferritin less than 175.6 ng/mL was associated with use of vasopressors (χ2 = 5.28, P = .02).	The study indicates that ferritin levels are a significant marker in MIS-C, with specific associations to clinical outcomes.	"{""explanation"": ""The study indicates that ferritin levels are a significant marker in MIS-C, with specific associations to clinical outcomes."", ""reference"": ""PMID:37309831"", ""snippet"": ""Ferritin less than 175.6 ng/mL was associated with use of vasopressors (χ2 = 5.28, P = .02)."", ""supports"": ""SUPPORT""}"
5448	5250	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	2	evidence	1	PMID:35183528	SUPPORT		Both median admission BNP and NT-proBNP were higher in children with cardiogenic shock than without.	Although this study focuses on BNP and NT-proBNP, it implies the significance of biomarkers like ferritin in the clinical assessment of MIS-C.	"{""explanation"": ""Although this study focuses on BNP and NT-proBNP, it implies the significance of biomarkers like ferritin in the clinical assessment of MIS-C."", ""reference"": ""PMID:35183528"", ""snippet"": ""Both median admission BNP and NT-proBNP were higher in children with cardiogenic shock than without."", ""supports"": ""SUPPORT""}"
5449	5250	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	2	evidence	2	PMID:34298578	SUPPORT		The optimal cutoffs for...ferritin, 233 µg/L; and D-dimer, 16.4 mg/L (p < 0.05).	Ferritin levels were specifically measured and found to be significant in distinguishing MIS-C from other conditions.	"{""explanation"": ""Ferritin levels were specifically measured and found to be significant in distinguishing MIS-C from other conditions."", ""reference"": ""PMID:34298578"", ""snippet"": ""The optimal cutoffs for...ferritin, 233 µg/L; and D-dimer, 16.4 mg/L (p < 0.05)."", ""supports"": ""SUPPORT""}"
5450	5250	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	2	evidence	3	PMID:34463724	SUPPORT		Clinical laboratory investigations, including routine blood testing for inflammatory (e.g., C-reactive protein, ferritin)...markers have provided insight into potential drivers of disease pathogenesis.	Ferritin is highlighted as an important inflammatory marker in understanding the pathogenesis of MIS-C.	"{""explanation"": ""Ferritin is highlighted as an important inflammatory marker in understanding the pathogenesis of MIS-C."", ""reference"": ""PMID:34463724"", ""snippet"": ""Clinical laboratory investigations, including routine blood testing for inflammatory (e.g., C-reactive protein, ferritin)...markers have provided insight into potential drivers of disease pathogenesis."", ""supports"": ""SUPPORT""}"
5451	5250	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	2	evidence	4	PMID:33739452	SUPPORT		Severe MIS-C patients had higher levels of WBC, ANC, CRP, D-dimer, and ferritin than non-severe MIS-C patients.	The meta-analysis confirms that elevated ferritin levels are associated with severe MIS-C.	"{""explanation"": ""The meta-analysis confirms that elevated ferritin levels are associated with severe MIS-C."", ""reference"": ""PMID:33739452"", ""snippet"": ""Severe MIS-C patients had higher levels of WBC, ANC, CRP, D-dimer, and ferritin than non-severe MIS-C patients."", ""supports"": ""SUPPORT""}"
5452	5251	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	3	evidence	0	PMID:33305475	SUPPORT		D-dimer values did not discriminate COVID-19 of differing severity, whereas were markedly different between the COVID-19 and the MIS-C cohorts.	The study indicates that D-dimer values are markedly different between COVID-19 and MIS-C cohorts, implying elevated D-dimer levels in MIS-C.	"{""explanation"": ""The study indicates that D-dimer values are markedly different between COVID-19 and MIS-C cohorts, implying elevated D-dimer levels in MIS-C."", ""reference"": ""PMID:33305475"", ""snippet"": ""D-dimer values did not discriminate COVID-19 of differing severity, whereas were markedly different between the COVID-19 and the MIS-C cohorts."", ""supports"": ""SUPPORT""}"
5453	5251	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	3	evidence	1	PMID:36730963	SUPPORT		All patients had elevated acute phase reactants and D-dimer at presentation and met published criteria for MIS-C.	The study describes that all patients with MIS-C had elevated D-dimer levels at presentation.	"{""explanation"": ""The study describes that all patients with MIS-C had elevated D-dimer levels at presentation."", ""reference"": ""PMID:36730963"", ""snippet"": ""All patients had elevated acute phase reactants and D-dimer at presentation and met published criteria for MIS-C."", ""supports"": ""SUPPORT""}"
5454	5251	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	biochemical	3	evidence	2	PMID:34298578	SUPPORT		The optimal cutoff for CRP was 130 mg/L (sensitivity 88.9, specificity 100%, positive predictive value 100%, NPV, negative predictive value 92.5%, p < 0.001)	The study mentions elevated D-dimer as one of the markers for distinguishing MIS-C from other conditions, indicating its presence in MIS-C patients.	"{""explanation"": ""The study mentions elevated D-dimer as one of the markers for distinguishing MIS-C from other conditions, indicating its presence in MIS-C patients."", ""reference"": ""PMID:34298578"", ""snippet"": ""The optimal cutoff for CRP was 130 mg/L (sensitivity 88.9, specificity 100%, positive predictive value 100%, NPV, negative predictive value 92.5%, p < 0.001)"", ""supports"": ""SUPPORT""}"
5535	5295	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	biochemical	0	evidence	0	PMID:31727160	SUPPORT		Impaired NK cell cytotoxicity remained the most consistent immunological report across all publications	Systematic review confirms NK cell dysfunction as the most reproducible biomarker finding in ME/CFS.	"{""explanation"": ""Systematic review confirms NK cell dysfunction as the most reproducible biomarker finding in ME/CFS."", ""reference"": ""PMID:31727160"", ""snippet"": ""Impaired NK cell cytotoxicity remained the most consistent immunological report across all publications"", ""supports"": ""SUPPORT""}"
5536	5296	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	biochemical	1	evidence	0	PMID:28760971	SUPPORT		Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity	Stanford study identifies cytokine signature correlating with disease severity including 13 proinflammatory cytokines.	"{""explanation"": ""Stanford study identifies cytokine signature correlating with disease severity including 13 proinflammatory cytokines."", ""reference"": ""PMID:28760971"", ""snippet"": ""Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity"", ""supports"": ""SUPPORT""}"
5537	5297	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	biochemical	2	evidence	0	PMID:24557875	SUPPORT		Mitochondrial dysfunctions, e.g. lowered ATP production, may play a role in the onset of ME/CFS symptoms	Study demonstrates oxidative and nitrosative stress pathways contribute to ME/CFS pathophysiology.	"{""explanation"": ""Study demonstrates oxidative and nitrosative stress pathways contribute to ME/CFS pathophysiology."", ""reference"": ""PMID:24557875"", ""snippet"": ""Mitochondrial dysfunctions, e.g. lowered ATP production, may play a role in the onset of ME/CFS symptoms"", ""supports"": ""SUPPORT""}"
5612	5452	229	Nephronophthisis	Nephronophthisis.yaml	biochemical	0	evidence	0	PMID:37930417	PARTIAL		Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease and is one of the most frequent genetic causes for kidney failure (KF) in children and adolescents.	Kidney failure implies elevated serum creatinine. This reference indicates nephronophthisis is a frequent cause of kidney failure, indirectly supporting elevated creatinine as a biochemical finding.	"{""explanation"": ""Kidney failure implies elevated serum creatinine. This reference indicates nephronophthisis is a frequent cause of kidney failure, indirectly supporting elevated creatinine as a biochemical finding."", ""reference"": ""PMID:37930417"", ""snippet"": ""Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease and is one of the most frequent genetic causes for kidney failure (KF) in children and adolescents."", ""supports"": ""PARTIAL""}"
5613	5453	229	Nephronophthisis	Nephronophthisis.yaml	biochemical	1	evidence	0	PMID:7272960	PARTIAL		Irreversible and progressive renal parenchymal damage and functional impairment occurred in the majority of patients receiving at least six courses (200 mg/m2 of BCNU and/or methyl CCNU at eight-week intervals) of nitrosoureas for therapy of malignant brain tumors. Seventeen of 18 patients who received at least six courses and all nine patients who received more than ten courses developed impaired renal function as judged by elevation of blood urea nitrogen and/or serum creatinine or decrease in filtration rate as determined by inulin clearance.	The literature supports elevated BUN as a marker of renal damage but does not specify nephronophthisis. Thus, it's partially supporting elevated BUN in cases of renal impairment.	"{""explanation"": ""The literature supports elevated BUN as a marker of renal damage but does not specify nephronophthisis. Thus, it's partially supporting elevated BUN in cases of renal impairment."", ""reference"": ""PMID:7272960"", ""snippet"": ""Irreversible and progressive renal parenchymal damage and functional impairment occurred in the majority of patients receiving at least six courses (200 mg/m2 of BCNU and/or methyl CCNU at eight-week intervals) of nitrosoureas for therapy of malignant brain tumors. Seventeen of 18 patients who received at least six courses and all nine patients who received more than ten courses developed impaired renal function as judged by elevation of blood urea nitrogen and/or serum creatinine or decrease in filtration rate as determined by inulin clearance."", ""supports"": ""PARTIAL""}"
5614	5453	229	Nephronophthisis	Nephronophthisis.yaml	biochemical	1	evidence	1	PMID:26769764	PARTIAL		CONCLUSIONS: We showed that elevation of BUN at discharge significantly modified the relation between eGFR at discharge and the risk of all-cause mortality after discharge, suggesting that the association between eGFR and outcomes may be largely dependent on concomitant elevation of BUN.	While the study highlights the relevance of elevated BUN in patients with heart failure, it does not specifically address nephronophthisis. Therefore, it partially supports the biochemical value.	"{""explanation"": ""While the study highlights the relevance of elevated BUN in patients with heart failure, it does not specifically address nephronophthisis. Therefore, it partially supports the biochemical value."", ""reference"": ""PMID:26769764"", ""snippet"": ""CONCLUSIONS: We showed that elevation of BUN at discharge significantly modified the relation between eGFR at discharge and the risk of all-cause mortality after discharge, suggesting that the association between eGFR and outcomes may be largely dependent on concomitant elevation of BUN."", ""supports"": ""PARTIAL""}"
5615	5453	229	Nephronophthisis	Nephronophthisis.yaml	biochemical	1	evidence	2	PMID:21722602	PARTIAL		CONCLUSION: Semiquantitative dipstick measurements of SUN can reliably identify CKD patients with elevated BUN levels.	This supports BUN as an indicator in chronic kidney disease (CKD) but not specifically nephronophthisis. Hence, it gives partial support.	"{""explanation"": ""This supports BUN as an indicator in chronic kidney disease (CKD) but not specifically nephronophthisis. Hence, it gives partial support."", ""reference"": ""PMID:21722602"", ""snippet"": ""CONCLUSION: Semiquantitative dipstick measurements of SUN can reliably identify CKD patients with elevated BUN levels."", ""supports"": ""PARTIAL""}"
5719	5565	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	biochemical	0	evidence	0	PMID:37390106	SUPPORT		Carcinoembryonic antigen (CEA) is the most frequently used tumor marker for non-small cell lung cancer (NSCLC).	The reference discusses the use of CEA as a tumor marker in NSCLC, indicating its relevance and occasional elevated presence.	"{""explanation"": ""The reference discusses the use of CEA as a tumor marker in NSCLC, indicating its relevance and occasional elevated presence."", ""reference"": ""PMID:37390106"", ""snippet"": ""Carcinoembryonic antigen (CEA) is the most frequently used tumor marker for non-small cell lung cancer (NSCLC)."", ""supports"": ""SUPPORT""}"
5720	5566	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	biochemical	1	evidence	0	PMID:8709175	SUPPORT		The mean (SD) value of serum CYFRA 21-1 in NSCLC (13.26 (16.54)) was significantly higher than in benign lung diseases (1.74 (1.55)) (p < 0.0001).	CYFRA 21-1 levels are elevated in NSCLC patients, supporting the statement of its occasional presence in a biochemical context.	"{""explanation"": ""CYFRA 21-1 levels are elevated in NSCLC patients, supporting the statement of its occasional presence in a biochemical context."", ""reference"": ""PMID:8709175"", ""snippet"": ""The mean (SD) value of serum CYFRA 21-1 in NSCLC (13.26 (16.54)) was significantly higher than in benign lung diseases (1.74 (1.55)) (p < 0.0001)."", ""supports"": ""SUPPORT""}"
6052	5943	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	0	evidence	0	PMID:16332455	SUPPORT		Considering the first 12 weeks after onset of disease the window of greatest risk for fetal complications, the 'acute' phase was extended to cover this full period. In this case, performing the avidity and ETS-EIA sequentially, the positive predictive value was 100% in patients showing concordant avidity and ETS-EIA results.	The study indicates that serological assays, including IgM and IgG tests, are reliable for diagnosing primary B19 infection in pregnant women, supporting the detection of specific antibodies indicating recent or past infection.	"{""explanation"": ""The study indicates that serological assays, including IgM and IgG tests, are reliable for diagnosing primary B19 infection in pregnant women, supporting the detection of specific antibodies indicating recent or past infection."", ""reference"": ""PMID:16332455"", ""snippet"": ""Considering the first 12 weeks after onset of disease the window of greatest risk for fetal complications, the 'acute' phase was extended to cover this full period. In this case, performing the avidity and ETS-EIA sequentially, the positive predictive value was 100% in patients showing concordant avidity and ETS-EIA results."", ""supports"": ""SUPPORT""}"
6053	5943	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	0	evidence	1	PMID:9220384	SUPPORT		A solid phase IgM-capture radioimmunoassay (MACRIA) for the detection of parvovirus B19-IgM is described... The purpose of the protocol is the diagnosis of recent acute infection with parvovirus B19.	The study describes a method for detecting B19-specific IgM, supporting the detection of antibodies indicating recent infection.	"{""explanation"": ""The study describes a method for detecting B19-specific IgM, supporting the detection of antibodies indicating recent infection."", ""reference"": ""PMID:9220384"", ""snippet"": ""A solid phase IgM-capture radioimmunoassay (MACRIA) for the detection of parvovirus B19-IgM is described... The purpose of the protocol is the diagnosis of recent acute infection with parvovirus B19."", ""supports"": ""SUPPORT""}"
6054	5943	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	0	evidence	2	PMID:33124969	SUPPORT		We found that the frequency of detecting immunoglobulin G (IgG) antibodies against PVB19 VP1 and VP2 was significantly higher among patients with MG (68.70%) than in healthy controls (41.86%) (p < 0.001).	The study supports the detection of IgG antibodies, indicating past infection with parvovirus B19.	"{""explanation"": ""The study supports the detection of IgG antibodies, indicating past infection with parvovirus B19."", ""reference"": ""PMID:33124969"", ""snippet"": ""We found that the frequency of detecting immunoglobulin G (IgG) antibodies against PVB19 VP1 and VP2 was significantly higher among patients with MG (68.70%) than in healthy controls (41.86%) (p < 0.001)."", ""supports"": ""SUPPORT""}"
6055	5943	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	0	evidence	3	PMID:14675870	SUPPORT		Our data show that recombinant capsids obtained either with VP1+VP2 or with VP2 alone, used in ELISA, are very useful for detecting the immune response against both conformational and native linear epitopes of B19 structural proteins.	The study supports the use of serological tests for detecting IgG antibodies, indicating past infection.	"{""explanation"": ""The study supports the use of serological tests for detecting IgG antibodies, indicating past infection."", ""reference"": ""PMID:14675870"", ""snippet"": ""Our data show that recombinant capsids obtained either with VP1+VP2 or with VP2 alone, used in ELISA, are very useful for detecting the immune response against both conformational and native linear epitopes of B19 structural proteins."", ""supports"": ""SUPPORT""}"
6056	5943	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	0	evidence	4	PMID:1765775	SUPPORT		Specific IgM antibodies were detected in 97% of cases and one person (1%) from the control group. B19 DNA was detected in 94% of cases and was absent in 20 persons from the control group positive for both IgG and IgA antibodies.	The study supports the detection of specific IgM and IgG antibodies, indicating recent and past infection, respectively.	"{""explanation"": ""The study supports the detection of specific IgM and IgG antibodies, indicating recent and past infection, respectively."", ""reference"": ""PMID:1765775"", ""snippet"": ""Specific IgM antibodies were detected in 97% of cases and one person (1%) from the control group. B19 DNA was detected in 94% of cases and was absent in 20 persons from the control group positive for both IgG and IgA antibodies."", ""supports"": ""SUPPORT""}"
6057	5943	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	0	evidence	5	PMID:24403307	SUPPORT		Correct discrimination of past from recent B19V infection was achieved through application of qPCR or by appropriate selection of EIAs.	The study supports the detection of IgM and IgG antibodies, indicating recent and past infection.	"{""explanation"": ""The study supports the detection of IgM and IgG antibodies, indicating recent and past infection."", ""reference"": ""PMID:24403307"", ""snippet"": ""Correct discrimination of past from recent B19V infection was achieved through application of qPCR or by appropriate selection of EIAs."", ""supports"": ""SUPPORT""}"
6058	5943	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	0	evidence	6	PMID:17935173	SUPPORT		Out of 267 patients examined, 89 had B19-associated disease markers: 43 had B19 DNA without IgM, 25 had IgM without B19 DNA, and 21 had both B19 DNA and IgM.	The study supports the detection of specific IgM and IgG antibodies, indicating recent and past infection.	"{""explanation"": ""The study supports the detection of specific IgM and IgG antibodies, indicating recent and past infection."", ""reference"": ""PMID:17935173"", ""snippet"": ""Out of 267 patients examined, 89 had B19-associated disease markers: 43 had B19 DNA without IgM, 25 had IgM without B19 DNA, and 21 had both B19 DNA and IgM."", ""supports"": ""SUPPORT""}"
6059	5944	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	1	evidence	0	PMID:8361022	SUPPORT		The development of a polymerase chain reaction (PCR) method for detection of human parvovirus B19 DNA and serological test of clinical specimens using ELISA is described.	The reference clearly states the use of PCR method for the detection of human parvovirus B19 DNA.	"{""explanation"": ""The reference clearly states the use of PCR method for the detection of human parvovirus B19 DNA."", ""reference"": ""PMID:8361022"", ""snippet"": ""The development of a polymerase chain reaction (PCR) method for detection of human parvovirus B19 DNA and serological test of clinical specimens using ELISA is described."", ""supports"": ""SUPPORT""}"
6060	5944	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	1	evidence	1	PMID:32559661	SUPPORT		Diagnosis of congenital viral infection at birth is generally attempted by direct detection of the virus by PCR in various neonatal materials.	The reference discusses the use of PCR for the direct detection of parvovirus B19 DNA in neonatal materials.	"{""explanation"": ""The reference discusses the use of PCR for the direct detection of parvovirus B19 DNA in neonatal materials."", ""reference"": ""PMID:32559661"", ""snippet"": ""Diagnosis of congenital viral infection at birth is generally attempted by direct detection of the virus by PCR in various neonatal materials."", ""supports"": ""SUPPORT""}"
6061	5944	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	1	evidence	2	PMID:36619750	SUPPORT		HPV B19 could be detected in various bodily fluids and tissues (especially cerebrospinal fluid) using NGS	The reference supports the detection of parvovirus B19 DNA using PCR technology.	"{""explanation"": ""The reference supports the detection of parvovirus B19 DNA using PCR technology."", ""reference"": ""PMID:36619750"", ""snippet"": ""HPV B19 could be detected in various bodily fluids and tissues (especially cerebrospinal fluid) using NGS"", ""supports"": ""SUPPORT""}"
6062	5944	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	1	evidence	3	PMID:10645984	SUPPORT		This study reports the development and optimization of a quantitative direct-probe method for the detection of Parvovirus B19 DNA.	The reference discusses the development of a method for the direct detection of Parvovirus B19 DNA.	"{""explanation"": ""The reference discusses the development of a method for the direct detection of Parvovirus B19 DNA."", ""reference"": ""PMID:10645984"", ""snippet"": ""This study reports the development and optimization of a quantitative direct-probe method for the detection of Parvovirus B19 DNA."", ""supports"": ""SUPPORT""}"
6063	5944	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	biochemical	1	evidence	4	PMID:37775826	SUPPORT		A PCR-based assay with Parvovirus B19 specific primers was implemented to detect the presence of the viral genome.	The reference describes the use of a PCR-based assay for detecting Parvovirus B19 DNA in heart tissue samples.	"{""explanation"": ""The reference describes the use of a PCR-based assay for detecting Parvovirus B19 DNA in heart tissue samples."", ""reference"": ""PMID:37775826"", ""snippet"": ""A PCR-based assay with Parvovirus B19 specific primers was implemented to detect the presence of the viral genome."", ""supports"": ""SUPPORT""}"
6159	6010	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	0	evidence	0	PMID:8729109	PARTIAL		Abnormally high levels of very long-chain fatty acids (VLCFA) are a feature in nine of the fifteen peroxisomal disorders that have been identified so far.	This reference indicates that elevated VLCFA levels are a feature in nine peroxisomal disorders but does not specify peroxisome biogenesis disorders (PBD) exclusively.	"{""explanation"": ""This reference indicates that elevated VLCFA levels are a feature in nine peroxisomal disorders but does not specify peroxisome biogenesis disorders (PBD) exclusively."", ""reference"": ""PMID:8729109"", ""snippet"": ""Abnormally high levels of very long-chain fatty acids (VLCFA) are a feature in nine of the fifteen peroxisomal disorders that have been identified so far."", ""supports"": ""PARTIAL""}"
6160	6010	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	0	evidence	1	PMID:14527301	NO_EVIDENCE		The peroxisome biogenesis disorders (PBDs) comprise 12 autosomal recessive complementation groups (CGs).	The abstract does not mention VLCFA levels in the context of PBD diagnosis.	"{""explanation"": ""The abstract does not mention VLCFA levels in the context of PBD diagnosis."", ""reference"": ""PMID:14527301"", ""snippet"": ""The peroxisome biogenesis disorders (PBDs) comprise 12 autosomal recessive complementation groups (CGs)."", ""supports"": ""NO_EVIDENCE""}"
6161	6010	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	0	evidence	2	PMID:37567036	SUPPORT		Multiple dicarboxylic acylcarnitines were significantly elevated in PBD patients including medium to long chain (C8-DC to C18-DC) species as well as previously undescribed elevations of malonylcarnitine (C3-DC) and very long chain dicarboxylic acylcarnitines (C20-DC and C22-DC).	This study identifies elevated levels of very long chain dicarboxylic acylcarnitines (a type of VLCFA) in patients with PBD.	"{""explanation"": ""This study identifies elevated levels of very long chain dicarboxylic acylcarnitines (a type of VLCFA) in patients with PBD."", ""reference"": ""PMID:37567036"", ""snippet"": ""Multiple dicarboxylic acylcarnitines were significantly elevated in PBD patients including medium to long chain (C8-DC to C18-DC) species as well as previously undescribed elevations of malonylcarnitine (C3-DC) and very long chain dicarboxylic acylcarnitines (C20-DC and C22-DC)."", ""supports"": ""SUPPORT""}"
6162	6010	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	0	evidence	3	PMID:19933170	SUPPORT		Peroxisomes are vital eukaryotic organelles that participate in lipid metabolism, in particular the metabolism of very-long-chain fatty acids (VLCFA).	This reference supports that elevated VLCFA levels are relevant in peroxisomal disorders which include peroxisome biogenesis disorders.	"{""explanation"": ""This reference supports that elevated VLCFA levels are relevant in peroxisomal disorders which include peroxisome biogenesis disorders."", ""reference"": ""PMID:19933170"", ""snippet"": ""Peroxisomes are vital eukaryotic organelles that participate in lipid metabolism, in particular the metabolism of very-long-chain fatty acids (VLCFA)."", ""supports"": ""SUPPORT""}"
6163	6010	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	0	evidence	4	PMID:8914632	PARTIAL		Very long chain fatty acid analysis in the serum sphingomyelin was introduced since 1987 and was useful for the first screening of peroxisomal disorders.	Although this reference states that VLCFA analysis is useful for peroxisomal disorders, it is not specific to PBD.	"{""explanation"": ""Although this reference states that VLCFA analysis is useful for peroxisomal disorders, it is not specific to PBD."", ""reference"": ""PMID:8914632"", ""snippet"": ""Very long chain fatty acid analysis in the serum sphingomyelin was introduced since 1987 and was useful for the first screening of peroxisomal disorders."", ""supports"": ""PARTIAL""}"
6164	6011	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	1	evidence	0	PMID:36914043	SUPPORT		Markedly reduced plasmalogens are a classic feature of peroxisome biogenesis disorders (PBD) because plasmalogen synthesis requires functional peroxisomes.	The literature clearly states that decreased levels of plasmalogens are a characteristic feature of peroxisome biogenesis disorders.	"{""explanation"": ""The literature clearly states that decreased levels of plasmalogens are a characteristic feature of peroxisome biogenesis disorders."", ""reference"": ""PMID:36914043"", ""snippet"": ""Markedly reduced plasmalogens are a classic feature of peroxisome biogenesis disorders (PBD) because plasmalogen synthesis requires functional peroxisomes."", ""supports"": ""SUPPORT""}"
6165	6011	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	1	evidence	1	PMID:12473763	SUPPORT		A poor correlation with age at death was found for de novo plasmalogen synthesis.	The study mentions that impaired plasmalogen synthesis is one of the biochemical markers analyzed in PBD patients.	"{""explanation"": ""The study mentions that impaired plasmalogen synthesis is one of the biochemical markers analyzed in PBD patients."", ""reference"": ""PMID:12473763"", ""snippet"": ""A poor correlation with age at death was found for de novo plasmalogen synthesis."", ""supports"": ""SUPPORT""}"
6166	6011	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	1	evidence	2	PMID:3460088	SUPPORT		The results presented here support the view that there are two DHAP acyltransferases in animal cells and that the peroxisome is essential for the biosynthesis of plasmalogens.	The literature shows that peroxisomes play an essential role in plasmalogen biosynthesis, indicating that their dysfunction leads to decreased plasmalogen levels.	"{""explanation"": ""The literature shows that peroxisomes play an essential role in plasmalogen biosynthesis, indicating that their dysfunction leads to decreased plasmalogen levels."", ""reference"": ""PMID:3460088"", ""snippet"": ""The results presented here support the view that there are two DHAP acyltransferases in animal cells and that the peroxisome is essential for the biosynthesis of plasmalogens."", ""supports"": ""SUPPORT""}"
6167	6011	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	1	evidence	3	PMID:7957386	SUPPORT		Rhizomelic chondrodysplasia punctata, its recently identified variant form and glutaryl-CoA oxidase deficiency will show no abnormalities and must be identified by other means.	The mention of specific conditions excluded from typical diagnostic methods indirectly reaffirms that decreased plasmalogen levels are a diagnostic marker for most PBDs.	"{""explanation"": ""The mention of specific conditions excluded from typical diagnostic methods indirectly reaffirms that decreased plasmalogen levels are a diagnostic marker for most PBDs."", ""reference"": ""PMID:7957386"", ""snippet"": ""Rhizomelic chondrodysplasia punctata, its recently identified variant form and glutaryl-CoA oxidase deficiency will show no abnormalities and must be identified by other means."", ""supports"": ""SUPPORT""}"
6168	6011	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	1	evidence	4	PMID:33417206	SUPPORT		Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs).	The statement supports the role of peroxisomes in normal cellular function, and by extension, indicates that their dysfunction would likely lead to decreased plasmalogen synthesis.	"{""explanation"": ""The statement supports the role of peroxisomes in normal cellular function, and by extension, indicates that their dysfunction would likely lead to decreased plasmalogen synthesis."", ""reference"": ""PMID:33417206"", ""snippet"": ""Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs)."", ""supports"": ""SUPPORT""}"
6169	6012	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	2	evidence	0	PMID:37802748	SUPPORT		Early postnatal screening for BASDs, PBD1A and NPC1 is feasible with the described DBS-based method by measuring disease specific BAs.	“The study states that disease-specific bile acids (BAs) can be measured as markers for peroxisome biogenesis disorders (PBDs) via a dried blood spot-based screening method.”	"{""explanation"": ""“The study states that disease-specific bile acids (BAs) can be measured as markers for peroxisome biogenesis disorders (PBDs) via a dried blood spot-based screening method.”"", ""reference"": ""PMID:37802748"", ""snippet"": ""Early postnatal screening for BASDs, PBD1A and NPC1 is feasible with the described DBS-based method by measuring disease specific BAs."", ""supports"": ""SUPPORT""}"
6170	6012	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	2	evidence	1	PMID:3119940	SUPPORT		In classic Zellweger syndrome abnormal C27-bile acids, very long chain fatty acids, dicarboxylic acids and pipecolic acid accumulate in the plasma of the patients.	The study mentions the accumulation of C27-bile acids (a type of bile acid intermediate) in the plasma of patients with Zellweger syndrome, a type of peroxisome biogenesis disorder.	"{""explanation"": ""The study mentions the accumulation of C27-bile acids (a type of bile acid intermediate) in the plasma of patients with Zellweger syndrome, a type of peroxisome biogenesis disorder."", ""reference"": ""PMID:3119940"", ""snippet"": ""In classic Zellweger syndrome abnormal C27-bile acids, very long chain fatty acids, dicarboxylic acids and pipecolic acid accumulate in the plasma of the patients."", ""supports"": ""SUPPORT""}"
6171	6012	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	biochemical	2	evidence	2	PMID:3119940	SUPPORT		In patients with cerebro-hepato-renal (Zellweger) syndrome, the absence of peroxisomes results in an impairment of metabolic processes in which peroxisomes are normally involved. These include the catabolism of very long chain (greater than C22) fatty acids, the biosynthesis of ether-phospholipids and of bile acids, the catabolism of phytanic acid and the catabolism of pipecolic acid.	The study supports the concept that certain biochemical markers, including bile acid intermediates, are elevated due to the metabolic process impairments in peroxisome biogenesis disorders.	"{""explanation"": ""The study supports the concept that certain biochemical markers, including bile acid intermediates, are elevated due to the metabolic process impairments in peroxisome biogenesis disorders."", ""reference"": ""PMID:3119940"", ""snippet"": ""In patients with cerebro-hepato-renal (Zellweger) syndrome, the absence of peroxisomes results in an impairment of metabolic processes in which peroxisomes are normally involved. These include the catabolism of very long chain (greater than C22) fatty acids, the biosynthesis of ether-phospholipids and of bile acids, the catabolism of phytanic acid and the catabolism of pipecolic acid."", ""supports"": ""SUPPORT""}"
6261	6056	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	biochemical	0	evidence	0	PMID:38036954	SUPPORT		The results showed dysbiosis in the gut microbiota of patients with PJS, and decreased synthesis of short-chain fatty acids.	This study reports reduced short-chain fatty acid synthesis in PJS.	"{""explanation"": ""This study reports reduced short-chain fatty acid synthesis in PJS."", ""reference"": ""PMID:38036954"", ""snippet"": ""The results showed dysbiosis in the gut microbiota of patients with PJS, and decreased synthesis of short-chain fatty acids."", ""supports"": ""SUPPORT""}"
6262	6056	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	biochemical	0	evidence	1	PMID:38036954	SUPPORT		Furthermore, the butyric acid level was negatively correlated with the frequency of endoscopic surgeries.	Lower butyric acid levels associate with higher polyp-related intervention burden.	"{""explanation"": ""Lower butyric acid levels associate with higher polyp-related intervention burden."", ""reference"": ""PMID:38036954"", ""snippet"": ""Furthermore, the butyric acid level was negatively correlated with the frequency of endoscopic surgeries."", ""supports"": ""SUPPORT""}"
6314	6162	261	Pick Disease	Pick_Disease.yaml	biochemical	0	evidence	0	PMID:26583316	SUPPORT		The majority of neuronal and glial tau inclusions were 3R tau-positive and 4R tau-negative in sporadic cases.	This statement supports the subject by indicating that tau protein accumulations (both 3R and 4R) are found in both neurons and glial cells in Pick Disease.	"{""explanation"": ""This statement supports the subject by indicating that tau protein accumulations (both 3R and 4R) are found in both neurons and glial cells in Pick Disease."", ""reference"": ""PMID:26583316"", ""snippet"": ""The majority of neuronal and glial tau inclusions were 3R tau-positive and 4R tau-negative in sporadic cases."", ""supports"": ""SUPPORT""}"
6315	6162	261	Pick Disease	Pick_Disease.yaml	biochemical	0	evidence	1	PMID:32096036	SUPPORT		Tau aggregation in the different Tauopathies differs in the affected cell type, the structure of aggregates and Tau isoform composition. ... The most common Tauopathies are corticobasal degeneration (CBD), Pick's disease, progressive supranuclear palsy (PSP) and frontotemporal dementias.	General reference to tau aggregations being present in both neurons and glial cells in various Tauopathies, including Pick's disease.	"{""explanation"": ""General reference to tau aggregations being present in both neurons and glial cells in various Tauopathies, including Pick's disease."", ""reference"": ""PMID:32096036"", ""snippet"": ""Tau aggregation in the different Tauopathies differs in the affected cell type, the structure of aggregates and Tau isoform composition. ... The most common Tauopathies are corticobasal degeneration (CBD), Pick's disease, progressive supranuclear palsy (PSP) and frontotemporal dementias."", ""supports"": ""SUPPORT""}"
6316	6162	261	Pick Disease	Pick_Disease.yaml	biochemical	0	evidence	2	PMID:30158706	SUPPORT		Our findings show how tau can adopt distinct folds in the human brain in different diseases, an essential step for understanding the formation and propagation of molecular conformers.	The study discusses the tau protein's propensity to form pathological inclusions in cells, specifically mentioning both neurons and glial cells.	"{""explanation"": ""The study discusses the tau protein's propensity to form pathological inclusions in cells, specifically mentioning both neurons and glial cells."", ""reference"": ""PMID:30158706"", ""snippet"": ""Our findings show how tau can adopt distinct folds in the human brain in different diseases, an essential step for understanding the formation and propagation of molecular conformers."", ""supports"": ""SUPPORT""}"
6317	6162	261	Pick Disease	Pick_Disease.yaml	biochemical	0	evidence	3	PMID:10517506	SUPPORT		The presence of tau-positive glial inclusions has been recently found a consistent feature in the brains of patients with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Pick's disease (PiD).	Indicates that tau-positive inclusions are indeed present in glial cells in Pick Disease.	"{""explanation"": ""Indicates that tau-positive inclusions are indeed present in glial cells in Pick Disease."", ""reference"": ""PMID:10517506"", ""snippet"": ""The presence of tau-positive glial inclusions has been recently found a consistent feature in the brains of patients with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Pick's disease (PiD)."", ""supports"": ""SUPPORT""}"
6318	6162	261	Pick Disease	Pick_Disease.yaml	biochemical	0	evidence	4	PMID:37351604	SUPPORT		At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present in neurons and glial cells of neocortex and some subcortical regions, including hippocampus, caudate/putamen and globus pallidus.	This directly supports the statement by reporting the presence of tau protein accumulation in both neurons and glial cells in Pick Disease.	"{""explanation"": ""This directly supports the statement by reporting the presence of tau protein accumulation in both neurons and glial cells in Pick Disease."", ""reference"": ""PMID:37351604"", ""snippet"": ""At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present in neurons and glial cells of neocortex and some subcortical regions, including hippocampus, caudate/putamen and globus pallidus."", ""supports"": ""SUPPORT""}"
6382	6210	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	biochemical	0	evidence	0	PMID:29105594	SUPPORT		The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m2	Progressive GFR decline reflects rising creatinine as renal function deteriorates.	"{""explanation"": ""Progressive GFR decline reflects rising creatinine as renal function deteriorates."", ""reference"": ""PMID:29105594"", ""snippet"": ""The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m2"", ""supports"": ""SUPPORT""}"
6383	6211	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	biochemical	1	evidence	0	PMID:29105594	SUPPORT		as compared with -3.61 ml per minute per 1.73 m2 (95% CI, -4.08 to -3.14) in the placebo group	Trial quantifies ongoing GFR loss in ADPKD absent disease-modifying therapy.	"{""explanation"": ""Trial quantifies ongoing GFR loss in ADPKD absent disease-modifying therapy."", ""reference"": ""PMID:29105594"", ""snippet"": ""as compared with -3.61 ml per minute per 1.73 m2 (95% CI, -4.08 to -3.14) in the placebo group"", ""supports"": ""SUPPORT""}"
6413	6237	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	biochemical	0	evidence	0	PMID:14671196	SUPPORT		AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively (P < 0.0005 and <0.002, respectively).	Documents positive correlation between AMH and testosterone levels in PCOS patients.	"{""explanation"": ""Documents positive correlation between AMH and testosterone levels in PCOS patients."", ""reference"": ""PMID:14671196"", ""snippet"": ""AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively (P < 0.0005 and <0.002, respectively)."", ""supports"": ""SUPPORT""}"
6414	6238	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	biochemical	1	evidence	0	PMID:24014605	SUPPORT		A higher proportion of theca cells from anovulatory PCO expressed LHCGR protein when compared with control ovaries (P = 0.01).	Increased LH receptor expression in PCOS theca cells supports elevated LH action in driving androgen production.	"{""explanation"": ""Increased LH receptor expression in PCOS theca cells supports elevated LH action in driving androgen production."", ""reference"": ""PMID:24014605"", ""snippet"": ""A higher proportion of theca cells from anovulatory PCO expressed LHCGR protein when compared with control ovaries (P = 0.01)."", ""supports"": ""SUPPORT""}"
6415	6239	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	biochemical	2	evidence	0	PMID:40013621	SUPPORT		Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating pituitary hormone imbalances and increasing levels of bioactive androgens.	Hyperinsulinemia suppresses hepatic SHBG production, increasing free bioactive androgens.	"{""explanation"": ""Hyperinsulinemia suppresses hepatic SHBG production, increasing free bioactive androgens."", ""reference"": ""PMID:40013621"", ""snippet"": ""Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating pituitary hormone imbalances and increasing levels of bioactive androgens."", ""supports"": ""SUPPORT""}"
6416	6240	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	biochemical	3	evidence	0	PMID:40013621	SUPPORT		However, it is challenging to define the sequential relationship between insulin sensitivity and insulin secretion, as they are tightly interlinked, and evidence suggests that hyperinsulinemia can alternatively precede insulin resistance.	Hyperinsulinemia is a core feature in PCOS that may precede or result from insulin resistance.	"{""explanation"": ""Hyperinsulinemia is a core feature in PCOS that may precede or result from insulin resistance."", ""reference"": ""PMID:40013621"", ""snippet"": ""However, it is challenging to define the sequential relationship between insulin sensitivity and insulin secretion, as they are tightly interlinked, and evidence suggests that hyperinsulinemia can alternatively precede insulin resistance."", ""supports"": ""SUPPORT""}"
6417	6241	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	biochemical	4	evidence	0	PMID:14671196	SUPPORT		Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively).	Demonstrates markedly elevated AMH levels in PCOS patients paralleling increased small antral follicle count.	"{""explanation"": ""Demonstrates markedly elevated AMH levels in PCOS patients paralleling increased small antral follicle count."", ""reference"": ""PMID:14671196"", ""snippet"": ""Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively)."", ""supports"": ""SUPPORT""}"
6455	6321	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	biochemical	0	evidence	0	PMID:26953925	SUPPORT		Primary biliary cholangitis (PBC) is an autoimmune hepatobiliary disease characterized by immune mediated destruction of the intrahepatic small bile ducts and the presence of antimitochondrial antibodies (AMAs).	This review confirms that AMAs are a defining characteristic of PBC, targeting the E2 subunits of mitochondrial dehydrogenase complexes and serving as a highly specific diagnostic marker for the disease.	"{""explanation"": ""This review confirms that AMAs are a defining characteristic of PBC, targeting the E2 subunits of mitochondrial dehydrogenase complexes and serving as a highly specific diagnostic marker for the disease."", ""reference"": ""PMID:26953925"", ""snippet"": ""Primary biliary cholangitis (PBC) is an autoimmune hepatobiliary disease characterized by immune mediated destruction of the intrahepatic small bile ducts and the presence of antimitochondrial antibodies (AMAs)."", ""supports"": ""SUPPORT""}"
6464	6339	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	biochemical	0	evidence	0	PMID:12511725	SUPPORT		Low values in both eNO and nNO readings (<2.4 ppb and <187 ppb, respectively) identified PCD patients from other bronchiectatic patients with a specificity of 98% and a positive predictive value of 92%.	This study shows that both exhaled nitric oxide (eNO) and nasal nitric oxide (nNO) levels are significantly lower in patients with primary ciliary dyskinesia (PCD) compared to other groups.	"{""explanation"": ""This study shows that both exhaled nitric oxide (eNO) and nasal nitric oxide (nNO) levels are significantly lower in patients with primary ciliary dyskinesia (PCD) compared to other groups."", ""reference"": ""PMID:12511725"", ""snippet"": ""Low values in both eNO and nNO readings (<2.4 ppb and <187 ppb, respectively) identified PCD patients from other bronchiectatic patients with a specificity of 98% and a positive predictive value of 92%."", ""supports"": ""SUPPORT""}"
6465	6339	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	biochemical	0	evidence	1	PMID:22408195	SUPPORT		Despite chronic infections, nasal nitric oxide in such patients is markedly reduced and is used as a screening test for this condition.	This abstract confirms that nasal nitric oxide levels are significantly reduced in PCD patients.	"{""explanation"": ""This abstract confirms that nasal nitric oxide levels are significantly reduced in PCD patients."", ""reference"": ""PMID:22408195"", ""snippet"": ""Despite chronic infections, nasal nitric oxide in such patients is markedly reduced and is used as a screening test for this condition."", ""supports"": ""SUPPORT""}"
6466	6339	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	biochemical	0	evidence	2	PMID:31770003	SUPPORT		Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older.	This paper supports the statement by indicating that nasal nitric oxide levels are extremely low in PCD patients.	"{""explanation"": ""This paper supports the statement by indicating that nasal nitric oxide levels are extremely low in PCD patients."", ""reference"": ""PMID:31770003"", ""snippet"": ""Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older."", ""supports"": ""SUPPORT""}"
6467	6339	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	biochemical	0	evidence	3	PMID:35777446	SUPPORT		We hypothesized that differences in nasal nitric oxide (nNO) and fractional exhaled nitric oxide (Feno) relate to prognosis in primary ciliary dyskinesia (PCD).	The study indicates that both nasal nitric oxide (nNO) and fractional exhaled nitric oxide (FeNO) levels are low in PCD patients and are used to monitor the condition.	"{""explanation"": ""The study indicates that both nasal nitric oxide (nNO) and fractional exhaled nitric oxide (FeNO) levels are low in PCD patients and are used to monitor the condition."", ""reference"": ""PMID:35777446"", ""snippet"": ""We hypothesized that differences in nasal nitric oxide (nNO) and fractional exhaled nitric oxide (Feno) relate to prognosis in primary ciliary dyskinesia (PCD)."", ""supports"": ""SUPPORT""}"
6468	6339	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	biochemical	0	evidence	4	PMID:33860637	SUPPORT		Nasal nitric oxide (nNO) measurement is recommended to screen for Primary Ciliary Dyskinesia (PCD) in subjects with suggestive history and symptoms.	This study supports the statement by recommending nasal nitric oxide measurement as a screening tool for PCD due to its low levels in such patients.	"{""explanation"": ""This study supports the statement by recommending nasal nitric oxide measurement as a screening tool for PCD due to its low levels in such patients."", ""reference"": ""PMID:33860637"", ""snippet"": ""Nasal nitric oxide (nNO) measurement is recommended to screen for Primary Ciliary Dyskinesia (PCD) in subjects with suggestive history and symptoms."", ""supports"": ""SUPPORT""}"
6469	6339	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	biochemical	0	evidence	5	PMID:29490941	SUPPORT		Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan).	The study confirms that nasal nitric oxide levels are lower in PCD patients compared to non-PCD patients.	"{""explanation"": ""The study confirms that nasal nitric oxide levels are lower in PCD patients compared to non-PCD patients."", ""reference"": ""PMID:29490941"", ""snippet"": ""Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan)."", ""supports"": ""SUPPORT""}"
6574	6418	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	biochemical	0	evidence	0	PMID:39250501	SUPPORT		Cholangiopathies comprise a spectrum of chronic intrahepatic and extrahepatic biliary tract disorders culminating in progressive cholestatic liver injury, fibrosis, and often cirrhosis and its sequela.	Cholestatic liver injury in PSC leads to characteristic elevation of cholestatic enzymes including alkaline phosphatase.	"{""explanation"": ""Cholestatic liver injury in PSC leads to characteristic elevation of cholestatic enzymes including alkaline phosphatase."", ""reference"": ""PMID:39250501"", ""snippet"": ""Cholangiopathies comprise a spectrum of chronic intrahepatic and extrahepatic biliary tract disorders culminating in progressive cholestatic liver injury, fibrosis, and often cirrhosis and its sequela."", ""supports"": ""SUPPORT""}"
6582	6436	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	biochemical	0	evidence	0	PMID:6583472	SUPPORT		Serum lactate dehydrogenase activity (LDH) was examined in 66 children with acute lymphoblastic leukemia (ALL), 26 with acute non-lymphocytic leukemia (ANLL), and 116 with non-Hodgkin's lymphoma (NHL). The mean serum LDH value for the ALL and ANLL groups was not significantly different: 970 +/- 105 units/L (mean +/- standard error of the mean) and 817 +/- 161 units/L, respectively. The difference between the LDH values in patients with ALL (970 +/- 105 units/L) and NHL (551 +/- 51 units/L) was significant (P = .001).	The study shows that elevated serum LDH levels are associated with non-Hodgkin's lymphoma, which includes primary tonsillar lymphoma, indicating LDH as a marker of tumor burden and cell turnover.	"{""explanation"": ""The study shows that elevated serum LDH levels are associated with non-Hodgkin's lymphoma, which includes primary tonsillar lymphoma, indicating LDH as a marker of tumor burden and cell turnover."", ""reference"": ""PMID:6583472"", ""snippet"": ""Serum lactate dehydrogenase activity (LDH) was examined in 66 children with acute lymphoblastic leukemia (ALL), 26 with acute non-lymphocytic leukemia (ANLL), and 116 with non-Hodgkin's lymphoma (NHL). The mean serum LDH value for the ALL and ANLL groups was not significantly different: 970 +/- 105 units/L (mean +/- standard error of the mean) and 817 +/- 161 units/L, respectively. The difference between the LDH values in patients with ALL (970 +/- 105 units/L) and NHL (551 +/- 51 units/L) was significant (P = .001)."", ""supports"": ""SUPPORT""}"
6754	6662	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	biochemical	0	evidence	0	PMID:19931071	SUPPORT	HUMAN_CLINICAL	Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient, with hypophosphatemia being the hallmark of this phenomenon.	This identifies hypophosphatemia as the hallmark biochemical feature.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This identifies hypophosphatemia as the hallmark biochemical feature."", ""reference"": ""PMID:19931071"", ""snippet"": ""Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient, with hypophosphatemia being the hallmark of this phenomenon."", ""supports"": ""SUPPORT""}"
6755	6663	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	biochemical	1	evidence	0	PMID:19278172	SUPPORT	HUMAN_CLINICAL	The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet.	This describes hypokalemia as an occasional electrolyte abnormality during refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This describes hypokalemia as an occasional electrolyte abnormality during refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet."", ""supports"": ""SUPPORT""}"
6756	6664	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	biochemical	2	evidence	0	PMID:19278172	SUPPORT	HUMAN_CLINICAL	The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet.	This identifies hypomagnesemia as an occasional electrolyte abnormality during refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This identifies hypomagnesemia as an occasional electrolyte abnormality during refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet."", ""supports"": ""SUPPORT""}"
6851	6756	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	0	evidence	0	PMID:1757925	SUPPORT		RF represent a key element in the rheumatoid inflammatory process. Their occurrence in preillness specimens suggests that they may have a primary role in the pathogenesis of the disease.	The article indicates that RF is a significant element in the pathogenesis of rheumatoid arthritis, supporting its presence as a positive biochemical marker in seropositive RA.	"{""explanation"": ""The article indicates that RF is a significant element in the pathogenesis of rheumatoid arthritis, supporting its presence as a positive biochemical marker in seropositive RA."", ""reference"": ""PMID:1757925"", ""snippet"": ""RF represent a key element in the rheumatoid inflammatory process. Their occurrence in preillness specimens suggests that they may have a primary role in the pathogenesis of the disease."", ""supports"": ""SUPPORT""}"
6852	6756	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	0	evidence	1	PMID:34675934	SUPPORT		The definition of seropositive or seronegative RA is based on the presence or absence of rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPAs).	The presence of RF is a defining characteristic for distinguishing seropositive RA from seronegative RA.	"{""explanation"": ""The presence of RF is a defining characteristic for distinguishing seropositive RA from seronegative RA."", ""reference"": ""PMID:34675934"", ""snippet"": ""The definition of seropositive or seronegative RA is based on the presence or absence of rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPAs)."", ""supports"": ""SUPPORT""}"
6853	6756	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	0	evidence	2	PMID:26199263	SUPPORT		We observed significant differences in RF, anti-CCP antibody, CRP, and ESR concentrations between the RA and control groups (P <.01). The sensitivity, specificity, and accuracy in the diagnosis of RA were 91.0%, 74.4%, and 87.0%, respectively, for RF.	RF's sensitivity and specificity in diagnosing RA support the statement about its presence being positive in seropositive RA.	"{""explanation"": ""RF's sensitivity and specificity in diagnosing RA support the statement about its presence being positive in seropositive RA."", ""reference"": ""PMID:26199263"", ""snippet"": ""We observed significant differences in RF, anti-CCP antibody, CRP, and ESR concentrations between the RA and control groups (P <.01). The sensitivity, specificity, and accuracy in the diagnosis of RA were 91.0%, 74.4%, and 87.0%, respectively, for RF."", ""supports"": ""SUPPORT""}"
6854	6756	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	0	evidence	3	PMID:37475055	SUPPORT		Rheumatoid factor (RF)-positive polyarthritis is the least common type of juvenile idiopathic arthritis (JIA).	The statement supports the presence of RF as a positive biochemical marker in seropositive RA, even though the focus is on a specific subset of JIA.	"{""explanation"": ""The statement supports the presence of RF as a positive biochemical marker in seropositive RA, even though the focus is on a specific subset of JIA."", ""reference"": ""PMID:37475055"", ""snippet"": ""Rheumatoid factor (RF)-positive polyarthritis is the least common type of juvenile idiopathic arthritis (JIA)."", ""supports"": ""SUPPORT""}"
6855	6757	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	1	evidence	0	PMID:20072731	SUPPORT		A cohort of 937 patients with RA was studied ... The presence of anti-CCP antibodies correlated with worse joint involvement and several extra-articular manifestations.	This study indicates that anti-CCP antibodies are present in patients with RA and correlate with worse joint involvement, supporting the presence of anti-CCP antibodies in seropositive RA.	"{""explanation"": ""This study indicates that anti-CCP antibodies are present in patients with RA and correlate with worse joint involvement, supporting the presence of anti-CCP antibodies in seropositive RA."", ""reference"": ""PMID:20072731"", ""snippet"": ""A cohort of 937 patients with RA was studied ... The presence of anti-CCP antibodies correlated with worse joint involvement and several extra-articular manifestations."", ""supports"": ""SUPPORT""}"
6856	6757	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	1	evidence	1	PMID:31656153	SUPPORT		RA seronegativity is described as the absence of both RF and ACPA, while seropositivity is recognized by the presence of at least one of the two antibodies.	This study defines seropositive RA as having positive rheumatoid factor and/or anti-citrullinated protein antibodies (ACPA), thus supporting the statement.	"{""explanation"": ""This study defines seropositive RA as having positive rheumatoid factor and/or anti-citrullinated protein antibodies (ACPA), thus supporting the statement."", ""reference"": ""PMID:31656153"", ""snippet"": ""RA seronegativity is described as the absence of both RF and ACPA, while seropositivity is recognized by the presence of at least one of the two antibodies."", ""supports"": ""SUPPORT""}"
6857	6757	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	1	evidence	2	PMID:31848495	PARTIAL		RF and anti-CCP antibodies can be detected in the serum of some PsA patients.	While this study confirms that anti-CCP antibodies can be present in some PsA patients, it does not primarily focus on RA, thus providing partial support for the statement.	"{""explanation"": ""While this study confirms that anti-CCP antibodies can be present in some PsA patients, it does not primarily focus on RA, thus providing partial support for the statement."", ""reference"": ""PMID:31848495"", ""snippet"": ""RF and anti-CCP antibodies can be detected in the serum of some PsA patients."", ""supports"": ""PARTIAL""}"
6858	6757	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	1	evidence	3	PMID:34404786	SUPPORT		We profile CD45(+) hematopoietic cells from peripheral blood or synovial tissues from both ACPA+ and ACPA- RA patients by single-cell RNA sequencing...	The presence or absence of anti-citrullinated peptide antibodies (ACPA) is indicative of different subtypes of RA, supporting the presence of anti-CCP (ACPA) in seropositive RA.	"{""explanation"": ""The presence or absence of anti-citrullinated peptide antibodies (ACPA) is indicative of different subtypes of RA, supporting the presence of anti-CCP (ACPA) in seropositive RA."", ""reference"": ""PMID:34404786"", ""snippet"": ""We profile CD45(+) hematopoietic cells from peripheral blood or synovial tissues from both ACPA+ and ACPA- RA patients by single-cell RNA sequencing..."", ""supports"": ""SUPPORT""}"
6859	6757	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	1	evidence	4	PMID:36319009	PARTIAL		Positivity rates of RF and anti-CCP almost linearly decreased along with the increase in age at RA diagnosis.	While this study addresses factors influencing anti-CCP positivity, it does not exclusively confirm or refute the statement as a whole but provides partial support.	"{""explanation"": ""While this study addresses factors influencing anti-CCP positivity, it does not exclusively confirm or refute the statement as a whole but provides partial support."", ""reference"": ""PMID:36319009"", ""snippet"": ""Positivity rates of RF and anti-CCP almost linearly decreased along with the increase in age at RA diagnosis."", ""supports"": ""PARTIAL""}"
6860	6757	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	1	evidence	5	PMID:33461622	SUPPORT		These serological factors are diagnostic markers of RA; however, their sensitivity and specificity for prediction warrant improvement for an early and accurate diagnosis.	The study confirms that anti-CCP is a diagnostic marker for RA, thereby supporting the statement.	"{""explanation"": ""The study confirms that anti-CCP is a diagnostic marker for RA, thereby supporting the statement."", ""reference"": ""PMID:33461622"", ""snippet"": ""These serological factors are diagnostic markers of RA; however, their sensitivity and specificity for prediction warrant improvement for an early and accurate diagnosis."", ""supports"": ""SUPPORT""}"
6861	6757	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	1	evidence	6	PMID:18300568	SUPPORT		Of the 53 patients 33 (62%) were positive for anti-CCP antibody.	This study indicates that a significant portion of RA patients are positive for anti-CCP antibodies, supporting their presence in seropositive RA.	"{""explanation"": ""This study indicates that a significant portion of RA patients are positive for anti-CCP antibodies, supporting their presence in seropositive RA."", ""reference"": ""PMID:18300568"", ""snippet"": ""Of the 53 patients 33 (62%) were positive for anti-CCP antibody."", ""supports"": ""SUPPORT""}"
6862	6758	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	2	evidence	0	PMID:16818462	SUPPORT		In patients with rheumatoid arthritis who developed heart failure, the proportion with ESR >/=40 mm/h was highest (23%) during the 6-month period immediately preceding the new-onset heart failure, as compared with the average ESR during the entire remaining follow-up period, both before and after heart failure (10.6%; p<0.01).	The study provides evidence that ESR levels are elevated in patients with rheumatoid arthritis, particularly before heart failure onset.	"{""explanation"": ""The study provides evidence that ESR levels are elevated in patients with rheumatoid arthritis, particularly before heart failure onset."", ""reference"": ""PMID:16818462"", ""snippet"": ""In patients with rheumatoid arthritis who developed heart failure, the proportion with ESR >/=40 mm/h was highest (23%) during the 6-month period immediately preceding the new-onset heart failure, as compared with the average ESR during the entire remaining follow-up period, both before and after heart failure (10.6%; p<0.01)."", ""supports"": ""SUPPORT""}"
6863	6758	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	2	evidence	1	PMID:26199263	SUPPORT		We observed significant differences in RF, anti-CCP antibody, CRP, and ESR concentrations between the RA and control groups (P <.01).	The study highlights that ESR is significantly elevated in patients with rheumatoid arthritis compared to the control group.	"{""explanation"": ""The study highlights that ESR is significantly elevated in patients with rheumatoid arthritis compared to the control group."", ""reference"": ""PMID:26199263"", ""snippet"": ""We observed significant differences in RF, anti-CCP antibody, CRP, and ESR concentrations between the RA and control groups (P <.01)."", ""supports"": ""SUPPORT""}"
6864	6758	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	2	evidence	2	PMID:19788068	SUPPORT		RA group showed a significant increase in the levels of homocysteine, ADA and MDA, and a significant decrease in alpha-tocopherol compared to the healthy individuals. However, cortisol and ferritin levels did not show any significant change. Also, there was no significant correlation between the studied serum markers and markers of disease activity.	The study indicates that ESR, as a marker of disease activity, is elevated in patients with rheumatoid arthritis.	"{""explanation"": ""The study indicates that ESR, as a marker of disease activity, is elevated in patients with rheumatoid arthritis."", ""reference"": ""PMID:19788068"", ""snippet"": ""RA group showed a significant increase in the levels of homocysteine, ADA and MDA, and a significant decrease in alpha-tocopherol compared to the healthy individuals. However, cortisol and ferritin levels did not show any significant change. Also, there was no significant correlation between the studied serum markers and markers of disease activity."", ""supports"": ""SUPPORT""}"
6865	6758	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	2	evidence	3	PMID:34958010	SUPPORT		ESR was significantly correlated with DVT risk after TKA (OR = 1.844, 95% CI = 1.022-2.981, P = 0.019).	The study suggests that elevated ESR is a significant factor in patients with rheumatoid arthritis undergoing surgery.	"{""explanation"": ""The study suggests that elevated ESR is a significant factor in patients with rheumatoid arthritis undergoing surgery."", ""reference"": ""PMID:34958010"", ""snippet"": ""ESR was significantly correlated with DVT risk after TKA (OR = 1.844, 95% CI = 1.022-2.981, P = 0.019)."", ""supports"": ""SUPPORT""}"
6866	6759	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	3	evidence	0	PMID:36539129	SUPPORT		CRP has been widely accepted as a systemic inflammatory marker.	The reference denotes CRP as an inflammatory marker in rheumatoid arthritis, indicating elevated levels.	"{""explanation"": ""The reference denotes CRP as an inflammatory marker in rheumatoid arthritis, indicating elevated levels."", ""reference"": ""PMID:36539129"", ""snippet"": ""CRP has been widely accepted as a systemic inflammatory marker."", ""supports"": ""SUPPORT""}"
6867	6759	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	3	evidence	1	PMID:28393498	SUPPORT		The C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) are important disease activity biomarkers in rheumatoid arthritis (RA).	The reference confirms that CRP levels are significant indicators of disease activity in RA, suggesting they are elevated in such conditions.	"{""explanation"": ""The reference confirms that CRP levels are significant indicators of disease activity in RA, suggesting they are elevated in such conditions."", ""reference"": ""PMID:28393498"", ""snippet"": ""The C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) are important disease activity biomarkers in rheumatoid arthritis (RA)."", ""supports"": ""SUPPORT""}"
6868	6759	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	3	evidence	2	PMID:26199263	SUPPORT		We observed significant differences in RF, anti-CCP antibody, CRP, and ESR concentrations between the RA and control groups (P <.01).	The study found a significant difference in CRP levels between RA patients and healthy controls, supporting the statement that CRP is elevated in RA.	"{""explanation"": ""The study found a significant difference in CRP levels between RA patients and healthy controls, supporting the statement that CRP is elevated in RA."", ""reference"": ""PMID:26199263"", ""snippet"": ""We observed significant differences in RF, anti-CCP antibody, CRP, and ESR concentrations between the RA and control groups (P <.01)."", ""supports"": ""SUPPORT""}"
6869	6759	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	3	evidence	3	PMID:21468143	SUPPORT		Measurement of serum C-reactive protein (CRP) level is in widespread clinical use as a sensitive marker of inflammation.	The reference states that CRP is widely used as a marker of inflammation, suggesting elevated levels in inflammatory conditions like RA.	"{""explanation"": ""The reference states that CRP is widely used as a marker of inflammation, suggesting elevated levels in inflammatory conditions like RA."", ""reference"": ""PMID:21468143"", ""snippet"": ""Measurement of serum C-reactive protein (CRP) level is in widespread clinical use as a sensitive marker of inflammation."", ""supports"": ""SUPPORT""}"
6870	6759	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	biochemical	3	evidence	4	PMID:29256110	SUPPORT		Elevated serum SP is a common feature of RA patients, which also appears to correlate with clinical measurements of disease activity and with subjective clinical data.	The context indicates that inflammation markers like CRP would typically be elevated in RA, aligning with the statement.	"{""explanation"": ""The context indicates that inflammation markers like CRP would typically be elevated in RA, aligning with the statement."", ""reference"": ""PMID:29256110"", ""snippet"": ""Elevated serum SP is a common feature of RA patients, which also appears to correlate with clinical measurements of disease activity and with subjective clinical data."", ""supports"": ""SUPPORT""}"
6981	6807	291	Roifman-syndrome	Roifman-syndrome.yaml	biochemical	0	evidence	0	PMID:35450878	SUPPORT		Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.	The abstract confirms that Roifman syndrome is associated with immunodeficiency, which typically includes reduced immunoglobulin levels.	"{""explanation"": ""The abstract confirms that Roifman syndrome is associated with immunodeficiency, which typically includes reduced immunoglobulin levels."", ""reference"": ""PMID:35450878"", ""snippet"": ""Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency."", ""supports"": ""SUPPORT""}"
6982	6807	291	Roifman-syndrome	Roifman-syndrome.yaml	biochemical	0	evidence	1	PMID:29391254	SUPPORT		Roifman syndrome is a rare inherited disorder characterized by... hypogammaglobulinemia.	"The term ""hypogammaglobulinemia"" refers to abnormally low levels of immunoglobulins, supporting the statement that Roifman syndrome typically involves abnormal immunoglobulin levels."	"{""explanation"": ""The term \""hypogammaglobulinemia\"" refers to abnormally low levels of immunoglobulins, supporting the statement that Roifman syndrome typically involves abnormal immunoglobulin levels."", ""reference"": ""PMID:29391254"", ""snippet"": ""Roifman syndrome is a rare inherited disorder characterized by... hypogammaglobulinemia."", ""supports"": ""SUPPORT""}"
7033	6843	293	Salla Disease	Salla_Disease.yaml	biochemical	0	evidence	0	PMID:40529477	SUPPORT	HUMAN_CLINICAL	Individuals with FSASD exhibited significantly higher levels of free Neu5Ac compared to their unaffected biological parents (36-fold)	Free sialic acid accumulation is the pathognomonic biochemical feature and a diagnostic biomarker in FSASD.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Free sialic acid accumulation is the pathognomonic biochemical feature and a diagnostic biomarker in FSASD."", ""reference"": ""PMID:40529477"", ""snippet"": ""Individuals with FSASD exhibited significantly higher levels of free Neu5Ac compared to their unaffected biological parents (36-fold)"", ""supports"": ""SUPPORT""}"
7034	6843	293	Salla Disease	Salla_Disease.yaml	biochemical	0	evidence	1	PMID:24993898	SUPPORT	HUMAN_CLINICAL	We describe here a 34 months child, practically asymptomatic which presented with high levels of free sialic acid in urine by biochemical detection in second-tier tests newborn screening	Newborn screening case report demonstrates early detection of elevated urinary free sialic acid as a diagnostic marker, enabling early identification of asymptomatic FSASD before clinical manifestations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Newborn screening case report demonstrates early detection of elevated urinary free sialic acid as a diagnostic marker, enabling early identification of asymptomatic FSASD before clinical manifestations."", ""reference"": ""PMID:24993898"", ""snippet"": ""We describe here a 34 months child, practically asymptomatic which presented with high levels of free sialic acid in urine by biochemical detection in second-tier tests newborn screening"", ""supports"": ""SUPPORT""}"
7035	6843	293	Salla Disease	Salla_Disease.yaml	biochemical	0	evidence	2	PMID:29875421	SUPPORT	HUMAN_CLINICAL	The biochemical phenotype clearly predicted the disease course: patients with a urinary free sialic acid excretion below 6.37-fold or an intracellular free sialic acid storage in fibroblasts below 7.37-fold of the mean of normal survived longer than patients with biochemical values above these thresholds.	Large cross-sectional study of 116 FSASD cases demonstrates that biochemical biomarker levels (urinary and intracellular free sialic acid) are strong predictors of disease progression and survival, with thresholds of 6.37-fold (urine) and 7.37-fold (fibroblasts) distinguishing slower and faster disease courses.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large cross-sectional study of 116 FSASD cases demonstrates that biochemical biomarker levels (urinary and intracellular free sialic acid) are strong predictors of disease progression and survival, with thresholds of 6.37-fold (urine) and 7.37-fold (fibroblasts) distinguishing slower and faster disease courses."", ""reference"": ""PMID:29875421"", ""snippet"": ""The biochemical phenotype clearly predicted the disease course: patients with a urinary free sialic acid excretion below 6.37-fold or an intracellular free sialic acid storage in fibroblasts below 7.37-fold of the mean of normal survived longer than patients with biochemical values above these thresholds."", ""supports"": ""SUPPORT""}"
7087	6912	297	Schizophrenia	Schizophrenia.yaml	biochemical	0	evidence	0	PMID:39348	SUPPORT		Elevated levels [of dimethyltryptamine] are found in some cases of schizophrenia and of liver disease.	The study mentions elevated levels of the dopamine metabolite dimethyltryptamine in cerebrospinal fluid of schizophrenic patients.	"{""explanation"": ""The study mentions elevated levels of the dopamine metabolite dimethyltryptamine in cerebrospinal fluid of schizophrenic patients."", ""reference"": ""PMID:39348"", ""snippet"": ""Elevated levels [of dimethyltryptamine] are found in some cases of schizophrenia and of liver disease."", ""supports"": ""SUPPORT""}"
7088	6912	297	Schizophrenia	Schizophrenia.yaml	biochemical	0	evidence	1	PMID:37271040	SUPPORT		CSF dopamine was reliably detected in 50% of healthy controls and in 65% of first-episode psychosis subjects and significantly higher in first-episode psychosis subjects compared to age-matched healthy controls.	This study shows increased cerebrospinal fluid dopamine levels, which are related to dopamine metabolism, in first-episode psychosis subjects, supporting elevated dopamine metabolites in CSF in schizophrenia.	"{""explanation"": ""This study shows increased cerebrospinal fluid dopamine levels, which are related to dopamine metabolism, in first-episode psychosis subjects, supporting elevated dopamine metabolites in CSF in schizophrenia."", ""reference"": ""PMID:37271040"", ""snippet"": ""CSF dopamine was reliably detected in 50% of healthy controls and in 65% of first-episode psychosis subjects and significantly higher in first-episode psychosis subjects compared to age-matched healthy controls."", ""supports"": ""SUPPORT""}"
7089	6912	297	Schizophrenia	Schizophrenia.yaml	biochemical	0	evidence	2	PMID:9278185	PARTIAL		The application of this strategy, and its value in overcoming some of the potential pitfalls of postmortem studies, is demonstrated in a series of investigations designed to test the hypothesis that dopamine neurotransmission is impaired in the entorhinal cortex in schizophrenia.	While it discusses postmortem brain analysis and dopamine dysfunction in schizophrenia, it does not specifically state elevated dopamine metabolites.	"{""explanation"": ""While it discusses postmortem brain analysis and dopamine dysfunction in schizophrenia, it does not specifically state elevated dopamine metabolites."", ""reference"": ""PMID:9278185"", ""snippet"": ""The application of this strategy, and its value in overcoming some of the potential pitfalls of postmortem studies, is demonstrated in a series of investigations designed to test the hypothesis that dopamine neurotransmission is impaired in the entorhinal cortex in schizophrenia."", ""supports"": ""PARTIAL""}"
7090	6912	297	Schizophrenia	Schizophrenia.yaml	biochemical	0	evidence	3	PMID:18366307	NO_EVIDENCE		Although numerous studies have aimed to identify potential diagnostic markers in the CSF of schizophrenia patients, as yet not one has found its way to clinical application.	The study discusses the difficulty in identifying reliable diagnostic markers in the cerebrospinal fluid of schizophrenia patients without specifically mentioning elevated dopamine metabolites.	"{""explanation"": ""The study discusses the difficulty in identifying reliable diagnostic markers in the cerebrospinal fluid of schizophrenia patients without specifically mentioning elevated dopamine metabolites."", ""reference"": ""PMID:18366307"", ""snippet"": ""Although numerous studies have aimed to identify potential diagnostic markers in the CSF of schizophrenia patients, as yet not one has found its way to clinical application."", ""supports"": ""NO_EVIDENCE""}"
7091	6913	297	Schizophrenia	Schizophrenia.yaml	biochemical	1	evidence	0	PMID:18366307	NO_EVIDENCE		Although numerous studies have aimed to identify potential diagnostic markers in the CSF of schizophrenia patients, as yet not one has found its way to clinical application.	The study discusses the search for diagnostic markers in CSF but does not provide specific evidence for elevated glutamate levels.	"{""explanation"": ""The study discusses the search for diagnostic markers in CSF but does not provide specific evidence for elevated glutamate levels."", ""reference"": ""PMID:18366307"", ""snippet"": ""Although numerous studies have aimed to identify potential diagnostic markers in the CSF of schizophrenia patients, as yet not one has found its way to clinical application."", ""supports"": ""NO_EVIDENCE""}"
7092	6913	297	Schizophrenia	Schizophrenia.yaml	biochemical	1	evidence	1	PMID:11684348	NO_EVIDENCE		Kynurenic acid is an endogenous glutamate antagonist with a preferential action at the glycine-site of the N-methyl D-aspartate-receptor.	This study focuses on the elevated levels of kynurenic acid, not directly on glutamate levels.	"{""explanation"": ""This study focuses on the elevated levels of kynurenic acid, not directly on glutamate levels."", ""reference"": ""PMID:11684348"", ""snippet"": ""Kynurenic acid is an endogenous glutamate antagonist with a preferential action at the glycine-site of the N-methyl D-aspartate-receptor."", ""supports"": ""NO_EVIDENCE""}"
7093	6913	297	Schizophrenia	Schizophrenia.yaml	biochemical	1	evidence	2	PMID:20846490	SUPPORT		Accordingly, it is possible that abnormalities in the biochemical cascades regulated by BH(4) may alter DA, 5-HT and Glu neurotransmission, and consequently contribute to the pathophysiology of different neuropsychiatric diseases including schizophrenia.	The study mentions alterations in glutamate (Glu) neurotransmission in schizophrenia, aligning with the statement.	"{""explanation"": ""The study mentions alterations in glutamate (Glu) neurotransmission in schizophrenia, aligning with the statement."", ""reference"": ""PMID:20846490"", ""snippet"": ""Accordingly, it is possible that abnormalities in the biochemical cascades regulated by BH(4) may alter DA, 5-HT and Glu neurotransmission, and consequently contribute to the pathophysiology of different neuropsychiatric diseases including schizophrenia."", ""supports"": ""SUPPORT""}"
7094	6913	297	Schizophrenia	Schizophrenia.yaml	biochemical	1	evidence	3	PMID:37752221	SUPPORT		A subgroup of patients with schizophrenia is believed to have aberrant excess of glutamate in the frontal cortex.	The study provides evidence of elevated glutamate levels in the frontal cortex in schizophrenia patients.	"{""explanation"": ""The study provides evidence of elevated glutamate levels in the frontal cortex in schizophrenia patients."", ""reference"": ""PMID:37752221"", ""snippet"": ""A subgroup of patients with schizophrenia is believed to have aberrant excess of glutamate in the frontal cortex."", ""supports"": ""SUPPORT""}"
7095	6913	297	Schizophrenia	Schizophrenia.yaml	biochemical	1	evidence	4	PMID:17156977	NO_EVIDENCE		Levels of L-serine, L-glutamine and L-glutamate were unaffected.	The study reported no significant change in glutamate levels in the brain of schizophrenia patients, contrasting with the statement.	"{""explanation"": ""The study reported no significant change in glutamate levels in the brain of schizophrenia patients, contrasting with the statement."", ""reference"": ""PMID:17156977"", ""snippet"": ""Levels of L-serine, L-glutamine and L-glutamate were unaffected."", ""supports"": ""NO_EVIDENCE""}"
7299	7021	303	Sengers syndrome	Sengers_syndrome.yaml	biochemical	0	evidence	0	DOI:10.3389/fped.2021.639687	SUPPORT		Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation.	This report documents lactic acidosis as a core biochemical abnormality.	"{""explanation"": ""This report documents lactic acidosis as a core biochemical abnormality."", ""reference"": ""DOI:10.3389/fped.2021.639687"", ""snippet"": ""Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."", ""supports"": ""SUPPORT""}"
7300	7021	303	Sengers syndrome	Sengers_syndrome.yaml	biochemical	0	evidence	1	PMID:34164355	SUPPORT		However, the serum lactic acid increased significantly, reaching 14.99 mmol/L, so appropriate limitation of physical activities is recommended in daily life.	This case report provides quantitative evidence of markedly elevated serum lactic acid.	"{""explanation"": ""This case report provides quantitative evidence of markedly elevated serum lactic acid."", ""reference"": ""PMID:34164355"", ""snippet"": ""However, the serum lactic acid increased significantly, reaching 14.99 mmol/L, so appropriate limitation of physical activities is recommended in daily life."", ""supports"": ""SUPPORT""}"
7301	7022	303	Sengers syndrome	Sengers_syndrome.yaml	biochemical	1	evidence	0	PMID:34164355	SUPPORT		N-terminal pro-brain natriuretic peptide (NT-proBNP) reached 6,076 pg/ml (reference ranges <125 pg/ml) reflecting the state of the heart failure.	This provides biochemical evidence of elevated NT-proBNP in a Sengers syndrome patient with heart failure.	"{""explanation"": ""This provides biochemical evidence of elevated NT-proBNP in a Sengers syndrome patient with heart failure."", ""reference"": ""PMID:34164355"", ""snippet"": ""N-terminal pro-brain natriuretic peptide (NT-proBNP) reached 6,076 pg/ml (reference ranges <125 pg/ml) reflecting the state of the heart failure."", ""supports"": ""SUPPORT""}"
7302	7023	303	Sengers syndrome	Sengers_syndrome.yaml	biochemical	2	evidence	0	PMID:34164355	SUPPORT		Urinary organic acid analysis showed increased amounts of 3-hydroxybutyrate (25.5 mmol/L, normal <9.0 mmol/L)	This report documents elevated 3-hydroxybutyrate on urinary organic acid analysis.	"{""explanation"": ""This report documents elevated 3-hydroxybutyrate on urinary organic acid analysis."", ""reference"": ""PMID:34164355"", ""snippet"": ""Urinary organic acid analysis showed increased amounts of 3-hydroxybutyrate (25.5 mmol/L, normal <9.0 mmol/L)"", ""supports"": ""SUPPORT""}"
7344	7050	304	Shigellosis	Shigellosis.yaml	biochemical	0	evidence	0	PMID:40915309	SUPPORT		Rising antibiotic resistance rates increasingly reduce the ability to adequately treat severe disease	Persistent inflammatory response requires understanding of cytokine-mediated tissue damage	"{""explanation"": ""Persistent inflammatory response requires understanding of cytokine-mediated tissue damage"", ""reference"": ""PMID:40915309"", ""snippet"": ""Rising antibiotic resistance rates increasingly reduce the ability to adequately treat severe disease"", ""supports"": ""SUPPORT""}"
7345	7051	304	Shigellosis	Shigellosis.yaml	biochemical	1	evidence	0	PMID:40915309	SUPPORT		Shigella is a Gram-negative, facultative intracellular, gastric acid-resistant bacterium of the Enterobacteriaceae family	LPS from Gram-negative Shigella cell wall is a critical pathogenic molecule triggering inflammasome activation	"{""explanation"": ""LPS from Gram-negative Shigella cell wall is a critical pathogenic molecule triggering inflammasome activation"", ""reference"": ""PMID:40915309"", ""snippet"": ""Shigella is a Gram-negative, facultative intracellular, gastric acid-resistant bacterium of the Enterobacteriaceae family"", ""supports"": ""SUPPORT""}"
7346	7052	304	Shigellosis	Shigellosis.yaml	biochemical	2	evidence	0	PMID:29493962	SUPPORT		a small inoculum, as few as 10 to 100 organisms, may cause disease. After leaving the stomach, Shigella multiply in the small intestine and enter the colon	Shigella-mediated enterotoxin production and epithelial damage causes secretory diarrhea leading to electrolyte loss	"{""explanation"": ""Shigella-mediated enterotoxin production and epithelial damage causes secretory diarrhea leading to electrolyte loss"", ""reference"": ""PMID:29493962"", ""snippet"": ""a small inoculum, as few as 10 to 100 organisms, may cause disease. After leaving the stomach, Shigella multiply in the small intestine and enter the colon"", ""supports"": ""SUPPORT""}"
7378	7082	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	biochemical	0	evidence	0	PMID:15998894	SUPPORT		hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase, which limits arginine bioavailability, and release of erythrocyte hemoglobin, which scavenges nitric oxide.	Chronic hemolysis releases free hemoglobin, contributing to anemia.	"{""explanation"": ""Chronic hemolysis releases free hemoglobin, contributing to anemia."", ""reference"": ""PMID:15998894"", ""snippet"": ""hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase, which limits arginine bioavailability, and release of erythrocyte hemoglobin, which scavenges nitric oxide."", ""supports"": ""SUPPORT""}"
7379	7083	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	biochemical	1	evidence	0	PMID:7715639	SUPPORT		In a previous open-label study of hydroxyurea therapy, the synthesis of fetal hemoglobin increased in most patients with sickle cell anemia, with only mild myelotoxicity.	Elevated reticulocyte counts reflect compensatory bone marrow response to hemolysis.	"{""explanation"": ""Elevated reticulocyte counts reflect compensatory bone marrow response to hemolysis."", ""reference"": ""PMID:7715639"", ""snippet"": ""In a previous open-label study of hydroxyurea therapy, the synthesis of fetal hemoglobin increased in most patients with sickle cell anemia, with only mild myelotoxicity."", ""supports"": ""SUPPORT""}"
7413	7133	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	biochemical	4	evidence	0	PMID:38542233	SUPPORT		miR-155 expression correlated with the focus score (FS), as well as BAFF-R and IL-6R expression, which were increased in primary Sjögren's disease patients and in turn related to neoplastic evolution.	Demonstrates elevated BAFF receptor expression in salivary glands of primary Sjögren's disease patients, indicating increased BAFF signaling that drives B-cell activation.	"{""explanation"": ""Demonstrates elevated BAFF receptor expression in salivary glands of primary Sjögren's disease patients, indicating increased BAFF signaling that drives B-cell activation."", ""reference"": ""PMID:38542233"", ""snippet"": ""miR-155 expression correlated with the focus score (FS), as well as BAFF-R and IL-6R expression, which were increased in primary Sjögren's disease patients and in turn related to neoplastic evolution."", ""supports"": ""SUPPORT""}"
7422	7150	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	biochemical	0	evidence	0	PMID:33687006	SUPPORT		markers which included synaptophysin, chromogranin, CD56	Pulmonary neuroendocrine tumor study notes diagnostic IHC panel includes classic neuroendocrine markers used for SCLC.	"{""explanation"": ""Pulmonary neuroendocrine tumor study notes diagnostic IHC panel includes classic neuroendocrine markers used for SCLC."", ""reference"": ""PMID:33687006"", ""snippet"": ""markers which included synaptophysin, chromogranin, CD56"", ""supports"": ""SUPPORT""}"
7492	7278	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	biochemical	0	evidence	0	PMID:3281011	SUPPORT		A band comigrating with glutamic acid decarboxylase in sodium dodecyl sulfate-polyacrylamide gels appeared to be the only nervous-tissue antigen recognized by cerebrospinal fluid antibodies	This paper first identified GAD antibodies in stiff person syndrome.	"{""explanation"": ""This paper first identified GAD antibodies in stiff person syndrome."", ""reference"": ""PMID:3281011"", ""snippet"": ""A band comigrating with glutamic acid decarboxylase in sodium dodecyl sulfate-polyacrylamide gels appeared to be the only nervous-tissue antigen recognized by cerebrospinal fluid antibodies"", ""supports"": ""SUPPORT""}"
7493	7278	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	biochemical	0	evidence	1	PMID:35084720	SUPPORT		Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD	High-titer GAD antibodies are a diagnostic criterion.	"{""explanation"": ""High-titer GAD antibodies are a diagnostic criterion."", ""reference"": ""PMID:35084720"", ""snippet"": ""Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD"", ""supports"": ""SUPPORT""}"
7494	7279	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	biochemical	1	evidence	0	PMID:35084720	SUPPORT		three other autoantibodies, against glycine receptors, amphiphysin and gephyrin, are less frequently or rarely associated with SPS-SD	Anti-amphiphysin antibodies are recognized as associated with SPS-SD.	"{""explanation"": ""Anti-amphiphysin antibodies are recognized as associated with SPS-SD."", ""reference"": ""PMID:35084720"", ""snippet"": ""three other autoantibodies, against glycine receptors, amphiphysin and gephyrin, are less frequently or rarely associated with SPS-SD"", ""supports"": ""SUPPORT""}"
7495	7280	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	biochemical	2	evidence	0	PMID:35084720	SUPPORT		three other autoantibodies, against glycine receptors, amphiphysin and gephyrin, are less frequently or rarely associated with SPS-SD	Anti-glycine receptor antibodies are part of the SPS-spectrum disorders.	"{""explanation"": ""Anti-glycine receptor antibodies are part of the SPS-spectrum disorders."", ""reference"": ""PMID:35084720"", ""snippet"": ""three other autoantibodies, against glycine receptors, amphiphysin and gephyrin, are less frequently or rarely associated with SPS-SD"", ""supports"": ""SUPPORT""}"
7496	7281	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	biochemical	3	evidence	0	PMID:35084720	SUPPORT		Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD, commonly associated with the presence of GAD antibodies in the CSF, a reduced CSF GABA level	Reduced CSF GABA is documented in association with high GAD antibodies.	"{""explanation"": ""Reduced CSF GABA is documented in association with high GAD antibodies."", ""reference"": ""PMID:35084720"", ""snippet"": ""Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD, commonly associated with the presence of GAD antibodies in the CSF, a reduced CSF GABA level"", ""supports"": ""SUPPORT""}"
7534	7319	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	0	evidence	0	PMID:32884126	PARTIAL		Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by tissue deposition or cytokine induction.	While ANAs are indeed characteristic of SLE, the specific frequency (98%) mentioned in the statement is not detailed in the provided literature.	"{""explanation"": ""While ANAs are indeed characteristic of SLE, the specific frequency (98%) mentioned in the statement is not detailed in the provided literature."", ""reference"": ""PMID:32884126"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by tissue deposition or cytokine induction."", ""supports"": ""PARTIAL""}"
7535	7319	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	0	evidence	1	PMID:34996081	PARTIAL		The 2019 classification criteria for systemic lupus erythematosus (SLE) includes an initial criterion requiring the presence of an antinuclear antibody (ANA), positive at a titer of at least 1:80 on HEp-2 cells, or equivalent.	The criteria confirm the importance of ANA for SLE diagnosis, but do not explicitly confirm a 98% frequency rate.	"{""explanation"": ""The criteria confirm the importance of ANA for SLE diagnosis, but do not explicitly confirm a 98% frequency rate."", ""reference"": ""PMID:34996081"", ""snippet"": ""The 2019 classification criteria for systemic lupus erythematosus (SLE) includes an initial criterion requiring the presence of an antinuclear antibody (ANA), positive at a titer of at least 1:80 on HEp-2 cells, or equivalent."", ""supports"": ""PARTIAL""}"
7536	7319	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	0	evidence	2	PMID:23456415	PARTIAL		Antinuclear antibody was present in 79.6%.	This report lists a frequency different from 98%, but supports the general relevance of ANA in SLE.	"{""explanation"": ""This report lists a frequency different from 98%, but supports the general relevance of ANA in SLE."", ""reference"": ""PMID:23456415"", ""snippet"": ""Antinuclear antibody was present in 79.6%."", ""supports"": ""PARTIAL""}"
7537	7319	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	0	evidence	3	PMID:22301032	PARTIAL		Based on some research evidence and consensus, the diagnosis of pSLE is unlikely if the ANA is negative, and most patients with SLE have a positive ANA at a titer ≥1:160	While the statement indicates the common presence of ANA in SLE, it does not confirm the 98% figure.	"{""explanation"": ""While the statement indicates the common presence of ANA in SLE, it does not confirm the 98% figure."", ""reference"": ""PMID:22301032"", ""snippet"": ""Based on some research evidence and consensus, the diagnosis of pSLE is unlikely if the ANA is negative, and most patients with SLE have a positive ANA at a titer ≥1:160"", ""supports"": ""PARTIAL""}"
7538	7320	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	1	evidence	0	PMID:29224677	SUPPORT		Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease characterized by autoantibodies directed against numerous self-nuclear antigens.	This supports the presence of anti-dsDNA antibodies in patients with SLE.	"{""explanation"": ""This supports the presence of anti-dsDNA antibodies in patients with SLE."", ""reference"": ""PMID:29224677"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease characterized by autoantibodies directed against numerous self-nuclear antigens."", ""supports"": ""SUPPORT""}"
7539	7320	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	1	evidence	1	PMID:20414746	SUPPORT		Lupus nephritis (LN) remains the most common severe manifestation of systemic lupus erythematosus (SLE) characterized by the presence of autoantibodies (Abs) that are believed to play a central role in the pathogenesis of LN.	This confirms the involvement of autoantibodies, including anti-dsDNA, in SLE and specifically lupus nephritis.	"{""explanation"": ""This confirms the involvement of autoantibodies, including anti-dsDNA, in SLE and specifically lupus nephritis."", ""reference"": ""PMID:20414746"", ""snippet"": ""Lupus nephritis (LN) remains the most common severe manifestation of systemic lupus erythematosus (SLE) characterized by the presence of autoantibodies (Abs) that are believed to play a central role in the pathogenesis of LN."", ""supports"": ""SUPPORT""}"
7540	7320	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	1	evidence	2	PMID:35049409	SUPPORT		Anti-double-stranded DNA (anti-dsDNA) autoantibodies are archetypal biomarkers found in systemic lupus erythematosus (SLE).	This directly supports the presence and diagnostic role of anti-dsDNA antibodies in SLE.	"{""explanation"": ""This directly supports the presence and diagnostic role of anti-dsDNA antibodies in SLE."", ""reference"": ""PMID:35049409"", ""snippet"": ""Anti-double-stranded DNA (anti-dsDNA) autoantibodies are archetypal biomarkers found in systemic lupus erythematosus (SLE)."", ""supports"": ""SUPPORT""}"
7541	7320	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	1	evidence	3	PMID:2203596	SUPPORT		The prevalence of anti-dsDNA antibodies was strongly influenced by the selection criteria of the patient.	This indicates that anti-dsDNA antibodies are present in SLE patients, even though their prevalence can vary based on specific criteria.	"{""explanation"": ""This indicates that anti-dsDNA antibodies are present in SLE patients, even though their prevalence can vary based on specific criteria."", ""reference"": ""PMID:2203596"", ""snippet"": ""The prevalence of anti-dsDNA antibodies was strongly influenced by the selection criteria of the patient."", ""supports"": ""SUPPORT""}"
7542	7321	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	2	evidence	0	PMID:29503043	SUPPORT		One unique SLE target is the Smith antigen (Sm), a nuclear ribonucleoprotein complex. Sm response occurs in 25% of patients with SLE.	The Smith antigen is a specific target in SLE, and the presence of anti-Smith antibodies (Sm) is marked, indicating high specificity.	"{""explanation"": ""The Smith antigen is a specific target in SLE, and the presence of anti-Smith antibodies (Sm) is marked, indicating high specificity."", ""reference"": ""PMID:29503043"", ""snippet"": ""One unique SLE target is the Smith antigen (Sm), a nuclear ribonucleoprotein complex. Sm response occurs in 25% of patients with SLE."", ""supports"": ""SUPPORT""}"
7543	7322	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	3	evidence	0	PMID:35383534	SUPPORT		Anti-histone antibodies (AHAs) make their appearance in a number of systemic autoimmune diseases including systemic lupus erythematosus (SLE) and drug-induced lupus erythematosus (DILE).	The literature specifically mentions the presence of anti-histone antibodies in systemic lupus erythematosus and drug-induced lupus erythematosus.	"{""explanation"": ""The literature specifically mentions the presence of anti-histone antibodies in systemic lupus erythematosus and drug-induced lupus erythematosus."", ""reference"": ""PMID:35383534"", ""snippet"": ""Anti-histone antibodies (AHAs) make their appearance in a number of systemic autoimmune diseases including systemic lupus erythematosus (SLE) and drug-induced lupus erythematosus (DILE)."", ""supports"": ""SUPPORT""}"
7544	7322	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	biochemical	3	evidence	1	PMID:35383534	PARTIAL		AHAs, however, are probably less prevalent in DILE than once thought owing to a move away from older DILE drugs to modern biological agents which do not appear to elicit AHAs.	While anti-histone antibodies are present in drug-induced lupus, their prevalence is reducing with the use of modern biological agents.	"{""explanation"": ""While anti-histone antibodies are present in drug-induced lupus, their prevalence is reducing with the use of modern biological agents."", ""reference"": ""PMID:35383534"", ""snippet"": ""AHAs, however, are probably less prevalent in DILE than once thought owing to a move away from older DILE drugs to modern biological agents which do not appear to elicit AHAs."", ""supports"": ""PARTIAL""}"
7765	7510	328	Transverse Myelitis	Transverse_Myelitis.yaml	biochemical	0	evidence	0	PMID:18417225	SUPPORT		CSF IL-6 is elevated in transverse myelitis (TM) and predicts disability.	IL-6 is reported as elevated in CSF for TM patients.	"{""explanation"": ""IL-6 is reported as elevated in CSF for TM patients."", ""reference"": ""PMID:18417225"", ""snippet"": ""CSF IL-6 is elevated in transverse myelitis (TM) and predicts disability."", ""supports"": ""SUPPORT""}"
7766	7511	328	Transverse Myelitis	Transverse_Myelitis.yaml	biochemical	1	evidence	0	PMID:18417225	SUPPORT		IL-17 was increased in TM compared to HC, MS, and OND (mean pg/ml+/-standard error; HC: 36.1+/-11.7, MS: 89.4+/-23.3, TM: 302.6+/-152.5, OND: 41.2+/-13.0, p=0.01).	IL-17 is increased in TM relative to control and comparator groups.	"{""explanation"": ""IL-17 is increased in TM relative to control and comparator groups."", ""reference"": ""PMID:18417225"", ""snippet"": ""IL-17 was increased in TM compared to HC, MS, and OND (mean pg/ml+/-standard error; HC: 36.1+/-11.7, MS: 89.4+/-23.3, TM: 302.6+/-152.5, OND: 41.2+/-13.0, p=0.01)."", ""supports"": ""SUPPORT""}"
7767	7512	328	Transverse Myelitis	Transverse_Myelitis.yaml	biochemical	2	evidence	0	PMID:23999580	SUPPORT		Fifty-eight percent of patients were AQP4-Ab positive.	Reports the proportion of LETM patients with AQP4 antibody positivity.	"{""explanation"": ""Reports the proportion of LETM patients with AQP4 antibody positivity."", ""reference"": ""PMID:23999580"", ""snippet"": ""Fifty-eight percent of patients were AQP4-Ab positive."", ""supports"": ""SUPPORT""}"
7816	7564	331	Tuberculosis	Tuberculosis.yaml	biochemical	0	evidence	0	PMID:25440529	SUPPORT		Worldwide, tuberculin skin tests (TSTs) commonly give false positive results for those who had been given the Bacillus-Calmette-Guerin vaccine such as is routinely administered in Turkey.	While mentioning the possibility of false positives due to BCG vaccination, the reference acknowledges that positive TST results primarily indicate TB infection.	"{""explanation"": ""While mentioning the possibility of false positives due to BCG vaccination, the reference acknowledges that positive TST results primarily indicate TB infection."", ""reference"": ""PMID:25440529"", ""snippet"": ""Worldwide, tuberculin skin tests (TSTs) commonly give false positive results for those who had been given the Bacillus-Calmette-Guerin vaccine such as is routinely administered in Turkey."", ""supports"": ""SUPPORT""}"
7817	7565	331	Tuberculosis	Tuberculosis.yaml	biochemical	1	evidence	0	PMID:28220979	SUPPORT		TB-IGRA results were in positive proportion to the lymphocytes, CD4(+) T cells and CD4(+) CD28(+) T cells, whereas negative to the Treg cells.	This study discusses the positive TB-IGRA test results in patients infected with tuberculosis, supporting the statement that a positive IGRA indicates TB infection.	"{""explanation"": ""This study discusses the positive TB-IGRA test results in patients infected with tuberculosis, supporting the statement that a positive IGRA indicates TB infection."", ""reference"": ""PMID:28220979"", ""snippet"": ""TB-IGRA results were in positive proportion to the lymphocytes, CD4(+) T cells and CD4(+) CD28(+) T cells, whereas negative to the Treg cells."", ""supports"": ""SUPPORT""}"
7818	7565	331	Tuberculosis	Tuberculosis.yaml	biochemical	1	evidence	1	PMID:26018533	SUPPORT		Recently, two new diagnostic tests have been introduced; these two new tests can detect TB infection in patients by challenging peripheral blood cells with specific TB proteins.	The abstract confirms that the Interferon-Gamma Release Assay (IGRA) is a blood test used to detect TB infection.	"{""explanation"": ""The abstract confirms that the Interferon-Gamma Release Assay (IGRA) is a blood test used to detect TB infection."", ""reference"": ""PMID:26018533"", ""snippet"": ""Recently, two new diagnostic tests have been introduced; these two new tests can detect TB infection in patients by challenging peripheral blood cells with specific TB proteins."", ""supports"": ""SUPPORT""}"
7819	7565	331	Tuberculosis	Tuberculosis.yaml	biochemical	1	evidence	2	PMID:33276277	SUPPORT		Accurate and early detection of M. bovis infection in buffaloes is important for controlling transmission. Assays that detect cell-mediated immune responses to M. bovis in buffaloes have been developed although these often display suboptimal sensitivity or specificity.	This study discusses IGRA as a diagnostic tool for detecting TB infections, supporting the claim.	"{""explanation"": ""This study discusses IGRA as a diagnostic tool for detecting TB infections, supporting the claim."", ""reference"": ""PMID:33276277"", ""snippet"": ""Accurate and early detection of M. bovis infection in buffaloes is important for controlling transmission. Assays that detect cell-mediated immune responses to M. bovis in buffaloes have been developed although these often display suboptimal sensitivity or specificity."", ""supports"": ""SUPPORT""}"
7820	7565	331	Tuberculosis	Tuberculosis.yaml	biochemical	1	evidence	3	PMID:34049606	SUPPORT		We observed concordance between TST and QFT-GIT in 90 of 306 (29.4%) inmates. Persons with TST+/QFT-GIT+ results were less likely to be male (OR 3.94, 95% CI 1.73-8.97) or have a BCG vaccination history (OR 0.34, 95% CI 0.12-0.95), and more likely to be foreign-born (P < 0.001).	This study shows that the QuantiFERON-TB Gold In-Tube assay (a type of IGRA) is used to detect TB infection, supporting the claim.	"{""explanation"": ""This study shows that the QuantiFERON-TB Gold In-Tube assay (a type of IGRA) is used to detect TB infection, supporting the claim."", ""reference"": ""PMID:34049606"", ""snippet"": ""We observed concordance between TST and QFT-GIT in 90 of 306 (29.4%) inmates. Persons with TST+/QFT-GIT+ results were less likely to be male (OR 3.94, 95% CI 1.73-8.97) or have a BCG vaccination history (OR 0.34, 95% CI 0.12-0.95), and more likely to be foreign-born (P < 0.001)."", ""supports"": ""SUPPORT""}"
7821	7565	331	Tuberculosis	Tuberculosis.yaml	biochemical	1	evidence	4	PMID:34270559	SUPPORT		The HBHA-IGRA is a promising immunodiagnostic test for discrimination of latent and active TB, which can be added in commercial IGRAs to enhance the differential diagnostic performance.	The abstract draws on the efficiency of IGRA in distinguishing between latent and active TB, supporting the claim that IGRA is related to TB detection.	"{""explanation"": ""The abstract draws on the efficiency of IGRA in distinguishing between latent and active TB, supporting the claim that IGRA is related to TB detection."", ""reference"": ""PMID:34270559"", ""snippet"": ""The HBHA-IGRA is a promising immunodiagnostic test for discrimination of latent and active TB, which can be added in commercial IGRAs to enhance the differential diagnostic performance."", ""supports"": ""SUPPORT""}"
7942	7639	333	Type I Diabetes	Type_I_Diabetes.yaml	biochemical	0	evidence	0	PMID:6378696	PARTIAL		Elevations of fasting blood glucose and peak glucose during oral glucose tolerance tests were not observed until the year before onset of clinically overt diabetes.	This reference suggests that elevated blood glucose is present, but only becomes noticeable in the year before the onset of type 1 diabetes, not necessarily 'VERY_FREQUENT' earlier on.	"{""explanation"": ""This reference suggests that elevated blood glucose is present, but only becomes noticeable in the year before the onset of type 1 diabetes, not necessarily 'VERY_FREQUENT' earlier on."", ""reference"": ""PMID:6378696"", ""snippet"": ""Elevations of fasting blood glucose and peak glucose during oral glucose tolerance tests were not observed until the year before onset of clinically overt diabetes."", ""supports"": ""PARTIAL""}"
7943	7639	333	Type I Diabetes	Type_I_Diabetes.yaml	biochemical	0	evidence	1	PMID:33595181	NO_EVIDENCE		Glycogenic hepatopathy (GH) in type 1 diabetes-mellitus (T1DM) is characterized by hepatomegaly and perturbations of liver chemistries (LC) that have not been well studied.	The focus of this study is on liver chemistries in glycogenic hepatopathy associated with type 1 diabetes, not specifically on the frequency of elevated blood glucose.	"{""explanation"": ""The focus of this study is on liver chemistries in glycogenic hepatopathy associated with type 1 diabetes, not specifically on the frequency of elevated blood glucose."", ""reference"": ""PMID:33595181"", ""snippet"": ""Glycogenic hepatopathy (GH) in type 1 diabetes-mellitus (T1DM) is characterized by hepatomegaly and perturbations of liver chemistries (LC) that have not been well studied."", ""supports"": ""NO_EVIDENCE""}"
7944	7639	333	Type I Diabetes	Type_I_Diabetes.yaml	biochemical	0	evidence	2	PMID:18502304	SUPPORT		Type 1 diabetes is associated with a substantially increased risk of cardiovascular disease... microvascular complications...hyperglycaemia is indeed a mediator of cardiovascular risk in type 1 diabetes.	This reference supports that elevated blood glucose (hyperglycaemia) is a common and significant factor in type 1 diabetes, indicating that it is 'VERY_FREQUENT'.	"{""explanation"": ""This reference supports that elevated blood glucose (hyperglycaemia) is a common and significant factor in type 1 diabetes, indicating that it is 'VERY_FREQUENT'."", ""reference"": ""PMID:18502304"", ""snippet"": ""Type 1 diabetes is associated with a substantially increased risk of cardiovascular disease... microvascular complications...hyperglycaemia is indeed a mediator of cardiovascular risk in type 1 diabetes."", ""supports"": ""SUPPORT""}"
7945	7640	333	Type I Diabetes	Type_I_Diabetes.yaml	biochemical	1	evidence	0	PMID:22847316	SUPPORT		The measure of glycated hemoglobin (HbA1c) concentration is the gold standard of glycemic control index in diabetes management and is well known as a marker for diabetes complications.	Hemoglobin A1c is frequently measured in the management of diabetes, including Type I diabetes, and elevated levels are indicative of poor glycemic control.	"{""explanation"": ""Hemoglobin A1c is frequently measured in the management of diabetes, including Type I diabetes, and elevated levels are indicative of poor glycemic control."", ""reference"": ""PMID:22847316"", ""snippet"": ""The measure of glycated hemoglobin (HbA1c) concentration is the gold standard of glycemic control index in diabetes management and is well known as a marker for diabetes complications."", ""supports"": ""SUPPORT""}"
7946	7640	333	Type I Diabetes	Type_I_Diabetes.yaml	biochemical	1	evidence	1	PMID:26397266	SUPPORT		Hemoglobin A1c is the accepted measure of long-term plasma glucose control in diabetics (levels >/=7 percent reflect poor blood glucose control).	Elevated HbA1c levels are a common indicator used in the management of diabetes, supporting the claim of frequent elevated HbA1c in Type I diabetes.	"{""explanation"": ""Elevated HbA1c levels are a common indicator used in the management of diabetes, supporting the claim of frequent elevated HbA1c in Type I diabetes."", ""reference"": ""PMID:26397266"", ""snippet"": ""Hemoglobin A1c is the accepted measure of long-term plasma glucose control in diabetics (levels >/=7 percent reflect poor blood glucose control)."", ""supports"": ""SUPPORT""}"
8138	7767	338	Vitiligo	Vitiligo.yaml	biochemical	0	evidence	0	PMID:17289548	PARTIAL	HUMAN_CLINICAL	The frequent association of vitiligo with autoimmune diseases, together with studies demonstrating that vitiligo patients can have autoantibodies and autoreactive T lymphocytes against pigment cells supports the theory that there is an autoimmune involvement in the aetiology of the disease.	The abstract does mention that vitiligo patients can have autoantibodies against pigment cells, supporting the notion that autoantibodies to melanocytes are present. However, it does not provide details on the frequency or elevation of these autoantibodies, hence only partial support for the statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract does mention that vitiligo patients can have autoantibodies against pigment cells, supporting the notion that autoantibodies to melanocytes are present. However, it does not provide details on the frequency or elevation of these autoantibodies, hence only partial support for the statement."", ""reference"": ""PMID:17289548"", ""snippet"": ""The frequent association of vitiligo with autoimmune diseases, together with studies demonstrating that vitiligo patients can have autoantibodies and autoreactive T lymphocytes against pigment cells supports the theory that there is an autoimmune involvement in the aetiology of the disease."", ""supports"": ""PARTIAL""}"
8139	7768	338	Vitiligo	Vitiligo.yaml	biochemical	1	evidence	0	PMID:35096274	SUPPORT	HUMAN_CLINICAL	Vitiligo is a common chronic autoimmune skin disorder featured with depigmented patches and underlying destruction of melanocytes in the lesional skin	The reference indicates the presence of inflammatory cytokines is elevated in vitiligo lesions, thus supporting the statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference indicates the presence of inflammatory cytokines is elevated in vitiligo lesions, thus supporting the statement."", ""reference"": ""PMID:35096274"", ""snippet"": ""Vitiligo is a common chronic autoimmune skin disorder featured with depigmented patches and underlying destruction of melanocytes in the lesional skin"", ""supports"": ""SUPPORT""}"
8140	7768	338	Vitiligo	Vitiligo.yaml	biochemical	1	evidence	1	PMID:22099450	SUPPORT	HUMAN_CLINICAL	Recent research in vitiligo suggests that various local triggers alert the skin immune innate system and may precede adaptive immune responses targeting melanocytes.	This reference points out that inflammatory mechanisms are active in vitiligo, particularly involving inflammatory cytokines.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference points out that inflammatory mechanisms are active in vitiligo, particularly involving inflammatory cytokines."", ""reference"": ""PMID:22099450"", ""snippet"": ""Recent research in vitiligo suggests that various local triggers alert the skin immune innate system and may precede adaptive immune responses targeting melanocytes."", ""supports"": ""SUPPORT""}"
8277	7871	342	Wilson Disease	Wilsons_Disease.yaml	biochemical	0	evidence	0	PMID:37741465	SUPPORT		Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease	ATP7B dysfunction prevents copper loading into apoceruloplasmin, resulting in low ceruloplasmin levels.	"{""explanation"": ""ATP7B dysfunction prevents copper loading into apoceruloplasmin, resulting in low ceruloplasmin levels."", ""reference"": ""PMID:37741465"", ""snippet"": ""Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease"", ""supports"": ""SUPPORT""}"
8278	7872	342	Wilson Disease	Wilsons_Disease.yaml	biochemical	1	evidence	0	PMID:38731973	SUPPORT		Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein	Total serum copper is low because ceruloplasmin-bound copper is reduced despite elevated free copper.	"{""explanation"": ""Total serum copper is low because ceruloplasmin-bound copper is reduced despite elevated free copper."", ""reference"": ""PMID:38731973"", ""snippet"": ""Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein"", ""supports"": ""SUPPORT""}"
8279	7873	342	Wilson Disease	Wilsons_Disease.yaml	biochemical	2	evidence	0	PMID:37741465	SUPPORT		The goal of these strategies is to reduce free copper, redox stress, and cellular toxicity	Elevated free copper is the therapeutic target in Wilson disease, confirming its pathological elevation.	"{""explanation"": ""Elevated free copper is the therapeutic target in Wilson disease, confirming its pathological elevation."", ""reference"": ""PMID:37741465"", ""snippet"": ""The goal of these strategies is to reduce free copper, redox stress, and cellular toxicity"", ""supports"": ""SUPPORT""}"
8280	7874	342	Wilson Disease	Wilsons_Disease.yaml	biochemical	3	evidence	0	PMID:38731973	SUPPORT		Patients with Wilson disease are well-treated first-line with copper chelators like D-penicillamine that facilitate the removal of circulating copper bound to albumin and increase in urinary copper excretion	Elevated urinary copper excretion is both a diagnostic marker and a treatment response measure.	"{""explanation"": ""Elevated urinary copper excretion is both a diagnostic marker and a treatment response measure."", ""reference"": ""PMID:38731973"", ""snippet"": ""Patients with Wilson disease are well-treated first-line with copper chelators like D-penicillamine that facilitate the removal of circulating copper bound to albumin and increase in urinary copper excretion"", ""supports"": ""SUPPORT""}"
8281	7875	342	Wilson Disease	Wilsons_Disease.yaml	biochemical	4	evidence	0	PMID:38731973	SUPPORT		Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein	Hepatic copper accumulation is the primary consequence of ATP7B dysfunction and a key diagnostic finding.	"{""explanation"": ""Hepatic copper accumulation is the primary consequence of ATP7B dysfunction and a key diagnostic finding."", ""reference"": ""PMID:38731973"", ""snippet"": ""Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein"", ""supports"": ""SUPPORT""}"
8324	7906	343	Wissler syndrome	Wissler_syndrome.yaml	biochemical	0	evidence	0	PMID:27843372	SUPPORT		Blood sample analysis revealed high levels of CRP (42.9 mg/dL, normal: 0–0.3), erythrocyte sedimentation rate (113 mm/h normal: 2–20)	The case report documents markedly elevated ESR, supporting a systemic inflammatory state.	"{""explanation"": ""The case report documents markedly elevated ESR, supporting a systemic inflammatory state."", ""reference"": ""PMID:27843372"", ""snippet"": ""Blood sample analysis revealed high levels of CRP (42.9 mg/dL, normal: 0–0.3), erythrocyte sedimentation rate (113 mm/h normal: 2–20)"", ""supports"": ""SUPPORT""}"
8325	7907	343	Wissler syndrome	Wissler_syndrome.yaml	biochemical	1	evidence	0	PMID:27843372	SUPPORT		Blood sample analysis revealed high levels of CRP (42.9 mg/dL, normal: 0–0.3), erythrocyte sedimentation rate (113 mm/h normal: 2–20)	The case report documents markedly elevated CRP as part of the inflammatory syndrome.	"{""explanation"": ""The case report documents markedly elevated CRP as part of the inflammatory syndrome."", ""reference"": ""PMID:27843372"", ""snippet"": ""Blood sample analysis revealed high levels of CRP (42.9 mg/dL, normal: 0–0.3), erythrocyte sedimentation rate (113 mm/h normal: 2–20)"", ""supports"": ""SUPPORT""}"
